id	sid	tid	token	lemma	pos
cord-304472-mi5v6512	1	1	key	key	NNP
cord-304472-mi5v6512	1	2	:	:	:
cord-304472-mi5v6512	1	3	cord-304472-mi5v6512	cord-304472-mi5v6512	NN
cord-304472-mi5v6512	1	4	authors	author	NNS
cord-304472-mi5v6512	1	5	:	:	:
cord-304472-mi5v6512	1	6	Wilder	Wilder	NNP
cord-304472-mi5v6512	1	7	-	-	HYPH
cord-304472-mi5v6512	1	8	Smith	Smith	NNP
cord-304472-mi5v6512	1	9	,	,	,
cord-304472-mi5v6512	1	10	Annelies	Annelies	NNP
cord-304472-mi5v6512	1	11	title	title	NN
cord-304472-mi5v6512	1	12	:	:	:
cord-304472-mi5v6512	1	13	Dengue	dengue	NN
cord-304472-mi5v6512	1	14	vaccine	vaccine	NN
cord-304472-mi5v6512	1	15	development	development	NN
cord-304472-mi5v6512	1	16	by	by	IN
cord-304472-mi5v6512	1	17	the	the	DT
cord-304472-mi5v6512	1	18	year	year	NN
cord-304472-mi5v6512	1	19	2020	2020	CD
cord-304472-mi5v6512	1	20	:	:	:
cord-304472-mi5v6512	1	21	challenges	challenge	NNS
cord-304472-mi5v6512	1	22	and	and	CC
cord-304472-mi5v6512	1	23	prospects	prospect	NNS
cord-304472-mi5v6512	1	24	date	date	NN
cord-304472-mi5v6512	1	25	:	:	:
cord-304472-mi5v6512	1	26	2020	2020	CD
cord-304472-mi5v6512	1	27	-	-	SYM
cord-304472-mi5v6512	1	28	10	10	CD
cord-304472-mi5v6512	1	29	-	-	SYM
cord-304472-mi5v6512	1	30	18	18	CD
cord-304472-mi5v6512	1	31	journal	journal	NN
cord-304472-mi5v6512	1	32	:	:	:
cord-304472-mi5v6512	2	1	Curr	Curr	NNP
cord-304472-mi5v6512	2	2	Opin	Opin	NNP
cord-304472-mi5v6512	3	1	Virol	Virol	NNP
cord-304472-mi5v6512	3	2	DOI	DOI	NNP
cord-304472-mi5v6512	3	3	:	:	:
cord-304472-mi5v6512	3	4	10.1016	10.1016	CD
cord-304472-mi5v6512	3	5	/	/	SYM
cord-304472-mi5v6512	3	6	j.coviro.2020.09.004	j.coviro.2020.09.004	XX
cord-304472-mi5v6512	4	1	sha	sha	NNP
cord-304472-mi5v6512	4	2	:	:	:
cord-304472-mi5v6512	5	1	f6533dc0f96cfa09d06a47c68a4f0a7b1c4544c5	f6533dc0f96cfa09d06a47c68a4f0a7b1c4544c5	LS
cord-304472-mi5v6512	5	2	doc_id	doc_id	CD
cord-304472-mi5v6512	5	3	:	:	:
cord-304472-mi5v6512	5	4	304472	304472	CD
cord-304472-mi5v6512	5	5	cord_uid	cord_uid	NNS
cord-304472-mi5v6512	5	6	:	:	:
cord-304472-mi5v6512	5	7	mi5v6512	mi5v6512	.
cord-304472-mi5v6512	6	1	The	the	DT
cord-304472-mi5v6512	6	2	first	first	JJ
cord-304472-mi5v6512	6	3	licensed	licensed	JJ
cord-304472-mi5v6512	6	4	dengue	dengue	NN
cord-304472-mi5v6512	6	5	vaccine	vaccine	NN
cord-304472-mi5v6512	6	6	led	lead	VBD
cord-304472-mi5v6512	6	7	to	to	IN
cord-304472-mi5v6512	6	8	considerable	considerable	JJ
cord-304472-mi5v6512	6	9	controversy	controversy	NN
cord-304472-mi5v6512	6	10	,	,	,
cord-304472-mi5v6512	6	11	and	and	CC
cord-304472-mi5v6512	6	12	to	to	IN
cord-304472-mi5v6512	6	13	date	date	NN
cord-304472-mi5v6512	6	14	,	,	,
cord-304472-mi5v6512	6	15	no	no	DT
cord-304472-mi5v6512	6	16	dengue	dengue	NN
cord-304472-mi5v6512	6	17	vaccine	vaccine	NN
cord-304472-mi5v6512	6	18	is	be	VBZ
cord-304472-mi5v6512	6	19	in	in	IN
cord-304472-mi5v6512	6	20	widespread	widespread	JJ
cord-304472-mi5v6512	6	21	use	use	NN
cord-304472-mi5v6512	6	22	.	.	.
cord-304472-mi5v6512	7	1	All	all	DT
cord-304472-mi5v6512	7	2	three	three	CD
cord-304472-mi5v6512	7	3	leading	lead	VBG
cord-304472-mi5v6512	7	4	dengue	dengue	NN
cord-304472-mi5v6512	7	5	vaccine	vaccine	NN
cord-304472-mi5v6512	7	6	candidates	candidate	NNS
cord-304472-mi5v6512	7	7	are	be	VBP
cord-304472-mi5v6512	7	8	live	live	RB
cord-304472-mi5v6512	7	9	attenuated	attenuated	JJ
cord-304472-mi5v6512	7	10	vaccines	vaccine	NNS
cord-304472-mi5v6512	7	11	,	,	,
cord-304472-mi5v6512	7	12	with	with	IN
cord-304472-mi5v6512	7	13	the	the	DT
cord-304472-mi5v6512	7	14	main	main	JJ
cord-304472-mi5v6512	7	15	difference	difference	NN
cord-304472-mi5v6512	7	16	between	between	IN
cord-304472-mi5v6512	7	17	them	-PRON-	PRP
cord-304472-mi5v6512	7	18	being	be	VBG
cord-304472-mi5v6512	7	19	the	the	DT
cord-304472-mi5v6512	7	20	type	type	NN
cord-304472-mi5v6512	7	21	of	of	IN
cord-304472-mi5v6512	7	22	backbone	backbone	NN
cord-304472-mi5v6512	7	23	and	and	CC
cord-304472-mi5v6512	7	24	the	the	DT
cord-304472-mi5v6512	7	25	extent	extent	NN
cord-304472-mi5v6512	7	26	of	of	IN
cord-304472-mi5v6512	7	27	chimerization	chimerization	NN
cord-304472-mi5v6512	7	28	.	.	.
cord-304472-mi5v6512	8	1	While	while	IN
cord-304472-mi5v6512	8	2	CYD	CYD	NNP
cord-304472-mi5v6512	8	3	-	-	HYPH
cord-304472-mi5v6512	8	4	TDV	TDV	NNP
cord-304472-mi5v6512	8	5	(	(	-LRB-
cord-304472-mi5v6512	8	6	the	the	DT
cord-304472-mi5v6512	8	7	first	first	JJ
cord-304472-mi5v6512	8	8	licensed	licensed	JJ
cord-304472-mi5v6512	8	9	dengue	dengue	NN
cord-304472-mi5v6512	8	10	vaccine	vaccine	NN
cord-304472-mi5v6512	8	11	)	)	-RRB-
cord-304472-mi5v6512	8	12	does	do	VBZ
cord-304472-mi5v6512	8	13	not	not	RB
cord-304472-mi5v6512	8	14	include	include	VB
cord-304472-mi5v6512	8	15	non	non	JJ
cord-304472-mi5v6512	8	16	-	-	JJ
cord-304472-mi5v6512	8	17	structural	structural	JJ
cord-304472-mi5v6512	8	18	proteins	protein	NNS
cord-304472-mi5v6512	8	19	of	of	IN
cord-304472-mi5v6512	8	20	dengue	dengue	NN
cord-304472-mi5v6512	8	21	,	,	,
cord-304472-mi5v6512	8	22	TAK-003	tak-003	NN
cord-304472-mi5v6512	8	23	contains	contain	VBZ
cord-304472-mi5v6512	8	24	the	the	DT
cord-304472-mi5v6512	8	25	dengue	dengue	NN
cord-304472-mi5v6512	8	26	virus	virus	NN
cord-304472-mi5v6512	8	27	serotype	serotype	NN
cord-304472-mi5v6512	8	28	2	2	CD
cord-304472-mi5v6512	8	29	backbone	backbone	NN
cord-304472-mi5v6512	8	30	,	,	,
cord-304472-mi5v6512	8	31	and	and	CC
cord-304472-mi5v6512	8	32	the	the	DT
cord-304472-mi5v6512	8	33	Butantan	Butantan	NNP
cord-304472-mi5v6512	8	34	/	/	SYM
cord-304472-mi5v6512	8	35	Merck	Merck	NNP
cord-304472-mi5v6512	8	36	vaccine	vaccine	NN
cord-304472-mi5v6512	8	37	contains	contain	VBZ
cord-304472-mi5v6512	8	38	three	three	CD
cord-304472-mi5v6512	8	39	full	full	JJ
cord-304472-mi5v6512	8	40	-	-	HYPH
cord-304472-mi5v6512	8	41	genomes	genome	NNS
cord-304472-mi5v6512	8	42	of	of	IN
cord-304472-mi5v6512	8	43	the	the	DT
cord-304472-mi5v6512	8	44	four	four	CD
cord-304472-mi5v6512	8	45	dengue	dengue	NN
cord-304472-mi5v6512	8	46	virus	virus	NN
cord-304472-mi5v6512	8	47	serotypes	serotype	NNS
cord-304472-mi5v6512	8	48	.	.	.
cord-304472-mi5v6512	9	1	While	while	IN
cord-304472-mi5v6512	9	2	dengue	dengue	NN
cord-304472-mi5v6512	9	3	-	-	HYPH
cord-304472-mi5v6512	9	4	primed	prime	VBN
cord-304472-mi5v6512	9	5	individuals	individual	NNS
cord-304472-mi5v6512	9	6	can	can	MD
cord-304472-mi5v6512	9	7	already	already	RB
cord-304472-mi5v6512	9	8	benefit	benefit	VB
cord-304472-mi5v6512	9	9	from	from	IN
cord-304472-mi5v6512	9	10	vaccination	vaccination	NN
cord-304472-mi5v6512	9	11	against	against	IN
cord-304472-mi5v6512	9	12	all	all	DT
cord-304472-mi5v6512	9	13	four	four	CD
cord-304472-mi5v6512	9	14	serotypes	serotype	NNS
cord-304472-mi5v6512	9	15	with	with	IN
cord-304472-mi5v6512	9	16	the	the	DT
cord-304472-mi5v6512	9	17	first	first	JJ
cord-304472-mi5v6512	9	18	licensed	licensed	JJ
cord-304472-mi5v6512	9	19	dengue	dengue	NN
cord-304472-mi5v6512	9	20	vaccine	vaccine	NN
cord-304472-mi5v6512	9	21	CYD	CYD	NNP
cord-304472-mi5v6512	9	22	-	-	HYPH
cord-304472-mi5v6512	9	23	TDV	TDV	NNP
cord-304472-mi5v6512	9	24	,	,	,
cord-304472-mi5v6512	9	25	the	the	DT
cord-304472-mi5v6512	9	26	need	need	NN
cord-304472-mi5v6512	9	27	for	for	IN
cord-304472-mi5v6512	9	28	dengue	dengue	NN
cord-304472-mi5v6512	9	29	-	-	HYPH
cord-304472-mi5v6512	9	30	naive	naive	JJ
cord-304472-mi5v6512	9	31	population	population	NN
cord-304472-mi5v6512	9	32	has	have	VBZ
cord-304472-mi5v6512	9	33	not	not	RB
cord-304472-mi5v6512	9	34	yet	yet	RB
cord-304472-mi5v6512	9	35	been	be	VBN
cord-304472-mi5v6512	9	36	met	meet	VBN
cord-304472-mi5v6512	9	37	.	.	.
cord-304472-mi5v6512	10	1	To	to	TO
cord-304472-mi5v6512	10	2	improve	improve	VB
cord-304472-mi5v6512	10	3	tetravalent	tetravalent	NN
cord-304472-mi5v6512	10	4	protection	protection	NN
cord-304472-mi5v6512	10	5	,	,	,
cord-304472-mi5v6512	10	6	sequential	sequential	JJ
cord-304472-mi5v6512	10	7	vaccination	vaccination	NN
cord-304472-mi5v6512	10	8	should	should	MD
cord-304472-mi5v6512	10	9	be	be	VB
cord-304472-mi5v6512	10	10	considered	consider	VBN
cord-304472-mi5v6512	10	11	in	in	IN
cord-304472-mi5v6512	10	12	addition	addition	NN
cord-304472-mi5v6512	10	13	to	to	IN
cord-304472-mi5v6512	10	14	a	a	DT
cord-304472-mi5v6512	10	15	heterologous	heterologous	JJ
cord-304472-mi5v6512	10	16	prime	prime	JJ
cord-304472-mi5v6512	10	17	-	-	HYPH
cord-304472-mi5v6512	10	18	boost	boost	NN
cord-304472-mi5v6512	10	19	approach	approach	NN
cord-304472-mi5v6512	10	20	.	.	.
cord-304472-mi5v6512	11	1	Dengue	dengue	NN
cord-304472-mi5v6512	11	2	vaccine	vaccine	NN
cord-304472-mi5v6512	11	3	development	development	NN
cord-304472-mi5v6512	11	4	has	have	VBZ
cord-304472-mi5v6512	11	5	been	be	VBN
cord-304472-mi5v6512	11	6	hampered	hamper	VBN
cord-304472-mi5v6512	11	7	and	and	CC
cord-304472-mi5v6512	11	8	delayed	delay	VBN
cord-304472-mi5v6512	11	9	by	by	IN
cord-304472-mi5v6512	11	10	remarkable	remarkable	JJ
cord-304472-mi5v6512	11	11	challenges	challenge	NNS
cord-304472-mi5v6512	11	12	.	.	.
cord-304472-mi5v6512	12	1	The	the	DT
cord-304472-mi5v6512	12	2	four	four	CD
cord-304472-mi5v6512	12	3	genetically	genetically	RB
cord-304472-mi5v6512	12	4	succinct	succinct	JJ
cord-304472-mi5v6512	12	5	but	but	CC
cord-304472-mi5v6512	12	6	still	still	RB
cord-304472-mi5v6512	12	7	closely	closely	RB
cord-304472-mi5v6512	12	8	related	related	JJ
cord-304472-mi5v6512	12	9	dengue	dengue	NN
cord-304472-mi5v6512	12	10	serotypes	serotype	NNS
cord-304472-mi5v6512	12	11	are	be	VBP
cord-304472-mi5v6512	12	12	known	know	VBN
cord-304472-mi5v6512	12	13	to	to	TO
cord-304472-mi5v6512	12	14	interact	interact	VB
cord-304472-mi5v6512	12	15	immunologically	immunologically	RB
cord-304472-mi5v6512	12	16	with	with	IN
cord-304472-mi5v6512	12	17	potential	potential	NN
cord-304472-mi5v6512	12	18	for	for	IN
cord-304472-mi5v6512	12	19	disease	disease	NN
cord-304472-mi5v6512	12	20	enhancement	enhancement	NN
cord-304472-mi5v6512	12	21	.	.	.
cord-304472-mi5v6512	13	1	As	as	IN
cord-304472-mi5v6512	13	2	a	a	DT
cord-304472-mi5v6512	13	3	tetravalent	tetravalent	NN
cord-304472-mi5v6512	13	4	immune	immune	JJ
cord-304472-mi5v6512	13	5	response	response	NN
cord-304472-mi5v6512	13	6	is	be	VBZ
cord-304472-mi5v6512	13	7	desired	desire	VBN
cord-304472-mi5v6512	13	8	,	,	,
cord-304472-mi5v6512	13	9	when	when	WRB
cord-304472-mi5v6512	13	10	given	give	VBN
cord-304472-mi5v6512	13	11	a	a	DT
cord-304472-mi5v6512	13	12	mixture	mixture	NN
cord-304472-mi5v6512	13	13	of	of	IN
cord-304472-mi5v6512	13	14	all	all	DT
cord-304472-mi5v6512	13	15	four	four	CD
cord-304472-mi5v6512	13	16	serotypes	serotype	NNS
cord-304472-mi5v6512	13	17	in	in	IN
cord-304472-mi5v6512	13	18	a	a	DT
cord-304472-mi5v6512	13	19	tetravalent	tetravalent	NN
cord-304472-mi5v6512	13	20	live	live	RB
cord-304472-mi5v6512	13	21	-	-	HYPH
cord-304472-mi5v6512	13	22	attenuated	attenuated	JJ
cord-304472-mi5v6512	13	23	vaccine	vaccine	NN
cord-304472-mi5v6512	13	24	,	,	,
cord-304472-mi5v6512	13	25	each	each	DT
cord-304472-mi5v6512	13	26	component	component	NN
cord-304472-mi5v6512	13	27	would	would	MD
cord-304472-mi5v6512	13	28	need	need	VB
cord-304472-mi5v6512	13	29	to	to	TO
cord-304472-mi5v6512	13	30	independently	independently	RB
cord-304472-mi5v6512	13	31	result	result	VB
cord-304472-mi5v6512	13	32	in	in	IN
cord-304472-mi5v6512	13	33	four	four	CD
cord-304472-mi5v6512	13	34	different	different	JJ
cord-304472-mi5v6512	13	35	monotypic	monotypic	JJ
cord-304472-mi5v6512	13	36	immune	immune	JJ
cord-304472-mi5v6512	13	37	responses	response	NNS
cord-304472-mi5v6512	13	38	that	that	WDT
cord-304472-mi5v6512	13	39	are	be	VBP
cord-304472-mi5v6512	13	40	solid	solid	JJ
cord-304472-mi5v6512	13	41	to	to	IN
cord-304472-mi5v6512	13	42	each	each	DT
cord-304472-mi5v6512	13	43	serotype	serotype	NN
cord-304472-mi5v6512	13	44	.	.	.
cord-304472-mi5v6512	14	1	This	this	DT
cord-304472-mi5v6512	14	2	has	have	VBZ
cord-304472-mi5v6512	14	3	unfortunately	unfortunately	RB
cord-304472-mi5v6512	14	4	proven	prove	VBN
cord-304472-mi5v6512	14	5	to	to	TO
cord-304472-mi5v6512	14	6	be	be	VB
cord-304472-mi5v6512	14	7	difficult	difficult	JJ
cord-304472-mi5v6512	14	8	to	to	TO
cord-304472-mi5v6512	14	9	achieve	achieve	VB
cord-304472-mi5v6512	14	10	.	.	.
cord-304472-mi5v6512	15	1	Immune	immune	JJ
cord-304472-mi5v6512	15	2	correlatestopredictprotectionversusdiseaseenhancement	correlatestopredictprotectionversusdiseaseenhancement	NN
cord-304472-mi5v6512	15	3	are	be	VBP
cord-304472-mi5v6512	15	4	still	still	RB
cord-304472-mi5v6512	15	5	lacking	lack	VBG
cord-304472-mi5v6512	15	6	[	[	-LRB-
cord-304472-mi5v6512	15	7	1	1	CD
cord-304472-mi5v6512	15	8	]	]	-RRB-
cord-304472-mi5v6512	15	9	,	,	,
cord-304472-mi5v6512	15	10	and	and	CC
cord-304472-mi5v6512	15	11	plaque	plaque	NN
cord-304472-mi5v6512	15	12	reduction	reduction	NN
cord-304472-mi5v6512	15	13	neutralization	neutralization	NN
cord-304472-mi5v6512	15	14	assays	assay	NNS
cord-304472-mi5v6512	15	15	do	do	VBP
cord-304472-mi5v6512	15	16	not	not	RB
cord-304472-mi5v6512	15	17	reliably	reliably	RB
cord-304472-mi5v6512	15	18	differentiate	differentiate	VB
cord-304472-mi5v6512	15	19	between	between	IN
cord-304472-mi5v6512	15	20	serotype	serotype	NN
cord-304472-mi5v6512	15	21	-	-	HYPH
cord-304472-mi5v6512	15	22	specific	specific	JJ
cord-304472-mi5v6512	15	23	versus	versus	IN
cord-304472-mi5v6512	15	24	heterotypic	heterotypic	NNP
cord-304472-mi5v6512	15	25	antibodies	antibody	NNS
cord-304472-mi5v6512	15	26	[	[	-LRB-
cord-304472-mi5v6512	15	27	1,2	1,2	CD
cord-304472-mi5v6512	15	28	]	]	-RRB-
cord-304472-mi5v6512	15	29	.	.	.
cord-304472-mi5v6512	16	1	Other	other	JJ
cord-304472-mi5v6512	16	2	challenges	challenge	NNS
cord-304472-mi5v6512	16	3	include	include	VBP
cord-304472-mi5v6512	16	4	the	the	DT
cord-304472-mi5v6512	16	5	lack	lack	NN
cord-304472-mi5v6512	16	6	of	of	IN
cord-304472-mi5v6512	16	7	a	a	DT
cord-304472-mi5v6512	16	8	reliable	reliable	JJ
cord-304472-mi5v6512	16	9	animal	animal	NN
cord-304472-mi5v6512	16	10	model	model	NN
cord-304472-mi5v6512	16	11	.	.	.
cord-304472-mi5v6512	17	1	Furthermore	furthermore	RB
cord-304472-mi5v6512	17	2	,	,	,
cord-304472-mi5v6512	17	3	dengue	dengue	NN
cord-304472-mi5v6512	17	4	is	be	VBZ
cord-304472-mi5v6512	17	5	primarily	primarily	RB
cord-304472-mi5v6512	17	6	a	a	DT
cord-304472-mi5v6512	17	7	disease	disease	NN
cord-304472-mi5v6512	17	8	of	of	IN
cord-304472-mi5v6512	17	9	low	low	JJ
cord-304472-mi5v6512	17	10	and	and	CC
cord-304472-mi5v6512	17	11	middle	middle	JJ
cord-304472-mi5v6512	17	12	income	income	NN
cord-304472-mi5v6512	17	13	countries	country	NNS
cord-304472-mi5v6512	17	14	,	,	,
cord-304472-mi5v6512	17	15	thus	thus	RB
cord-304472-mi5v6512	17	16	dengue	dengue	NN
cord-304472-mi5v6512	17	17	research	research	NN
cord-304472-mi5v6512	17	18	often	often	RB
cord-304472-mi5v6512	17	19	does	do	VBZ
cord-304472-mi5v6512	17	20	not	not	RB
cord-304472-mi5v6512	17	21	receive	receive	VB
cord-304472-mi5v6512	17	22	the	the	DT
cord-304472-mi5v6512	17	23	level	level	NN
cord-304472-mi5v6512	17	24	of	of	IN
cord-304472-mi5v6512	17	25	funding	funding	NN
cord-304472-mi5v6512	17	26	needed	need	VBN
cord-304472-mi5v6512	17	27	to	to	TO
cord-304472-mi5v6512	17	28	accelerate	accelerate	VB
cord-304472-mi5v6512	17	29	vaccine	vaccine	NN
cord-304472-mi5v6512	17	30	development	development	NN
cord-304472-mi5v6512	17	31	[	[	-LRB-
cord-304472-mi5v6512	17	32	3	3	CD
cord-304472-mi5v6512	17	33	]	]	-RRB-
cord-304472-mi5v6512	17	34	.	.	.
cord-304472-mi5v6512	18	1	Unsurprisingly	unsurprisingly	RB
cord-304472-mi5v6512	18	2	then	then	RB
cord-304472-mi5v6512	18	3	,	,	,
cord-304472-mi5v6512	18	4	it	-PRON-	PRP
cord-304472-mi5v6512	18	5	has	have	VBZ
cord-304472-mi5v6512	18	6	taken	take	VBN
cord-304472-mi5v6512	18	7	several	several	JJ
cord-304472-mi5v6512	18	8	decades	decade	NNS
cord-304472-mi5v6512	18	9	to	to	TO
cord-304472-mi5v6512	18	10	develop	develop	VB
cord-304472-mi5v6512	18	11	a	a	DT
cord-304472-mi5v6512	18	12	vaccine	vaccine	NN
cord-304472-mi5v6512	18	13	.	.	.
cord-304472-mi5v6512	19	1	The	the	DT
cord-304472-mi5v6512	19	2	first	first	JJ
cord-304472-mi5v6512	19	3	licensed	licensed	JJ
cord-304472-mi5v6512	19	4	dengue	dengue	NN
cord-304472-mi5v6512	19	5	vaccine	vaccine	NN
cord-304472-mi5v6512	19	6	led	lead	VBN
cord-304472-mi5v6512	19	7	to	to	IN
cord-304472-mi5v6512	19	8	considerablecontroversy	considerablecontroversy	NNP
cord-304472-mi5v6512	19	9	[	[	-LRB-
cord-304472-mi5v6512	19	10	4	4	CD
cord-304472-mi5v6512	19	11	]	]	-RRB-
cord-304472-mi5v6512	19	12	,	,	,
cord-304472-mi5v6512	19	13	andto	andto	NNP
cord-304472-mi5v6512	19	14	date	date	NN
cord-304472-mi5v6512	19	15	,	,	,
cord-304472-mi5v6512	19	16	nodenguevaccine	nodenguevaccine	NNP
cord-304472-mi5v6512	19	17	is	be	VBZ
cord-304472-mi5v6512	19	18	in	in	IN
cord-304472-mi5v6512	19	19	widespread	widespread	JJ
cord-304472-mi5v6512	19	20	use	use	NN
cord-304472-mi5v6512	19	21	.	.	.
cord-304472-mi5v6512	20	1	Nevertheless	nevertheless	RB
cord-304472-mi5v6512	20	2	,	,	,
cord-304472-mi5v6512	20	3	we	-PRON-	PRP
cord-304472-mi5v6512	20	4	need	need	VBP
cord-304472-mi5v6512	20	5	to	to	TO
cord-304472-mi5v6512	20	6	press	press	VB
cord-304472-mi5v6512	20	7	on	on	IN
cord-304472-mi5v6512	20	8	.	.	.
cord-304472-mi5v6512	21	1	Dengue	dengue	NN
cord-304472-mi5v6512	21	2	was	be	VBD
cord-304472-mi5v6512	21	3	identified	identify	VBN
cord-304472-mi5v6512	21	4	as	as	IN
cord-304472-mi5v6512	21	5	one	one	CD
cord-304472-mi5v6512	21	6	of	of	IN
cord-304472-mi5v6512	21	7	the	the	DT
cord-304472-mi5v6512	21	8	10	10	CD
cord-304472-mi5v6512	21	9	threats	threat	NNS
cord-304472-mi5v6512	21	10	to	to	IN
cord-304472-mi5v6512	21	11	global	global	JJ
cord-304472-mi5v6512	21	12	health	health	NN
cord-304472-mi5v6512	21	13	in	in	IN
cord-304472-mi5v6512	21	14	2019	2019	CD
cord-304472-mi5v6512	21	15	by	by	IN
cord-304472-mi5v6512	21	16	WHO	WHO	NNP
cord-304472-mi5v6512	21	17	,	,	,
cord-304472-mi5v6512	21	18	underlining	underline	VBG
cord-304472-mi5v6512	21	19	the	the	DT
cord-304472-mi5v6512	21	20	urgent	urgent	JJ
cord-304472-mi5v6512	21	21	need	need	NN
cord-304472-mi5v6512	21	22	for	for	IN
cord-304472-mi5v6512	21	23	a	a	DT
cord-304472-mi5v6512	21	24	vaccine	vaccine	NN
cord-304472-mi5v6512	21	25	.	.	.
cord-304472-mi5v6512	22	1	The	the	DT
cord-304472-mi5v6512	22	2	primary	primary	JJ
cord-304472-mi5v6512	22	3	need	need	NN
cord-304472-mi5v6512	22	4	for	for	IN
cord-304472-mi5v6512	22	5	a	a	DT
cord-304472-mi5v6512	22	6	dengue	dengue	NN
cord-304472-mi5v6512	22	7	vaccine	vaccine	NN
cord-304472-mi5v6512	22	8	as	as	IN
cord-304472-mi5v6512	22	9	a	a	DT
cord-304472-mi5v6512	22	10	public	public	JJ
cord-304472-mi5v6512	22	11	health	health	NN
cord-304472-mi5v6512	22	12	tool	tool	NN
cord-304472-mi5v6512	22	13	is	be	VBZ
cord-304472-mi5v6512	22	14	the	the	DT
cord-304472-mi5v6512	22	15	unpredictable	unpredictable	JJ
cord-304472-mi5v6512	22	16	nature	nature	NN
cord-304472-mi5v6512	22	17	of	of	IN
cord-304472-mi5v6512	22	18	dengue	dengue	NN
cord-304472-mi5v6512	22	19	outbreaks	outbreak	NNS
cord-304472-mi5v6512	22	20	overwhelming	overwhelming	JJ
cord-304472-mi5v6512	22	21	already	already	RB
cord-304472-mi5v6512	22	22	existing	exist	VBG
cord-304472-mi5v6512	22	23	fragile	fragile	JJ
cord-304472-mi5v6512	22	24	health	health	NN
cord-304472-mi5v6512	22	25	care	care	NN
cord-304472-mi5v6512	22	26	systems	system	NNS
cord-304472-mi5v6512	22	27	,	,	,
cord-304472-mi5v6512	22	28	the	the	DT
cord-304472-mi5v6512	22	29	extremely	extremely	RB
cord-304472-mi5v6512	22	30	high	high	JJ
cord-304472-mi5v6512	22	31	annual	annual	JJ
cord-304472-mi5v6512	22	32	incidence	incidence	NN
cord-304472-mi5v6512	22	33	of	of	IN
cord-304472-mi5v6512	22	34	at	at	RB
cord-304472-mi5v6512	22	35	least	least	RBS
cord-304472-mi5v6512	22	36	100	100	CD
cord-304472-mi5v6512	22	37	million	million	CD
cord-304472-mi5v6512	22	38	cases	case	NNS
cord-304472-mi5v6512	22	39	and	and	CC
cord-304472-mi5v6512	22	40	the	the	DT
cord-304472-mi5v6512	22	41	epidemic	epidemic	NN
cord-304472-mi5v6512	22	42	trajectory	trajectory	NN
cord-304472-mi5v6512	22	43	which	which	WDT
cord-304472-mi5v6512	22	44	shows	show	VBZ
cord-304472-mi5v6512	22	45	a	a	DT
cord-304472-mi5v6512	22	46	relentless	relentless	JJ
cord-304472-mi5v6512	22	47	increase	increase	NN
cord-304472-mi5v6512	22	48	over	over	IN
cord-304472-mi5v6512	22	49	the	the	DT
cord-304472-mi5v6512	22	50	past	past	JJ
cord-304472-mi5v6512	22	51	two	two	CD
cord-304472-mi5v6512	22	52	decades	decade	NNS
cord-304472-mi5v6512	22	53	[	[	-LRB-
cord-304472-mi5v6512	22	54	2	2	CD
cord-304472-mi5v6512	22	55	,	,	,
cord-304472-mi5v6512	22	56	5,6	5,6	CD
cord-304472-mi5v6512	22	57	]	]	-RRB-
cord-304472-mi5v6512	22	58	.	.	.
cord-304472-mi5v6512	23	1	Dengue	dengue	NN
cord-304472-mi5v6512	23	2	infections	infection	NNS
cord-304472-mi5v6512	23	3	in	in	IN
cord-304472-mi5v6512	23	4	the	the	DT
cord-304472-mi5v6512	23	5	communities	community	NNS
cord-304472-mi5v6512	23	6	,	,	,
cord-304472-mi5v6512	23	7	and	and	CC
cord-304472-mi5v6512	23	8	even	even	RB
cord-304472-mi5v6512	23	9	hospitalized	hospitalize	VBN
cord-304472-mi5v6512	23	10	dengue	dengue	NN
cord-304472-mi5v6512	23	11	,	,	,
cord-304472-mi5v6512	23	12	lead	lead	VB
cord-304472-mi5v6512	23	13	to	to	IN
cord-304472-mi5v6512	23	14	inappropriate	inappropriate	JJ
cord-304472-mi5v6512	23	15	antibiotic	antibiotic	JJ
cord-304472-mi5v6512	23	16	use	use	NN
cord-304472-mi5v6512	23	17	in	in	IN
cord-304472-mi5v6512	23	18	more	more	JJR
cord-304472-mi5v6512	23	19	than	than	IN
cord-304472-mi5v6512	23	20	30%of	30%of	JJ
cord-304472-mi5v6512	23	21	cases	case	NNS
cord-304472-mi5v6512	23	22	[	[	-LRB-
cord-304472-mi5v6512	23	23	7	7	CD
cord-304472-mi5v6512	23	24	]	]	-RRB-
cord-304472-mi5v6512	23	25	.	.	.
cord-304472-mi5v6512	24	1	Dengue	dengue	NN
cord-304472-mi5v6512	24	2	has	have	VBZ
cord-304472-mi5v6512	24	3	also	also	RB
cord-304472-mi5v6512	24	4	become	become	VBN
cord-304472-mi5v6512	24	5	a	a	DT
cord-304472-mi5v6512	24	6	leading	leading	JJ
cord-304472-mi5v6512	24	7	problem	problem	NN
cord-304472-mi5v6512	24	8	in	in	IN
cord-304472-mi5v6512	24	9	international	international	JJ
cord-304472-mi5v6512	24	10	travelers	traveler	NNS
cord-304472-mi5v6512	24	11	[	[	-LRB-
cord-304472-mi5v6512	24	12	8	8	CD
cord-304472-mi5v6512	24	13	]	]	-RRB-
cord-304472-mi5v6512	24	14	[	[	-LRB-
cord-304472-mi5v6512	24	15	9	9	CD
cord-304472-mi5v6512	24	16	]	]	-RRB-
cord-304472-mi5v6512	24	17	[	[	-LRB-
cord-304472-mi5v6512	24	18	10	10	CD
cord-304472-mi5v6512	24	19	]	]	-RRB-
cord-304472-mi5v6512	24	20	[	[	-LRB-
cord-304472-mi5v6512	24	21	11	11	CD
cord-304472-mi5v6512	24	22	]	]	-RRB-
cord-304472-mi5v6512	24	23	[	[	-LRB-
cord-304472-mi5v6512	24	24	12	12	CD
cord-304472-mi5v6512	24	25	]	]	-RRB-
cord-304472-mi5v6512	24	26	.	.	.
cord-304472-mi5v6512	25	1	Certain	certain	JJ
cord-304472-mi5v6512	25	2	risk	risk	NN
cord-304472-mi5v6512	25	3	factors	factor	NNS
cord-304472-mi5v6512	25	4	are	be	VBP
cord-304472-mi5v6512	25	5	predictive	predictive	JJ
cord-304472-mi5v6512	25	6	of	of	IN
cord-304472-mi5v6512	25	7	more	more	RBR
cord-304472-mi5v6512	25	8	severe	severe	JJ
cord-304472-mi5v6512	25	9	disease	disease	NN
cord-304472-mi5v6512	25	10	outcome	outcome	NN
cord-304472-mi5v6512	25	11	such	such	JJ
cord-304472-mi5v6512	25	12	as	as	IN
cord-304472-mi5v6512	25	13	young	young	JJ
cord-304472-mi5v6512	25	14	or	or	CC
cord-304472-mi5v6512	25	15	old	old	JJ
cord-304472-mi5v6512	25	16	age	age	NN
cord-304472-mi5v6512	25	17	,	,	,
cord-304472-mi5v6512	25	18	prior	prior	JJ
cord-304472-mi5v6512	25	19	dengue	dengue	NN
cord-304472-mi5v6512	25	20	infection	infection	NN
cord-304472-mi5v6512	25	21	,	,	,
cord-304472-mi5v6512	25	22	diabetes	diabetes	NN
cord-304472-mi5v6512	25	23	,	,	,
cord-304472-mi5v6512	25	24	sickle	sickle	NN
cord-304472-mi5v6512	25	25	cell	cell	NN
cord-304472-mi5v6512	25	26	disease	disease	NN
cord-304472-mi5v6512	25	27	and	and	CC
cord-304472-mi5v6512	25	28	underlying	underlying	JJ
cord-304472-mi5v6512	25	29	medical	medical	JJ
cord-304472-mi5v6512	25	30	conditions	condition	NNS
cord-304472-mi5v6512	25	31	[	[	-LRB-
cord-304472-mi5v6512	25	32	2	2	CD
cord-304472-mi5v6512	25	33	,	,	,
cord-304472-mi5v6512	25	34	13	13	CD
cord-304472-mi5v6512	25	35	]	]	-RRB-
cord-304472-mi5v6512	25	36	.	.	.
cord-304472-mi5v6512	26	1	All	all	DT
cord-304472-mi5v6512	26	2	three	three	CD
cord-304472-mi5v6512	26	3	leading	lead	VBG
cord-304472-mi5v6512	26	4	dengue	dengue	NN
cord-304472-mi5v6512	26	5	vaccine	vaccine	NN
cord-304472-mi5v6512	26	6	candidates	candidate	NNS
cord-304472-mi5v6512	26	7	are	be	VBP
cord-304472-mi5v6512	26	8	liveattenuated	liveattenuate	VBN
cord-304472-mi5v6512	26	9	vaccines	vaccine	NNS
cord-304472-mi5v6512	26	10	,	,	,
cord-304472-mi5v6512	26	11	with	with	IN
cord-304472-mi5v6512	26	12	the	the	DT
cord-304472-mi5v6512	26	13	main	main	JJ
cord-304472-mi5v6512	26	14	difference	difference	NN
cord-304472-mi5v6512	26	15	between	between	IN
cord-304472-mi5v6512	26	16	them	-PRON-	PRP
cord-304472-mi5v6512	26	17	being	be	VBG
cord-304472-mi5v6512	26	18	the	the	DT
cord-304472-mi5v6512	26	19	type	type	NN
cord-304472-mi5v6512	26	20	of	of	IN
cord-304472-mi5v6512	26	21	backbone	backbone	NN
cord-304472-mi5v6512	26	22	and	and	CC
cord-304472-mi5v6512	26	23	the	the	DT
cord-304472-mi5v6512	26	24	extent	extent	NN
cord-304472-mi5v6512	26	25	of	of	IN
cord-304472-mi5v6512	26	26	chimerization	chimerization	NN
cord-304472-mi5v6512	26	27	.	.	.
cord-304472-mi5v6512	27	1	First	first	RB
cord-304472-mi5v6512	27	2	licensed	licensed	JJ
cord-304472-mi5v6512	27	3	dengue	dengue	NN
cord-304472-mi5v6512	27	4	vaccine	vaccine	NN
cord-304472-mi5v6512	27	5	CYD	CYD	NNP
cord-304472-mi5v6512	27	6	-	-	HYPH
cord-304472-mi5v6512	27	7	TDV	TDV	NNP
cord-304472-mi5v6512	27	8	,	,	,
cord-304472-mi5v6512	27	9	a	a	DT
cord-304472-mi5v6512	27	10	tetravalent	tetravalent	NN
cord-304472-mi5v6512	27	11	live	live	NN
cord-304472-mi5v6512	27	12	attenuated	attenuate	VBN
cord-304472-mi5v6512	27	13	with	with	IN
cord-304472-mi5v6512	27	14	a	a	DT
cord-304472-mi5v6512	27	15	yellow	yellow	JJ
cord-304472-mi5v6512	27	16	fever	fever	NN
cord-304472-mi5v6512	27	17	17D	17d	CD
cord-304472-mi5v6512	27	18	backbone	backbone	NN
cord-304472-mi5v6512	27	19	,	,	,
cord-304472-mi5v6512	27	20	is	be	VBZ
cord-304472-mi5v6512	27	21	the	the	DT
cord-304472-mi5v6512	27	22	first	first	JJ
cord-304472-mi5v6512	27	23	dengue	dengue	NN
cord-304472-mi5v6512	27	24	vaccine	vaccine	NN
cord-304472-mi5v6512	27	25	to	to	TO
cord-304472-mi5v6512	27	26	be	be	VB
cord-304472-mi5v6512	27	27	licensed	license	VBN
cord-304472-mi5v6512	27	28	,	,	,
cord-304472-mi5v6512	27	29	under	under	IN
cord-304472-mi5v6512	27	30	'	'	``
cord-304472-mi5v6512	27	31	Dengvaxia	Dengvaxia	NNP
cord-304472-mi5v6512	27	32	'	'	''
cord-304472-mi5v6512	27	33	.	.	.
cord-304472-mi5v6512	28	1	Despite	despite	IN
cord-304472-mi5v6512	28	2	being	be	VBG
cord-304472-mi5v6512	28	3	first	first	RB
cord-304472-mi5v6512	28	4	licensed	license	VBN
cord-304472-mi5v6512	28	5	in	in	IN
cord-304472-mi5v6512	28	6	2015	2015	CD
cord-304472-mi5v6512	28	7	in	in	IN
cord-304472-mi5v6512	28	8	Mexico	Mexico	NNP
cord-304472-mi5v6512	28	9	followed	follow	VBD
cord-304472-mi5v6512	28	10	by	by	IN
cord-304472-mi5v6512	28	11	20	20	CD
cord-304472-mi5v6512	28	12	other	other	JJ
cord-304472-mi5v6512	28	13	dengue	dengue	NN
cord-304472-mi5v6512	28	14	endemic	endemic	JJ
cord-304472-mi5v6512	28	15	countries	country	NNS
cord-304472-mi5v6512	28	16	based	base	VBN
cord-304472-mi5v6512	28	17	on	on	IN
cord-304472-mi5v6512	28	18	results	result	NNS
cord-304472-mi5v6512	28	19	from	from	IN
cord-304472-mi5v6512	28	20	Phase	phase	NN
cord-304472-mi5v6512	28	21	3	3	CD
cord-304472-mi5v6512	28	22	trials	trial	NNS
cord-304472-mi5v6512	28	23	conducted	conduct	VBN
cord-304472-mi5v6512	28	24	in	in	IN
cord-304472-mi5v6512	28	25	more	more	JJR
cord-304472-mi5v6512	28	26	than	than	IN
cord-304472-mi5v6512	28	27	30	30	CD
cord-304472-mi5v6512	28	28	000	000	CD
cord-304472-mi5v6512	28	29	children	child	NNS
cord-304472-mi5v6512	28	30	and	and	CC
cord-304472-mi5v6512	28	31	adolescents	adolescent	NNS
cord-304472-mi5v6512	28	32	aged	aged	JJ
cord-304472-mi5v6512	28	33	2À16	2à16	CD
cord-304472-mi5v6512	28	34	,	,	,
cord-304472-mi5v6512	28	35	it	-PRON-	PRP
cord-304472-mi5v6512	28	36	was	be	VBD
cord-304472-mi5v6512	28	37	only	only	RB
cord-304472-mi5v6512	28	38	introduced	introduce	VBN
cord-304472-mi5v6512	28	39	in	in	IN
cord-304472-mi5v6512	28	40	two	two	CD
cord-304472-mi5v6512	28	41	subnational	subnational	JJ
cord-304472-mi5v6512	28	42	public	public	JJ
cord-304472-mi5v6512	28	43	health	health	NN
cord-304472-mi5v6512	28	44	programs	program	NNS
cord-304472-mi5v6512	28	45	in	in	IN
cord-304472-mi5v6512	28	46	the	the	DT
cord-304472-mi5v6512	28	47	Philippines	Philippines	NNP
cord-304472-mi5v6512	28	48	and	and	CC
cord-304472-mi5v6512	28	49	Brazil	Brazil	NNP
cord-304472-mi5v6512	28	50	.	.	.
cord-304472-mi5v6512	29	1	The	the	DT
cord-304472-mi5v6512	29	2	Phase	phase	NN
cord-304472-mi5v6512	29	3	3	3	CD
cord-304472-mi5v6512	29	4	trials	trial	NNS
cord-304472-mi5v6512	29	5	revealed	reveal	VBD
cord-304472-mi5v6512	29	6	a	a	DT
cord-304472-mi5v6512	29	7	vaccine	vaccine	NN
cord-304472-mi5v6512	29	8	efficacy	efficacy	NN
cord-304472-mi5v6512	29	9	that	that	WDT
cord-304472-mi5v6512	29	10	differed	differ	VBD
cord-304472-mi5v6512	29	11	by	by	IN
cord-304472-mi5v6512	29	12	age	age	NN
cord-304472-mi5v6512	29	13	,	,	,
cord-304472-mi5v6512	29	14	serostatus	serostatus	NN
cord-304472-mi5v6512	29	15	and	and	CC
cord-304472-mi5v6512	29	16	serotype	serotype	NN
cord-304472-mi5v6512	29	17	.	.	.
cord-304472-mi5v6512	30	1	In	in	IN
cord-304472-mi5v6512	30	2	terms	term	NNS
cord-304472-mi5v6512	30	3	of	of	IN
cord-304472-mi5v6512	30	4	cumulative	cumulative	JJ
cord-304472-mi5v6512	30	5	incidence	incidence	NN
cord-304472-mi5v6512	30	6	,	,	,
cord-304472-mi5v6512	30	7	CYD	CYD	NNP
cord-304472-mi5v6512	30	8	-	-	HYPH
cord-304472-mi5v6512	30	9	TDV	TDV	NNP
cord-304472-mi5v6512	30	10	showed	show	VBD
cord-304472-mi5v6512	30	11	a	a	DT
cord-304472-mi5v6512	30	12	population	population	NN
cord-304472-mi5v6512	30	13	level	level	NN
cord-304472-mi5v6512	30	14	benefit	benefit	NN
cord-304472-mi5v6512	30	15	[	[	-LRB-
cord-304472-mi5v6512	30	16	14	14	CD
cord-304472-mi5v6512	30	17	]	]	-RRB-
cord-304472-mi5v6512	30	18	.	.	.
cord-304472-mi5v6512	31	1	Further	further	JJ
cord-304472-mi5v6512	31	2	post	post	VB
cord-304472-mi5v6512	31	3	-	-	JJ
cord-304472-mi5v6512	31	4	hoc	hoc	JJ
cord-304472-mi5v6512	31	5	retrospective	retrospective	JJ
cord-304472-mi5v6512	31	6	analyses	analysis	NNS
cord-304472-mi5v6512	31	7	of	of	IN
cord-304472-mi5v6512	31	8	the	the	DT
cord-304472-mi5v6512	31	9	long	long	JJ
cord-304472-mi5v6512	31	10	-	-	HYPH
cord-304472-mi5v6512	31	11	term	term	NN
cord-304472-mi5v6512	31	12	safety	safety	NN
cord-304472-mi5v6512	31	13	data	datum	NNS
cord-304472-mi5v6512	31	14	revealed	reveal	VBD
cord-304472-mi5v6512	31	15	an	an	DT
cord-304472-mi5v6512	31	16	excess	excess	JJ
cord-304472-mi5v6512	31	17	risk	risk	NN
cord-304472-mi5v6512	31	18	of	of	IN
cord-304472-mi5v6512	31	19	severe	severe	JJ
cord-304472-mi5v6512	31	20	dengue	dengue	NN
cord-304472-mi5v6512	31	21	in	in	IN
cord-304472-mi5v6512	31	22	those	those	DT
cord-304472-mi5v6512	31	23	who	who	WP
cord-304472-mi5v6512	31	24	were	be	VBD
cord-304472-mi5v6512	31	25	seronegative	seronegative	JJ
cord-304472-mi5v6512	31	26	at	at	IN
cord-304472-mi5v6512	31	27	baseline	baseline	NN
cord-304472-mi5v6512	31	28	.	.	.
cord-304472-mi5v6512	32	1	Serostatus	Serostatus	NNP
cord-304472-mi5v6512	32	2	refers	refer	VBZ
cord-304472-mi5v6512	32	3	to	to	IN
cord-304472-mi5v6512	32	4	whether	whether	IN
cord-304472-mi5v6512	32	5	a	a	DT
cord-304472-mi5v6512	32	6	person	person	NN
cord-304472-mi5v6512	32	7	has	have	VBZ
cord-304472-mi5v6512	32	8	had	have	VBN
cord-304472-mi5v6512	32	9	dengue	dengue	NN
cord-304472-mi5v6512	32	10	infections	infection	NNS
cord-304472-mi5v6512	32	11	in	in	IN
cord-304472-mi5v6512	32	12	the	the	DT
cord-304472-mi5v6512	32	13	past	past	NN
cord-304472-mi5v6512	32	14	[	[	-LRB-
cord-304472-mi5v6512	32	15	15	15	CD
cord-304472-mi5v6512	32	16	]	]	-RRB-
cord-304472-mi5v6512	32	17	.	.	.
cord-304472-mi5v6512	33	1	This	this	DT
cord-304472-mi5v6512	33	2	increased	increase	VBN
cord-304472-mi5v6512	33	3	risk	risk	NN
cord-304472-mi5v6512	33	4	in	in	IN
cord-304472-mi5v6512	33	5	seronegative	seronegative	JJ
cord-304472-mi5v6512	33	6	subjects	subject	NNS
cord-304472-mi5v6512	33	7	was	be	VBD
cord-304472-mi5v6512	33	8	observed	observe	VBN
cord-304472-mi5v6512	33	9	starting	start	VBG
cord-304472-mi5v6512	33	10	from	from	IN
cord-304472-mi5v6512	33	11	30	30	CD
cord-304472-mi5v6512	33	12	months	month	NNS
cord-304472-mi5v6512	33	13	after	after	IN
cord-304472-mi5v6512	33	14	administration	administration	NN
cord-304472-mi5v6512	33	15	of	of	IN
cord-304472-mi5v6512	33	16	the	the	DT
cord-304472-mi5v6512	33	17	first	first	JJ
cord-304472-mi5v6512	33	18	dose	dose	NN
cord-304472-mi5v6512	33	19	.	.	.
cord-304472-mi5v6512	34	1	A	a	DT
cord-304472-mi5v6512	34	2	plausible	plausible	JJ
cord-304472-mi5v6512	34	3	hypothesis	hypothesis	NN
cord-304472-mi5v6512	34	4	is	be	VBZ
cord-304472-mi5v6512	34	5	that	that	DT
cord-304472-mi5v6512	34	6	CYD	CYD	NNP
cord-304472-mi5v6512	34	7	-	-	HYPH
cord-304472-mi5v6512	34	8	TDV	TDV	NNP
cord-304472-mi5v6512	34	9	may	may	MD
cord-304472-mi5v6512	34	10	trigger	trigger	VB
cord-304472-mi5v6512	34	11	an	an	DT
cord-304472-mi5v6512	34	12	immune	immune	JJ
cord-304472-mi5v6512	34	13	response	response	NN
cord-304472-mi5v6512	34	14	to	to	IN
cord-304472-mi5v6512	34	15	dengue	dengue	NN
cord-304472-mi5v6512	34	16	in	in	IN
cord-304472-mi5v6512	34	17	seronegative	seronegative	JJ
cord-304472-mi5v6512	34	18	persons	person	NNS
cord-304472-mi5v6512	34	19	that	that	WDT
cord-304472-mi5v6512	34	20	predisposes	predispose	VBZ
cord-304472-mi5v6512	34	21	them	-PRON-	PRP
cord-304472-mi5v6512	34	22	to	to	IN
cord-304472-mi5v6512	34	23	a	a	DT
cord-304472-mi5v6512	34	24	higher	high	JJR
cord-304472-mi5v6512	34	25	risk	risk	NN
cord-304472-mi5v6512	34	26	of	of	IN
cord-304472-mi5v6512	34	27	severe	severe	JJ
cord-304472-mi5v6512	34	28	disease	disease	NN
cord-304472-mi5v6512	34	29	,	,	,
cord-304472-mi5v6512	34	30	analogue	analogue	JJ
cord-304472-mi5v6512	34	31	to	to	IN
cord-304472-mi5v6512	34	32	what	what	WP
cord-304472-mi5v6512	34	33	is	be	VBZ
cord-304472-mi5v6512	34	34	seen	see	VBN
cord-304472-mi5v6512	34	35	in	in	IN
cord-304472-mi5v6512	34	36	natural	natural	JJ
cord-304472-mi5v6512	34	37	secondary	secondary	JJ
cord-304472-mi5v6512	34	38	dengue	dengue	NN
cord-304472-mi5v6512	34	39	infections	infection	NNS
cord-304472-mi5v6512	34	40	[	[	-LRB-
cord-304472-mi5v6512	34	41	16	16	CD
cord-304472-mi5v6512	34	42	]	]	-RRB-
cord-304472-mi5v6512	34	43	.	.	.
cord-304472-mi5v6512	35	1	A	a	DT
cord-304472-mi5v6512	35	2	subsequent	subsequent	JJ
cord-304472-mi5v6512	35	3	infection	infection	NN
cord-304472-mi5v6512	35	4	with	with	IN
cord-304472-mi5v6512	35	5	the	the	DT
cord-304472-mi5v6512	35	6	first	first	JJ
cord-304472-mi5v6512	35	7	true	true	JJ
cord-304472-mi5v6512	35	8	wild	wild	JJ
cord-304472-mi5v6512	35	9	type	type	NN
cord-304472-mi5v6512	35	10	dengue	dengue	NN
cord-304472-mi5v6512	35	11	virus	virus	NN
cord-304472-mi5v6512	35	12	would	would	MD
cord-304472-mi5v6512	35	13	then	then	RB
cord-304472-mi5v6512	35	14	be	be	VB
cord-304472-mi5v6512	35	15	a	a	DT
cord-304472-mi5v6512	35	16	'	'	``
cord-304472-mi5v6512	35	17	secondary	secondary	JJ
cord-304472-mi5v6512	35	18	-	-	HYPH
cord-304472-mi5v6512	35	19	like	like	JJ
cord-304472-mi5v6512	35	20	'	'	''
cord-304472-mi5v6512	35	21	dengue	dengue	NN
cord-304472-mi5v6512	35	22	illness	illness	NN
cord-304472-mi5v6512	35	23	.	.	.
cord-304472-mi5v6512	36	1	Dengue	dengue	NN
cord-304472-mi5v6512	36	2	non	non	JJ
cord-304472-mi5v6512	36	3	-	-	JJ
cord-304472-mi5v6512	36	4	structural	structural	JJ
cord-304472-mi5v6512	36	5	proteins	protein	NNS
cord-304472-mi5v6512	36	6	(	(	-LRB-
cord-304472-mi5v6512	36	7	NS	NS	NNP
cord-304472-mi5v6512	36	8	)	)	-RRB-
cord-304472-mi5v6512	36	9	are	be	VBP
cord-304472-mi5v6512	36	10	absent	absent	JJ
cord-304472-mi5v6512	36	11	from	from	IN
cord-304472-mi5v6512	36	12	the	the	DT
cord-304472-mi5v6512	36	13	Sanofi	Sanofi	NNP
cord-304472-mi5v6512	36	14	dengue	dengue	NN
cord-304472-mi5v6512	36	15	-	-	HYPH
cord-304472-mi5v6512	36	16	yellow	yellow	JJ
cord-304472-mi5v6512	36	17	fever	fever	NN
cord-304472-mi5v6512	36	18	chimeric	chimeric	JJ
cord-304472-mi5v6512	36	19	vaccine	vaccine	NN
cord-304472-mi5v6512	36	20	.	.	.
cord-304472-mi5v6512	37	1	Given	give	VBN
cord-304472-mi5v6512	37	2	that	that	DT
cord-304472-mi5v6512	37	3	NS1	ns1	NN
cord-304472-mi5v6512	37	4	may	may	MD
cord-304472-mi5v6512	37	5	have	have	VB
cord-304472-mi5v6512	37	6	toxinlike	toxinlike	NN
cord-304472-mi5v6512	37	7	properties	property	NNS
cord-304472-mi5v6512	37	8	that	that	WDT
cord-304472-mi5v6512	37	9	disrupt	disrupt	VBP
cord-304472-mi5v6512	37	10	the	the	DT
cord-304472-mi5v6512	37	11	endothelial	endothelial	JJ
cord-304472-mi5v6512	37	12	glycocalyx	glycocalyx	NN
cord-304472-mi5v6512	37	13	through	through	IN
cord-304472-mi5v6512	37	14	either	either	CC
cord-304472-mi5v6512	37	15	inflammatory	inflammatory	NN
cord-304472-mi5v6512	37	16	-	-	HYPH
cord-304472-mi5v6512	37	17	dependent	dependent	JJ
cord-304472-mi5v6512	37	18	or	or	CC
cord-304472-mi5v6512	37	19	independent	independent	JJ
cord-304472-mi5v6512	37	20	pathways	pathway	NNS
cord-304472-mi5v6512	37	21	[	[	-LRB-
cord-304472-mi5v6512	37	22	17	17	CD
cord-304472-mi5v6512	37	23	]	]	-RRB-
cord-304472-mi5v6512	37	24	[	[	-LRB-
cord-304472-mi5v6512	37	25	18	18	CD
cord-304472-mi5v6512	37	26	]	]	-RRB-
cord-304472-mi5v6512	37	27	[	[	-LRB-
cord-304472-mi5v6512	37	28	19	19	CD
cord-304472-mi5v6512	37	29	]	]	-RRB-
cord-304472-mi5v6512	37	30	[	[	-LRB-
cord-304472-mi5v6512	37	31	20	20	CD
cord-304472-mi5v6512	37	32	]	]	-RRB-
cord-304472-mi5v6512	37	33	,	,	,
cord-304472-mi5v6512	37	34	the	the	DT
cord-304472-mi5v6512	37	35	absence	absence	NN
cord-304472-mi5v6512	37	36	of	of	IN
cord-304472-mi5v6512	37	37	NS1	ns1	NN
cord-304472-mi5v6512	37	38	in	in	IN
cord-304472-mi5v6512	37	39	CYD	CYD	NNP
cord-304472-mi5v6512	37	40	-	-	HYPH
cord-304472-mi5v6512	37	41	TDV	TDV	NNP
cord-304472-mi5v6512	37	42	could	could	MD
cord-304472-mi5v6512	37	43	also	also	RB
cord-304472-mi5v6512	37	44	be	be	VB
cord-304472-mi5v6512	37	45	a	a	DT
cord-304472-mi5v6512	37	46	potential	potential	JJ
cord-304472-mi5v6512	37	47	explanation	explanation	NN
cord-304472-mi5v6512	37	48	for	for	IN
cord-304472-mi5v6512	37	49	the	the	DT
cord-304472-mi5v6512	37	50	limited	limited	JJ
cord-304472-mi5v6512	37	51	vaccine	vaccine	NN
cord-304472-mi5v6512	37	52	performance	performance	NN
cord-304472-mi5v6512	37	53	.	.	.
cord-304472-mi5v6512	38	1	The	the	DT
cord-304472-mi5v6512	38	2	World	World	NNP
cord-304472-mi5v6512	38	3	Health	Health	NNP
cord-304472-mi5v6512	38	4	Organization	Organization	NNP
cord-304472-mi5v6512	38	5	(	(	-LRB-
cord-304472-mi5v6512	38	6	WHO	who	WP
cord-304472-mi5v6512	38	7	)	)	-RRB-
cord-304472-mi5v6512	38	8	recommends	recommend	VBZ
cord-304472-mi5v6512	38	9	that	that	IN
cord-304472-mi5v6512	38	10	for	for	IN
cord-304472-mi5v6512	38	11	countries	country	NNS
cord-304472-mi5v6512	38	12	considering	consider	VBG
cord-304472-mi5v6512	38	13	CYD	CYD	NNP
cord-304472-mi5v6512	38	14	-	-	HYPH
cord-304472-mi5v6512	38	15	TDV	TDV	NNP
cord-304472-mi5v6512	38	16	vaccination	vaccination	NN
cord-304472-mi5v6512	38	17	as	as	IN
cord-304472-mi5v6512	38	18	part	part	NN
cord-304472-mi5v6512	38	19	of	of	IN
cord-304472-mi5v6512	38	20	their	-PRON-	PRP$
cord-304472-mi5v6512	38	21	dengue	dengue	NN
cord-304472-mi5v6512	38	22	control	control	NN
cord-304472-mi5v6512	38	23	program	program	NN
cord-304472-mi5v6512	38	24	,	,	,
cord-304472-mi5v6512	38	25	a	a	DT
cord-304472-mi5v6512	38	26	pre	pre	JJ
cord-304472-mi5v6512	38	27	-	-	JJ
cord-304472-mi5v6512	38	28	vaccination	vaccination	JJ
cord-304472-mi5v6512	38	29	screening	screening	NN
cord-304472-mi5v6512	38	30	strategy	strategy	NN
cord-304472-mi5v6512	38	31	,	,	,
cord-304472-mi5v6512	38	32	in	in	IN
cord-304472-mi5v6512	38	33	which	which	WDT
cord-304472-mi5v6512	38	34	only	only	RB
cord-304472-mi5v6512	38	35	dengue	dengue	NN
cord-304472-mi5v6512	38	36	-	-	HYPH
cord-304472-mi5v6512	38	37	seropositive	seropositive	JJ
cord-304472-mi5v6512	38	38	persons	person	NNS
cord-304472-mi5v6512	38	39	are	be	VBP
cord-304472-mi5v6512	38	40	vaccinated	vaccinate	VBN
cord-304472-mi5v6512	38	41	,	,	,
cord-304472-mi5v6512	38	42	is	be	VBZ
cord-304472-mi5v6512	38	43	the	the	DT
cord-304472-mi5v6512	38	44	recommended	recommend	VBN
cord-304472-mi5v6512	38	45	strategy	strategy	NN
cord-304472-mi5v6512	38	46	[	[	-LRB-
cord-304472-mi5v6512	38	47	21	21	CD
cord-304472-mi5v6512	38	48	]	]	-RRB-
cord-304472-mi5v6512	38	49	.	.	.
cord-304472-mi5v6512	39	1	In	in	IN
cord-304472-mi5v6512	39	2	May	May	NNP
cord-304472-mi5v6512	39	3	2019	2019	CD
cord-304472-mi5v6512	39	4	,	,	,
cord-304472-mi5v6512	39	5	the	the	DT
cord-304472-mi5v6512	39	6	US	US	NNP
cord-304472-mi5v6512	39	7	Food	Food	NNP
cord-304472-mi5v6512	39	8	and	and	CC
cord-304472-mi5v6512	39	9	Drug	Drug	NNP
cord-304472-mi5v6512	39	10	Administration	Administration	NNP
cord-304472-mi5v6512	39	11	(	(	-LRB-
cord-304472-mi5v6512	39	12	FDA	FDA	NNP
cord-304472-mi5v6512	39	13	)	)	-RRB-
cord-304472-mi5v6512	39	14	approved	approve	VBD
cord-304472-mi5v6512	39	15	CYD	CYD	NNP
cord-304472-mi5v6512	39	16	-	-	HYPH
cord-304472-mi5v6512	39	17	TDV	TDV	NNP
cord-304472-mi5v6512	39	18	for	for	IN
cord-304472-mi5v6512	39	19	use	use	NN
cord-304472-mi5v6512	39	20	in	in	IN
cord-304472-mi5v6512	39	21	seropositive	seropositive	JJ
cord-304472-mi5v6512	39	22	individuals	individual	NNS
cord-304472-mi5v6512	39	23	9	9	CD
cord-304472-mi5v6512	39	24	through	through	IN
cord-304472-mi5v6512	39	25	16	16	CD
cord-304472-mi5v6512	39	26	years	year	NNS
cord-304472-mi5v6512	39	27	of	of	IN
cord-304472-mi5v6512	39	28	age	age	NN
cord-304472-mi5v6512	39	29	living	live	VBG
cord-304472-mi5v6512	39	30	in	in	IN
cord-304472-mi5v6512	39	31	endemic	endemic	JJ
cord-304472-mi5v6512	39	32	areas	area	NNS
cord-304472-mi5v6512	39	33	of	of	IN
cord-304472-mi5v6512	39	34	the	the	DT
cord-304472-mi5v6512	39	35	U.S.	U.S.	NNP
cord-304472-mi5v6512	40	1	The	the	DT
cord-304472-mi5v6512	40	2	European	European	NNP
cord-304472-mi5v6512	40	3	Medicine	Medicine	NNP
cord-304472-mi5v6512	40	4	agency	agency	NN
cord-304472-mi5v6512	40	5	also	also	RB
cord-304472-mi5v6512	40	6	endorsed	endorse	VBD
cord-304472-mi5v6512	40	7	the	the	DT
cord-304472-mi5v6512	40	8	use	use	NN
cord-304472-mi5v6512	40	9	of	of	IN
cord-304472-mi5v6512	40	10	this	this	DT
cord-304472-mi5v6512	40	11	vaccine	vaccine	NN
cord-304472-mi5v6512	40	12	in	in	IN
cord-304472-mi5v6512	40	13	seropositive	seropositive	JJ
cord-304472-mi5v6512	40	14	individuals	individual	NNS
cord-304472-mi5v6512	40	15	with	with	IN
cord-304472-mi5v6512	40	16	a	a	DT
cord-304472-mi5v6512	40	17	wider	wide	JJR
cord-304472-mi5v6512	40	18	age	age	NN
cord-304472-mi5v6512	40	19	range	range	NN
cord-304472-mi5v6512	40	20	.	.	.
cord-304472-mi5v6512	41	1	The	the	DT
cord-304472-mi5v6512	41	2	programmatic	programmatic	JJ
cord-304472-mi5v6512	41	3	use	use	NN
cord-304472-mi5v6512	41	4	of	of	IN
cord-304472-mi5v6512	41	5	CYD	CYD	NNP
cord-304472-mi5v6512	41	6	-	-	HYPH
cord-304472-mi5v6512	41	7	TDV	TDV	NNP
cord-304472-mi5v6512	41	8	,	,	,
cord-304472-mi5v6512	41	9	therefore	therefore	RB
cord-304472-mi5v6512	41	10	,	,	,
cord-304472-mi5v6512	41	11	requires	require	VBZ
cord-304472-mi5v6512	41	12	screening	screening	NN
cord-304472-mi5v6512	41	13	for	for	IN
cord-304472-mi5v6512	41	14	serostatus	serostatus	NN
cord-304472-mi5v6512	41	15	before	before	IN
cord-304472-mi5v6512	41	16	vaccination	vaccination	NN
cord-304472-mi5v6512	41	17	.	.	.
cord-304472-mi5v6512	42	1	IgG	IgG	NNP
cord-304472-mi5v6512	42	2	-	-	HYPH
cord-304472-mi5v6512	42	3	based	base	VBN
cord-304472-mi5v6512	42	4	enzyme	enzyme	NN
cord-304472-mi5v6512	42	5	-	-	HYPH
cord-304472-mi5v6512	42	6	linked	link	VBN
cord-304472-mi5v6512	42	7	immunosorbent	immunosorbent	JJ
cord-304472-mi5v6512	42	8	assays	assay	NNS
cord-304472-mi5v6512	42	9	(	(	-LRB-
cord-304472-mi5v6512	42	10	ELISAs	elisa	NNS
cord-304472-mi5v6512	42	11	)	)	-RRB-
cord-304472-mi5v6512	42	12	or	or	CC
cord-304472-mi5v6512	42	13	rapid	rapid	JJ
cord-304472-mi5v6512	42	14	diagnostic	diagnostic	JJ
cord-304472-mi5v6512	42	15	tests	test	NNS
cord-304472-mi5v6512	42	16	(	(	-LRB-
cord-304472-mi5v6512	42	17	RDTs	RDTs	NNP
cord-304472-mi5v6512	42	18	)	)	-RRB-
cord-304472-mi5v6512	42	19	can	can	MD
cord-304472-mi5v6512	42	20	be	be	VB
cord-304472-mi5v6512	42	21	used	use	VBN
cord-304472-mi5v6512	42	22	for	for	IN
cord-304472-mi5v6512	42	23	pre	pre	JJ
cord-304472-mi5v6512	42	24	-	-	JJ
cord-304472-mi5v6512	42	25	vaccination	vaccination	JJ
cord-304472-mi5v6512	42	26	screening	screening	NN
cord-304472-mi5v6512	42	27	,	,	,
cord-304472-mi5v6512	42	28	also	also	RB
cord-304472-mi5v6512	42	29	called	call	VBD
cord-304472-mi5v6512	42	30	a	a	DT
cord-304472-mi5v6512	42	31	'	'	``
cord-304472-mi5v6512	42	32	test	test	NN
cord-304472-mi5v6512	42	33	and	and	CC
cord-304472-mi5v6512	42	34	vaccinate	vaccinate	VB
cord-304472-mi5v6512	42	35	'	'	''
cord-304472-mi5v6512	42	36	strategy	strategy	NN
cord-304472-mi5v6512	42	37	.	.	.
cord-304472-mi5v6512	43	1	Ideally	ideally	RB
cord-304472-mi5v6512	43	2	,	,	,
cord-304472-mi5v6512	43	3	a	a	DT
cord-304472-mi5v6512	43	4	screening	screening	NN
cord-304472-mi5v6512	43	5	test	test	NN
cord-304472-mi5v6512	43	6	should	should	MD
cord-304472-mi5v6512	43	7	be	be	VB
cord-304472-mi5v6512	43	8	both	both	CC
cord-304472-mi5v6512	43	9	highly	highly	RB
cord-304472-mi5v6512	43	10	sensitive	sensitive	JJ
cord-304472-mi5v6512	43	11	and	and	CC
cord-304472-mi5v6512	43	12	specific	specific	JJ
cord-304472-mi5v6512	43	13	to	to	TO
cord-304472-mi5v6512	43	14	minimize	minimize	VB
cord-304472-mi5v6512	43	15	false	false	JJ
cord-304472-mi5v6512	43	16	positives	positive	NNS
cord-304472-mi5v6512	43	17	and	and	CC
cord-304472-mi5v6512	43	18	negatives	negative	NNS
cord-304472-mi5v6512	43	19	to	to	TO
cord-304472-mi5v6512	43	20	yield	yield	VB
cord-304472-mi5v6512	43	21	maximal	maximal	JJ
cord-304472-mi5v6512	43	22	population	population	NN
cord-304472-mi5v6512	43	23	level	level	NN
cord-304472-mi5v6512	43	24	benefit	benefit	NN
cord-304472-mi5v6512	43	25	and	and	CC
cord-304472-mi5v6512	43	26	minimize	minimize	VB
cord-304472-mi5v6512	43	27	harm	harm	NN
cord-304472-mi5v6512	43	28	by	by	IN
cord-304472-mi5v6512	43	29	correctly	correctly	RB
cord-304472-mi5v6512	43	30	screening	screen	VBG
cord-304472-mi5v6512	43	31	for	for	IN
cord-304472-mi5v6512	43	32	seropositive	seropositive	JJ
cord-304472-mi5v6512	43	33	individuals	individual	NNS
cord-304472-mi5v6512	43	34	only	only	RB
cord-304472-mi5v6512	43	35	[	[	-LRB-
cord-304472-mi5v6512	43	36	22	22	CD
cord-304472-mi5v6512	43	37	]	]	-RRB-
cord-304472-mi5v6512	43	38	.	.	.
cord-304472-mi5v6512	44	1	It	-PRON-	PRP
cord-304472-mi5v6512	44	2	should	should	MD
cord-304472-mi5v6512	44	3	also	also	RB
cord-304472-mi5v6512	44	4	be	be	VB
cord-304472-mi5v6512	44	5	affordable	affordable	JJ
cord-304472-mi5v6512	44	6	,	,	,
cord-304472-mi5v6512	44	7	simple	simple	JJ
cord-304472-mi5v6512	44	8	to	to	TO
cord-304472-mi5v6512	44	9	use	use	VB
cord-304472-mi5v6512	44	10	and	and	CC
cord-304472-mi5v6512	44	11	provide	provide	VB
cord-304472-mi5v6512	44	12	rapid	rapid	JJ
cord-304472-mi5v6512	44	13	results	result	NNS
cord-304472-mi5v6512	44	14	.	.	.
cord-304472-mi5v6512	45	1	Two	two	CD
cord-304472-mi5v6512	45	2	recent	recent	JJ
cord-304472-mi5v6512	45	3	comparative	comparative	JJ
cord-304472-mi5v6512	45	4	evaluations	evaluation	NNS
cord-304472-mi5v6512	45	5	on	on	IN
cord-304472-mi5v6512	45	6	currently	currently	RB
cord-304472-mi5v6512	45	7	available	available	JJ
cord-304472-mi5v6512	45	8	assays	assay	NNS
cord-304472-mi5v6512	45	9	showed	show	VBD
cord-304472-mi5v6512	45	10	high	high	JJ
cord-304472-mi5v6512	45	11	specificity	specificity	NN
cord-304472-mi5v6512	45	12	(	(	-LRB-
cord-304472-mi5v6512	45	13	>	>	NFP
cord-304472-mi5v6512	45	14	98	98	CD
cord-304472-mi5v6512	45	15	%	%	NN
cord-304472-mi5v6512	45	16	)	)	-RRB-
cord-304472-mi5v6512	45	17	for	for	IN
cord-304472-mi5v6512	45	18	all	all	DT
cord-304472-mi5v6512	45	19	immunoassays	immunoassay	NNS
cord-304472-mi5v6512	45	20	apart	apart	RB
cord-304472-mi5v6512	45	21	from	from	IN
cord-304472-mi5v6512	45	22	one	one	CD
cord-304472-mi5v6512	45	23	RDT	RDT	NNP
cord-304472-mi5v6512	45	24	,	,	,
cord-304472-mi5v6512	45	25	but	but	CC
cord-304472-mi5v6512	45	26	variable	variable	JJ
cord-304472-mi5v6512	45	27	sensitivities	sensitivity	NNS
cord-304472-mi5v6512	45	28	(	(	-LRB-
cord-304472-mi5v6512	45	29	higher	high	JJR
cord-304472-mi5v6512	45	30	sensitivities	sensitivity	NNS
cord-304472-mi5v6512	45	31	observed	observe	VBN
cord-304472-mi5v6512	45	32	for	for	IN
cord-304472-mi5v6512	45	33	the	the	DT
cord-304472-mi5v6512	45	34	ELISAs	elisa	NNS
cord-304472-mi5v6512	45	35	[	[	-LRB-
cord-304472-mi5v6512	45	36	89	89	CD
cord-304472-mi5v6512	45	37	%	%	NN
cord-304472-mi5v6512	45	38	and	and	CC
cord-304472-mi5v6512	45	39	93	93	CD
cord-304472-mi5v6512	45	40	%	%	NN
cord-304472-mi5v6512	45	41	]	]	-RRB-
cord-304472-mi5v6512	45	42	than	than	IN
cord-304472-mi5v6512	45	43	the	the	DT
cord-304472-mi5v6512	45	44	RDTs	rdt	NNS
cord-304472-mi5v6512	45	45	[	[	-LRB-
cord-304472-mi5v6512	45	46	48	48	CD
cord-304472-mi5v6512	45	47	-	-	SYM
cord-304472-mi5v6512	45	48	71	71	CD
cord-304472-mi5v6512	45	49	%	%	NN
cord-304472-mi5v6512	45	50	]	]	-RRB-
cord-304472-mi5v6512	45	51	)	)	-RRB-
cord-304472-mi5v6512	45	52	[	[	-LRB-
cord-304472-mi5v6512	45	53	23	23	CD
cord-304472-mi5v6512	45	54	,	,	,
cord-304472-mi5v6512	45	55	24	24	CD
cord-304472-mi5v6512	45	56	]	]	-RRB-
cord-304472-mi5v6512	45	57	Sensitivity	sensitivity	NN
cord-304472-mi5v6512	45	58	appeared	appear	VBD
cord-304472-mi5v6512	45	59	similar	similar	JJ
cord-304472-mi5v6512	45	60	in	in	IN
cord-304472-mi5v6512	45	61	samples	sample	NNS
cord-304472-mi5v6512	45	62	from	from	IN
cord-304472-mi5v6512	45	63	individuals	individual	NNS
cord-304472-mi5v6512	45	64	with	with	IN
cord-304472-mi5v6512	45	65	recent	recent	JJ
cord-304472-mi5v6512	45	66	and	and	CC
cord-304472-mi5v6512	45	67	remote	remote	JJ
cord-304472-mi5v6512	45	68	virologically	virologically	NN
cord-304472-mi5v6512	45	69	confirmed	confirm	VBD
cord-304472-mi5v6512	45	70	dengue	dengue	NN
cord-304472-mi5v6512	45	71	(	(	-LRB-
cord-304472-mi5v6512	45	72	VCD	VCD	NNP
cord-304472-mi5v6512	45	73	)	)	-RRB-
cord-304472-mi5v6512	45	74	.	.	.
cord-304472-mi5v6512	46	1	Cross	cross	NN
cord-304472-mi5v6512	46	2	-	-	NN
cord-304472-mi5v6512	46	3	reactivity	reactivity	NN
cord-304472-mi5v6512	46	4	to	to	IN
cord-304472-mi5v6512	46	5	other	other	JJ
cord-304472-mi5v6512	46	6	flaviviruses	flavivirus	NNS
cord-304472-mi5v6512	46	7	was	be	VBD
cord-304472-mi5v6512	46	8	low	low	JJ
cord-304472-mi5v6512	46	9	with	with	IN
cord-304472-mi5v6512	46	10	RDTs	rdt	NNS
cord-304472-mi5v6512	46	11	(	(	-LRB-
cord-304472-mi5v6512	46	12	<	<	XX
cord-304472-mi5v6512	46	13	/	/	SYM
cord-304472-mi5v6512	46	14	=	=	SYM
cord-304472-mi5v6512	46	15	7	7	CD
cord-304472-mi5v6512	46	16	%	%	NN
cord-304472-mi5v6512	46	17	)	)	-RRB-
cord-304472-mi5v6512	46	18	,	,	,
cord-304472-mi5v6512	46	19	but	but	CC
cord-304472-mi5v6512	46	20	more	more	RBR
cord-304472-mi5v6512	46	21	significant	significant	JJ
cord-304472-mi5v6512	46	22	with	with	IN
cord-304472-mi5v6512	46	23	ELISAs	elisa	NNS
cord-304472-mi5v6512	46	24	(	(	-LRB-
cord-304472-mi5v6512	46	25	up	up	IN
cord-304472-mi5v6512	46	26	to	to	TO
cord-304472-mi5v6512	46	27	51	51	CD
cord-304472-mi5v6512	46	28	%	%	NN
cord-304472-mi5v6512	46	29	for	for	IN
cord-304472-mi5v6512	46	30	West	West	NNP
cord-304472-mi5v6512	46	31	Nile	Nile	NNP
cord-304472-mi5v6512	46	32	and	and	CC
cord-304472-mi5v6512	46	33	34	34	CD
cord-304472-mi5v6512	46	34	%	%	NN
cord-304472-mi5v6512	46	35	for	for	IN
cord-304472-mi5v6512	46	36	Zika	Zika	NNP
cord-304472-mi5v6512	46	37	)	)	-RRB-
cord-304472-mi5v6512	46	38	.	.	.
cord-304472-mi5v6512	47	1	CYD	CYD	NNP
cord-304472-mi5v6512	47	2	-	-	HYPH
cord-304472-mi5v6512	47	3	TDV	TDV	NNP
cord-304472-mi5v6512	47	4	's	's	POS
cord-304472-mi5v6512	47	5	public	public	JJ
cord-304472-mi5v6512	47	6	health	health	NN
cord-304472-mi5v6512	47	7	utility	utility	NN
cord-304472-mi5v6512	47	8	is	be	VBZ
cord-304472-mi5v6512	47	9	limited	limit	VBN
cord-304472-mi5v6512	47	10	to	to	IN
cord-304472-mi5v6512	47	11	seropositive	seropositive	JJ
cord-304472-mi5v6512	47	12	persons	person	NNS
cord-304472-mi5v6512	47	13	.	.	.
cord-304472-mi5v6512	48	1	Implementation	implementation	NN
cord-304472-mi5v6512	48	2	research	research	NN
cord-304472-mi5v6512	48	3	is	be	VBZ
cord-304472-mi5v6512	48	4	now	now	RB
cord-304472-mi5v6512	48	5	needed	need	VBN
cord-304472-mi5v6512	48	6	on	on	IN
cord-304472-mi5v6512	48	7	how	how	WRB
cord-304472-mi5v6512	48	8	and	and	CC
cord-304472-mi5v6512	48	9	for	for	IN
cord-304472-mi5v6512	48	10	which	which	WDT
cord-304472-mi5v6512	48	11	settings	setting	NNS
cord-304472-mi5v6512	48	12	(	(	-LRB-
cord-304472-mi5v6512	48	13	e.g.	e.g.	IN
cord-304472-mi5v6512	48	14	school	school	NN
cord-304472-mi5v6512	48	15	settings	setting	NNS
cord-304472-mi5v6512	48	16	)	)	-RRB-
cord-304472-mi5v6512	48	17	a	a	DT
cord-304472-mi5v6512	48	18	prevaccination	prevaccination	NN
cord-304472-mi5v6512	48	19	screening	screening	NN
cord-304472-mi5v6512	48	20	can	can	MD
cord-304472-mi5v6512	48	21	be	be	VB
cord-304472-mi5v6512	48	22	rolled	roll	VBN
cord-304472-mi5v6512	48	23	out	out	RP
cord-304472-mi5v6512	48	24	for	for	IN
cord-304472-mi5v6512	48	25	programmatic	programmatic	JJ
cord-304472-mi5v6512	48	26	national	national	JJ
cord-304472-mi5v6512	48	27	or	or	CC
cord-304472-mi5v6512	48	28	subnational	subnational	JJ
cord-304472-mi5v6512	48	29	use	use	NN
cord-304472-mi5v6512	48	30	[	[	-LRB-
cord-304472-mi5v6512	48	31	25	25	CD
cord-304472-mi5v6512	48	32	]	]	-RRB-
cord-304472-mi5v6512	48	33	.	.	.
cord-304472-mi5v6512	49	1	In	in	IN
cord-304472-mi5v6512	49	2	private	private	JJ
cord-304472-mi5v6512	49	3	clinics	clinic	NNS
cord-304472-mi5v6512	49	4	and	and	CC
cord-304472-mi5v6512	49	5	travel	travel	NN
cord-304472-mi5v6512	49	6	medicine	medicine	NN
cord-304472-mi5v6512	49	7	settings	setting	NNS
cord-304472-mi5v6512	49	8	[	[	-LRB-
cord-304472-mi5v6512	49	9	26	26	CD
cord-304472-mi5v6512	49	10	]	]	-RRB-
cord-304472-mi5v6512	49	11	,	,	,
cord-304472-mi5v6512	49	12	blood	blood	NN
cord-304472-mi5v6512	49	13	is	be	VBZ
cord-304472-mi5v6512	49	14	often	often	RB
cord-304472-mi5v6512	49	15	taken	take	VBN
cord-304472-mi5v6512	49	16	before	before	IN
cord-304472-mi5v6512	49	17	hepatitis	hepatitis	NN
cord-304472-mi5v6512	49	18	B	B	NNP
cord-304472-mi5v6512	49	19	vaccination	vaccination	NN
cord-304472-mi5v6512	49	20	to	to	TO
cord-304472-mi5v6512	49	21	check	check	VB
cord-304472-mi5v6512	49	22	for	for	IN
cord-304472-mi5v6512	49	23	hepatitis	hepatitis	NN
cord-304472-mi5v6512	49	24	B	B	NNP
cord-304472-mi5v6512	49	25	serostatus	serostatus	NN
cord-304472-mi5v6512	49	26	and	and	CC
cord-304472-mi5v6512	49	27	other	other	JJ
cord-304472-mi5v6512	49	28	vaccine	vaccine	NN
cord-304472-mi5v6512	49	29	-	-	HYPH
cord-304472-mi5v6512	49	30	preventable	preventable	JJ
cord-304472-mi5v6512	49	31	diseases	disease	NNS
cord-304472-mi5v6512	49	32	;	;	:
cord-304472-mi5v6512	49	33	thus	thus	RB
cord-304472-mi5v6512	49	34	there	there	EX
cord-304472-mi5v6512	49	35	is	be	VBZ
cord-304472-mi5v6512	49	36	precedence	precedence	NN
cord-304472-mi5v6512	49	37	for	for	IN
cord-304472-mi5v6512	49	38	pre	pre	JJ
cord-304472-mi5v6512	49	39	-	-	JJ
cord-304472-mi5v6512	49	40	vaccination	vaccination	JJ
cord-304472-mi5v6512	49	41	screening	screening	NN
cord-304472-mi5v6512	49	42	.	.	.
cord-304472-mi5v6512	50	1	Research	research	NN
cord-304472-mi5v6512	50	2	is	be	VBZ
cord-304472-mi5v6512	50	3	also	also	RB
cord-304472-mi5v6512	50	4	needed	need	VBN
cord-304472-mi5v6512	50	5	to	to	TO
cord-304472-mi5v6512	50	6	evaluate	evaluate	VB
cord-304472-mi5v6512	50	7	vaccine	vaccine	NN
cord-304472-mi5v6512	50	8	schedules	schedule	NNS
cord-304472-mi5v6512	50	9	with	with	IN
cord-304472-mi5v6512	50	10	fewer	few	JJR
cord-304472-mi5v6512	50	11	doses	dose	NNS
cord-304472-mi5v6512	50	12	,	,	,
cord-304472-mi5v6512	50	13	assess	assess	VB
cord-304472-mi5v6512	50	14	the	the	DT
cord-304472-mi5v6512	50	15	need	need	NN
cord-304472-mi5v6512	50	16	and	and	CC
cord-304472-mi5v6512	50	17	timing	timing	NN
cord-304472-mi5v6512	50	18	for	for	IN
cord-304472-mi5v6512	50	19	booster	booster	NN
cord-304472-mi5v6512	50	20	doses	dose	NNS
cord-304472-mi5v6512	50	21	,	,	,
cord-304472-mi5v6512	50	22	and	and	CC
cord-304472-mi5v6512	50	23	identify	identify	VB
cord-304472-mi5v6512	50	24	populations	population	NNS
cord-304472-mi5v6512	50	25	that	that	WDT
cord-304472-mi5v6512	50	26	will	will	MD
cord-304472-mi5v6512	50	27	benefit	benefit	VB
cord-304472-mi5v6512	50	28	most	most	JJS
cord-304472-mi5v6512	50	29	from	from	IN
cord-304472-mi5v6512	50	30	this	this	DT
cord-304472-mi5v6512	50	31	vaccine	vaccine	NN
cord-304472-mi5v6512	50	32	[	[	-LRB-
cord-304472-mi5v6512	50	33	21	21	CD
cord-304472-mi5v6512	50	34	,	,	,
cord-304472-mi5v6512	50	35	27	27	CD
cord-304472-mi5v6512	50	36	,	,	,
cord-304472-mi5v6512	50	37	28	28	CD
cord-304472-mi5v6512	50	38	]	]	-RRB-
cord-304472-mi5v6512	50	39	.	.	.
cord-304472-mi5v6512	51	1	Lessons	lesson	NNS
cord-304472-mi5v6512	51	2	from	from	IN
cord-304472-mi5v6512	51	3	the	the	DT
cord-304472-mi5v6512	51	4	first	first	JJ
cord-304472-mi5v6512	51	5	licensed	licensed	JJ
cord-304472-mi5v6512	51	6	dengue	dengue	NN
cord-304472-mi5v6512	51	7	vaccine	vaccine	NN
cord-304472-mi5v6512	51	8	for	for	IN
cord-304472-mi5v6512	51	9	clinical	clinical	JJ
cord-304472-mi5v6512	51	10	trial	trial	NN
cord-304472-mi5v6512	51	11	designs	design	NNS
cord-304472-mi5v6512	52	1	Lessons	lesson	NNS
cord-304472-mi5v6512	52	2	from	from	IN
cord-304472-mi5v6512	52	3	the	the	DT
cord-304472-mi5v6512	52	4	first	first	JJ
cord-304472-mi5v6512	52	5	dengue	dengue	NN
cord-304472-mi5v6512	52	6	vaccine	vaccine	NN
cord-304472-mi5v6512	52	7	have	have	VBP
cord-304472-mi5v6512	52	8	shaped	shape	VBN
cord-304472-mi5v6512	52	9	how	how	WRB
cord-304472-mi5v6512	52	10	second	second	JJ
cord-304472-mi5v6512	52	11	-	-	HYPH
cord-304472-mi5v6512	52	12	generation	generation	NN
cord-304472-mi5v6512	52	13	dengue	dengue	NN
cord-304472-mi5v6512	52	14	vaccines	vaccine	NNS
cord-304472-mi5v6512	52	15	should	should	MD
cord-304472-mi5v6512	52	16	be	be	VB
cord-304472-mi5v6512	52	17	evaluated	evaluate	VBN
cord-304472-mi5v6512	52	18	.	.	.
cord-304472-mi5v6512	53	1	The	the	DT
cord-304472-mi5v6512	53	2	effect	effect	NN
cord-304472-mi5v6512	53	3	on	on	IN
cord-304472-mi5v6512	53	4	cellular	cellular	JJ
cord-304472-mi5v6512	53	5	immunity	immunity	NN
cord-304472-mi5v6512	53	6	needs	need	VBZ
cord-304472-mi5v6512	53	7	to	to	TO
cord-304472-mi5v6512	53	8	be	be	VB
cord-304472-mi5v6512	53	9	studied	study	VBN
cord-304472-mi5v6512	53	10	,	,	,
cord-304472-mi5v6512	53	11	including	include	VBG
cord-304472-mi5v6512	53	12	the	the	DT
cord-304472-mi5v6512	53	13	extent	extent	NN
cord-304472-mi5v6512	53	14	of	of	IN
cord-304472-mi5v6512	53	15	truly	truly	RB
cord-304472-mi5v6512	53	16	neutralizing	neutralize	VBG
cord-304472-mi5v6512	53	17	antibodies	antibody	NNS
cord-304472-mi5v6512	53	18	versus	versus	IN
cord-304472-mi5v6512	53	19	just	just	RB
cord-304472-mi5v6512	53	20	transient	transient	JJ
cord-304472-mi5v6512	53	21	cross	cross	JJ
cord-304472-mi5v6512	53	22	-	-	JJ
cord-304472-mi5v6512	53	23	protective	protective	JJ
cord-304472-mi5v6512	53	24	antibodies	antibody	NNS
cord-304472-mi5v6512	53	25	.	.	.
cord-304472-mi5v6512	54	1	Vaccine	vaccine	NN
cord-304472-mi5v6512	54	2	trial	trial	NN
cord-304472-mi5v6512	54	3	designs	design	NNS
cord-304472-mi5v6512	54	4	should	should	MD
cord-304472-mi5v6512	54	5	account	account	VB
cord-304472-mi5v6512	54	6	for	for	IN
cord-304472-mi5v6512	54	7	the	the	DT
cord-304472-mi5v6512	54	8	known	known	JJ
cord-304472-mi5v6512	54	9	period	period	NN
cord-304472-mi5v6512	54	10	of	of	IN
cord-304472-mi5v6512	54	11	crossprotection	crossprotection	NN
cord-304472-mi5v6512	54	12	between	between	IN
cord-304472-mi5v6512	54	13	serotypes	serotype	NNS
cord-304472-mi5v6512	54	14	which	which	WDT
cord-304472-mi5v6512	54	15	can	can	MD
cord-304472-mi5v6512	54	16	last	last	VB
cord-304472-mi5v6512	54	17	up	up	IN
cord-304472-mi5v6512	54	18	to	to	IN
cord-304472-mi5v6512	54	19	one	one	CD
cord-304472-mi5v6512	54	20	even	even	RB
cord-304472-mi5v6512	54	21	two	two	CD
cord-304472-mi5v6512	54	22	years	year	NNS
cord-304472-mi5v6512	54	23	before	before	IN
cord-304472-mi5v6512	54	24	safety	safety	NN
cord-304472-mi5v6512	54	25	signals	signal	NNS
cord-304472-mi5v6512	54	26	may	may	MD
cord-304472-mi5v6512	54	27	appear	appear	VB
cord-304472-mi5v6512	54	28	in	in	IN
cord-304472-mi5v6512	54	29	year	year	NN
cord-304472-mi5v6512	54	30	3	3	CD
cord-304472-mi5v6512	54	31	and	and	CC
cord-304472-mi5v6512	54	32	beyond	beyond	IN
cord-304472-mi5v6512	54	33	.	.	.
cord-304472-mi5v6512	55	1	Trial	trial	NN
cord-304472-mi5v6512	55	2	designs	design	NNS
cord-304472-mi5v6512	55	3	,	,	,
cord-304472-mi5v6512	55	4	therefore	therefore	RB
cord-304472-mi5v6512	55	5	,	,	,
cord-304472-mi5v6512	55	6	need	need	VBP
cord-304472-mi5v6512	55	7	to	to	TO
cord-304472-mi5v6512	55	8	be	be	VB
cord-304472-mi5v6512	55	9	extended	extend	VBN
cord-304472-mi5v6512	55	10	to	to	TO
cord-304472-mi5v6512	55	11	include	include	VB
cord-304472-mi5v6512	55	12	active	active	JJ
cord-304472-mi5v6512	55	13	surveillance	surveillance	NN
cord-304472-mi5v6512	55	14	of	of	IN
cord-304472-mi5v6512	55	15	trial	trial	NN
cord-304472-mi5v6512	55	16	participants	participant	NNS
cord-304472-mi5v6512	55	17	up	up	IN
cord-304472-mi5v6512	55	18	to	to	IN
cord-304472-mi5v6512	55	19	3À5	3à5	CD
cord-304472-mi5v6512	55	20	years	year	NNS
cord-304472-mi5v6512	55	21	[	[	-LRB-
cord-304472-mi5v6512	55	22	29	29	CD
cord-304472-mi5v6512	55	23	]	]	-RRB-
cord-304472-mi5v6512	55	24	.	.	.
cord-304472-mi5v6512	56	1	Furthermore	furthermore	RB
cord-304472-mi5v6512	56	2	,	,	,
cord-304472-mi5v6512	56	3	vaccine	vaccine	NN
cord-304472-mi5v6512	56	4	evaluation	evaluation	NN
cord-304472-mi5v6512	56	5	must	must	MD
cord-304472-mi5v6512	56	6	include	include	VB
cord-304472-mi5v6512	56	7	a	a	DT
cord-304472-mi5v6512	56	8	-	-	HYPH
cord-304472-mi5v6512	56	9	priori	priori	FW
cord-304472-mi5v6512	56	10	analysis	analysis	NN
cord-304472-mi5v6512	56	11	plans	plan	NNS
cord-304472-mi5v6512	56	12	for	for	IN
cord-304472-mi5v6512	56	13	stratification	stratification	NN
cord-304472-mi5v6512	56	14	by	by	IN
cord-304472-mi5v6512	56	15	serostatus	serostatus	NN
cord-304472-mi5v6512	56	16	and	and	CC
cord-304472-mi5v6512	56	17	serotype	serotype	NN
cord-304472-mi5v6512	56	18	.	.	.
cord-304472-mi5v6512	57	1	To	to	TO
cord-304472-mi5v6512	57	2	stratify	stratify	VB
cord-304472-mi5v6512	57	3	by	by	IN
cord-304472-mi5v6512	57	4	serostatus	serostatus	NN
cord-304472-mi5v6512	57	5	,	,	,
cord-304472-mi5v6512	57	6	baseline	baseline	JJ
cord-304472-mi5v6512	57	7	blood	blood	NN
cord-304472-mi5v6512	57	8	samples	sample	NNS
cord-304472-mi5v6512	57	9	need	need	VBP
cord-304472-mi5v6512	57	10	to	to	TO
cord-304472-mi5v6512	57	11	be	be	VB
cord-304472-mi5v6512	57	12	taken	take	VBN
cord-304472-mi5v6512	57	13	from	from	IN
cord-304472-mi5v6512	57	14	all	all	DT
cord-304472-mi5v6512	57	15	study	study	NN
cord-304472-mi5v6512	57	16	subjects	subject	NNS
cord-304472-mi5v6512	57	17	.	.	.
cord-304472-mi5v6512	58	1	When	when	WRB
cord-304472-mi5v6512	58	2	interpreting	interpret	VBG
cord-304472-mi5v6512	58	3	efficacy	efficacy	NN
cord-304472-mi5v6512	58	4	results	result	NNS
cord-304472-mi5v6512	58	5	,	,	,
cord-304472-mi5v6512	58	6	one	one	PRP
cord-304472-mi5v6512	58	7	has	have	VBZ
cord-304472-mi5v6512	58	8	to	to	TO
cord-304472-mi5v6512	58	9	consider	consider	VB
cord-304472-mi5v6512	58	10	the	the	DT
cord-304472-mi5v6512	58	11	predominance	predominance	NN
cord-304472-mi5v6512	58	12	of	of	IN
cord-304472-mi5v6512	58	13	a	a	DT
cord-304472-mi5v6512	58	14	given	give	VBN
cord-304472-mi5v6512	58	15	serotype	serotype	NN
cord-304472-mi5v6512	58	16	and	and	CC
cord-304472-mi5v6512	58	17	the	the	DT
cord-304472-mi5v6512	58	18	proportion	proportion	NN
cord-304472-mi5v6512	58	19	of	of	IN
cord-304472-mi5v6512	58	20	individuals	individual	NNS
cord-304472-mi5v6512	58	21	who	who	WP
cord-304472-mi5v6512	58	22	are	be	VBP
cord-304472-mi5v6512	58	23	seronegative	seronegative	JJ
cord-304472-mi5v6512	58	24	in	in	IN
cord-304472-mi5v6512	58	25	a	a	DT
cord-304472-mi5v6512	58	26	population	population	NN
cord-304472-mi5v6512	58	27	,	,	,
cord-304472-mi5v6512	58	28	which	which	WDT
cord-304472-mi5v6512	58	29	can	can	MD
cord-304472-mi5v6512	58	30	vary	vary	VB
cord-304472-mi5v6512	58	31	from	from	IN
cord-304472-mi5v6512	58	32	year	year	NN
cord-304472-mi5v6512	58	33	to	to	IN
cord-304472-mi5v6512	58	34	year	year	NN
cord-304472-mi5v6512	58	35	and	and	CC
cord-304472-mi5v6512	58	36	country	country	NN
cord-304472-mi5v6512	58	37	to	to	IN
cord-304472-mi5v6512	58	38	country	country	NN
cord-304472-mi5v6512	58	39	[	[	-LRB-
cord-304472-mi5v6512	58	40	30	30	CD
cord-304472-mi5v6512	58	41	]	]	-RRB-
cord-304472-mi5v6512	58	42	.	.	.
cord-304472-mi5v6512	59	1	Indeed	indeed	RB
cord-304472-mi5v6512	59	2	,	,	,
cord-304472-mi5v6512	59	3	the	the	DT
cord-304472-mi5v6512	59	4	vaccine	vaccine	NN
cord-304472-mi5v6512	59	5	trials	trial	NNS
cord-304472-mi5v6512	59	6	for	for	IN
cord-304472-mi5v6512	59	7	the	the	DT
cord-304472-mi5v6512	59	8	secondgeneration	secondgeneration	NN
cord-304472-mi5v6512	59	9	live	live	VBP
cord-304472-mi5v6512	59	10	dengue	dengue	NN
cord-304472-mi5v6512	59	11	vaccines	vaccine	NNS
cord-304472-mi5v6512	59	12	take	take	VBP
cord-304472-mi5v6512	59	13	these	these	DT
cord-304472-mi5v6512	59	14	trial	trial	NN
cord-304472-mi5v6512	59	15	specifications	specification	NNS
cord-304472-mi5v6512	59	16	into	into	IN
cord-304472-mi5v6512	59	17	account	account	NN
cord-304472-mi5v6512	59	18	.	.	.
cord-304472-mi5v6512	60	1	Non	non	JJ
cord-304472-mi5v6512	60	2	-	-	JJ
cord-304472-mi5v6512	60	3	structural	structural	JJ
cord-304472-mi5v6512	60	4	proteins	protein	NNS
cord-304472-mi5v6512	60	5	of	of	IN
cord-304472-mi5v6512	60	6	the	the	DT
cord-304472-mi5v6512	60	7	dengue	dengue	NN
cord-304472-mi5v6512	60	8	virus	virus	NN
cord-304472-mi5v6512	60	9	backbone	backbone	NN
cord-304472-mi5v6512	60	10	are	be	VBP
cord-304472-mi5v6512	60	11	at	at	IN
cord-304472-mi5v6512	60	12	least	least	JJS
cord-304472-mi5v6512	60	13	partially	partially	RB
cord-304472-mi5v6512	60	14	present	present	JJ
cord-304472-mi5v6512	60	15	in	in	IN
cord-304472-mi5v6512	60	16	second	second	JJ
cord-304472-mi5v6512	60	17	generation	generation	NN
cord-304472-mi5v6512	60	18	dengue	dengue	NN
cord-304472-mi5v6512	60	19	vaccines	vaccine	NNS
cord-304472-mi5v6512	60	20	.	.	.
cord-304472-mi5v6512	61	1	Two	two	CD
cord-304472-mi5v6512	61	2	chimeric	chimeric	JJ
cord-304472-mi5v6512	61	3	live	live	NN
cord-304472-mi5v6512	61	4	-	-	HYPH
cord-304472-mi5v6512	61	5	attenuated	attenuate	VBN
cord-304472-mi5v6512	61	6	dengue	dengue	NN
cord-304472-mi5v6512	61	7	vaccines	vaccine	NNS
cord-304472-mi5v6512	61	8	are	be	VBP
cord-304472-mi5v6512	61	9	now	now	RB
cord-304472-mi5v6512	61	10	in	in	IN
cord-304472-mi5v6512	61	11	Phase	phase	NN
cord-304472-mi5v6512	61	12	3	3	CD
cord-304472-mi5v6512	61	13	trials	trial	NNS
cord-304472-mi5v6512	61	14	:	:	:
cord-304472-mi5v6512	61	15	one	one	CD
cord-304472-mi5v6512	61	16	developed	develop	VBN
cord-304472-mi5v6512	61	17	by	by	IN
cord-304472-mi5v6512	61	18	Takeda	Takeda	NNP
cord-304472-mi5v6512	61	19	(	(	-LRB-
cord-304472-mi5v6512	61	20	TAK-003	tak-003	NN
cord-304472-mi5v6512	61	21	)	)	-RRB-
cord-304472-mi5v6512	61	22	and	and	CC
cord-304472-mi5v6512	61	23	one	one	CD
cord-304472-mi5v6512	61	24	by	by	IN
cord-304472-mi5v6512	61	25	the	the	DT
cord-304472-mi5v6512	61	26	National	National	NNP
cord-304472-mi5v6512	61	27	Institute	Institute	NNP
cord-304472-mi5v6512	61	28	of	of	IN
cord-304472-mi5v6512	61	29	Allergy	Allergy	NNP
cord-304472-mi5v6512	61	30	and	and	CC
cord-304472-mi5v6512	61	31	Infectious	Infectious	NNP
cord-304472-mi5v6512	61	32	Diseases	Diseases	NNPS
cord-304472-mi5v6512	62	1	(	(	-LRB-
cord-304472-mi5v6512	63	1	TV003	TV003	NNP
cord-304472-mi5v6512	63	2	/	/	SYM
cord-304472-mi5v6512	63	3	TV005	TV005	NNP
cord-304472-mi5v6512	63	4	)	)	-RRB-
cord-304472-mi5v6512	63	5	(	(	-LRB-
cord-304472-mi5v6512	63	6	Table	table	NN
cord-304472-mi5v6512	63	7	1	1	CD
cord-304472-mi5v6512	63	8	)	)	-RRB-
cord-304472-mi5v6512	63	9	.	.	.
cord-304472-mi5v6512	64	1	(	(	-LRB-
cord-304472-mi5v6512	64	2	1	1	LS
cord-304472-mi5v6512	64	3	)	)	-RRB-
cord-304472-mi5v6512	64	4	Takeda	Takeda	NNP
cord-304472-mi5v6512	64	5	's	's	POS
cord-304472-mi5v6512	65	1	TAK-003	tak-003	IN
cord-304472-mi5v6512	65	2	Takeda	Takeda	NNP
cord-304472-mi5v6512	65	3	's	's	POS
cord-304472-mi5v6512	65	4	live	live	RB
cord-304472-mi5v6512	65	5	-	-	HYPH
cord-304472-mi5v6512	65	6	attenuated	attenuated	JJ
cord-304472-mi5v6512	65	7	tetravalent	tetravalent	NN
cord-304472-mi5v6512	65	8	dengue	dengue	NN
cord-304472-mi5v6512	65	9	vaccine	vaccine	NN
cord-304472-mi5v6512	65	10	candidate	candidate	NN
cord-304472-mi5v6512	65	11	comprises	comprise	VBZ
cord-304472-mi5v6512	65	12	an	an	DT
cord-304472-mi5v6512	65	13	attenuated	attenuated	JJ
cord-304472-mi5v6512	65	14	DENV-2	DENV-2	NNP
cord-304472-mi5v6512	65	15	strain	strain	NN
cord-304472-mi5v6512	65	16	plus	plus	CC
cord-304472-mi5v6512	65	17	chimeric	chimeric	JJ
cord-304472-mi5v6512	65	18	viruses	virus	NNS
cord-304472-mi5v6512	65	19	containing	contain	VBG
cord-304472-mi5v6512	65	20	the	the	DT
cord-304472-mi5v6512	65	21	prM	prm	JJ
cord-304472-mi5v6512	65	22	and	and	CC
cord-304472-mi5v6512	65	23	E	e	NN
cord-304472-mi5v6512	65	24	genes	gene	NNS
cord-304472-mi5v6512	65	25	of	of	IN
cord-304472-mi5v6512	65	26	DENV-1	DENV-1	NNS
cord-304472-mi5v6512	65	27	,	,	,
cord-304472-mi5v6512	65	28	DENV-3	denv-3	NN
cord-304472-mi5v6512	65	29	and	and	CC
cord-304472-mi5v6512	65	30	DENV-4	DENV-4	NNP
cord-304472-mi5v6512	65	31	cloned	clone	VBD
cord-304472-mi5v6512	65	32	into	into	IN
cord-304472-mi5v6512	65	33	the	the	DT
cord-304472-mi5v6512	65	34	attenuated	attenuated	JJ
cord-304472-mi5v6512	65	35	DENV-2	DENV-2	NNP
cord-304472-mi5v6512	65	36	'	'	POS
cord-304472-mi5v6512	65	37	backbone	backbone	NN
cord-304472-mi5v6512	65	38	'	'	''
cord-304472-mi5v6512	65	39	[	[	-LRB-
cord-304472-mi5v6512	65	40	31	31	CD
cord-304472-mi5v6512	65	41	]	]	-RRB-
cord-304472-mi5v6512	65	42	.	.	.
cord-304472-mi5v6512	66	1	The	the	DT
cord-304472-mi5v6512	66	2	difference	difference	NN
cord-304472-mi5v6512	66	3	to	to	IN
cord-304472-mi5v6512	66	4	Dengvaxia	Dengvaxia	NNP
cord-304472-mi5v6512	66	5	therefore	therefore	RB
cord-304472-mi5v6512	66	6	is	be	VBZ
cord-304472-mi5v6512	66	7	the	the	DT
cord-304472-mi5v6512	66	8	presence	presence	NN
cord-304472-mi5v6512	66	9	of	of	IN
cord-304472-mi5v6512	66	10	non	non	JJ
cord-304472-mi5v6512	66	11	-	-	JJ
cord-304472-mi5v6512	66	12	structural	structural	JJ
cord-304472-mi5v6512	66	13	proteins	protein	NNS
cord-304472-mi5v6512	66	14	due	due	JJ
cord-304472-mi5v6512	66	15	to	to	IN
cord-304472-mi5v6512	66	16	the	the	DT
cord-304472-mi5v6512	66	17	DENV2	denv2	NN
cord-304472-mi5v6512	66	18	backbone	backbone	NN
cord-304472-mi5v6512	66	19	.	.	.
cord-304472-mi5v6512	67	1	TAD-003	TAD-003	NNP
cord-304472-mi5v6512	67	2	induces	induce	VBZ
cord-304472-mi5v6512	67	3	crossreactive	crossreactive	NNP
cord-304472-mi5v6512	67	4	T	T	NNP
cord-304472-mi5v6512	67	5	cell	cell	NN
cord-304472-mi5v6512	67	6	-	-	HYPH
cord-304472-mi5v6512	67	7	mediated	mediate	VBN
cord-304472-mi5v6512	67	8	responses	response	NNS
cord-304472-mi5v6512	67	9	that	that	WDT
cord-304472-mi5v6512	67	10	may	may	MD
cord-304472-mi5v6512	67	11	be	be	VB
cord-304472-mi5v6512	67	12	necessary	necessary	JJ
cord-304472-mi5v6512	67	13	for	for	IN
cord-304472-mi5v6512	67	14	broad	broad	JJ
cord-304472-mi5v6512	67	15	protection	protection	NN
cord-304472-mi5v6512	67	16	against	against	IN
cord-304472-mi5v6512	67	17	dengue	dengue	NN
cord-304472-mi5v6512	67	18	fever	fever	NN
cord-304472-mi5v6512	67	19	[	[	-LRB-
cord-304472-mi5v6512	67	20	31	31	CD
cord-304472-mi5v6512	67	21	,	,	,
cord-304472-mi5v6512	67	22	32	32	CD
cord-304472-mi5v6512	67	23	]	]	-RRB-
cord-304472-mi5v6512	67	24	.	.	.
cord-304472-mi5v6512	68	1	In	in	IN
cord-304472-mi5v6512	68	2	agreement	agreement	NN
cord-304472-mi5v6512	68	3	with	with	IN
cord-304472-mi5v6512	68	4	WHO	who	WP
cord-304472-mi5v6512	68	5	's	's	POS
cord-304472-mi5v6512	68	6	prequalification	prequalification	NN
cord-304472-mi5v6512	68	7	requirements	requirement	NNS
cord-304472-mi5v6512	68	8	for	for	IN
cord-304472-mi5v6512	68	9	dengue	dengue	NN
cord-304472-mi5v6512	68	10	vaccines	vaccine	NNS
cord-304472-mi5v6512	68	11	,	,	,
cord-304472-mi5v6512	68	12	Takeda	Takeda	NNP
cord-304472-mi5v6512	68	13	has	have	VBZ
cord-304472-mi5v6512	68	14	manufactured	manufacture	VBN
cord-304472-mi5v6512	68	15	a	a	DT
cord-304472-mi5v6512	68	16	lyophilized	lyophilized	JJ
cord-304472-mi5v6512	68	17	formulation	formulation	NN
cord-304472-mi5v6512	68	18	of	of	IN
cord-304472-mi5v6512	68	19	TAK-003	tak-003	NN
cord-304472-mi5v6512	68	20	that	that	WDT
cord-304472-mi5v6512	68	21	allows	allow	VBZ
cord-304472-mi5v6512	68	22	stable	stable	JJ
cord-304472-mi5v6512	68	23	storage	storage	NN
cord-304472-mi5v6512	68	24	at	at	IN
cord-304472-mi5v6512	68	25	+2	+2	HYPH
cord-304472-mi5v6512	68	26	degrees	degree	NNS
cord-304472-mi5v6512	68	27	C	c	NN
cord-304472-mi5v6512	68	28	to	to	IN
cord-304472-mi5v6512	68	29	+8	+8	CD
cord-304472-mi5v6512	68	30	degrees	degree	NNS
cord-304472-mi5v6512	68	31	C.	c.	NN
cord-304472-mi5v6512	69	1	In	in	IN
cord-304472-mi5v6512	69	2	a	a	DT
cord-304472-mi5v6512	69	3	randomized	randomized	JJ
cord-304472-mi5v6512	69	4	,	,	,
cord-304472-mi5v6512	69	5	doubleblind	doubleblind	NN
cord-304472-mi5v6512	69	6	,	,	,
cord-304472-mi5v6512	69	7	phase	phase	NN
cord-304472-mi5v6512	69	8	2	2	CD
cord-304472-mi5v6512	69	9	study	study	NN
cord-304472-mi5v6512	69	10	(	(	-LRB-
cord-304472-mi5v6512	69	11	NCT02193087	NCT02193087	NNP
cord-304472-mi5v6512	69	12	)	)	-RRB-
cord-304472-mi5v6512	69	13	in	in	IN
cord-304472-mi5v6512	69	14	1002	1002	CD
cord-304472-mi5v6512	69	15	healthy	healthy	JJ
cord-304472-mi5v6512	69	16	dengue	dengue	NN
cord-304472-mi5v6512	69	17	-	-	HYPH
cord-304472-mi5v6512	69	18	naive	naive	JJ
cord-304472-mi5v6512	69	19	adults	adult	NNS
cord-304472-mi5v6512	69	20	,	,	,
cord-304472-mi5v6512	69	21	18	18	CD
cord-304472-mi5v6512	69	22	-	-	SYM
cord-304472-mi5v6512	69	23	49	49	CD
cord-304472-mi5v6512	69	24	years	year	NNS
cord-304472-mi5v6512	69	25	of	of	IN
cord-304472-mi5v6512	69	26	age	age	NN
cord-304472-mi5v6512	69	27	,	,	,
cord-304472-mi5v6512	69	28	GMTs	gmt	NNS
cord-304472-mi5v6512	69	29	and	and	CC
cord-304472-mi5v6512	69	30	seropositivity	seropositivity	NN
cord-304472-mi5v6512	69	31	rates	rate	NNS
cord-304472-mi5v6512	69	32	to	to	IN
cord-304472-mi5v6512	69	33	all	all	DT
cord-304472-mi5v6512	69	34	four	four	CD
cord-304472-mi5v6512	69	35	serotypes	serotype	NNS
cord-304472-mi5v6512	69	36	were	be	VBD
cord-304472-mi5v6512	69	37	achieved	achieve	VBN
cord-304472-mi5v6512	69	38	[	[	-LRB-
cord-304472-mi5v6512	69	39	33	33	CD
cord-304472-mi5v6512	69	40	]	]	-RRB-
cord-304472-mi5v6512	69	41	.	.	.
cord-304472-mi5v6512	70	1	A	a	DT
cord-304472-mi5v6512	70	2	Multi	multi	JJ
cord-304472-mi5v6512	70	3	-	-	JJ
cord-304472-mi5v6512	70	4	Color	color	NN
cord-304472-mi5v6512	70	5	FluoroSpot	FluoroSpot	NNP
cord-304472-mi5v6512	70	6	(	(	-LRB-
cord-304472-mi5v6512	70	7	MCF	MCF	NNP
cord-304472-mi5v6512	70	8	)	)	-RRB-
cord-304472-mi5v6512	70	9	assay	assay	NN
cord-304472-mi5v6512	70	10	enabled	enable	VBD
cord-304472-mi5v6512	70	11	quantitation	quantitation	NN
cord-304472-mi5v6512	70	12	of	of	IN
cord-304472-mi5v6512	70	13	serotype	serotype	NN
cord-304472-mi5v6512	70	14	-	-	HYPH
cord-304472-mi5v6512	70	15	specific	specific	JJ
cord-304472-mi5v6512	70	16	and	and	CC
cord-304472-mi5v6512	70	17	cross	cross	JJ
cord-304472-mi5v6512	70	18	-	-	JJ
cord-304472-mi5v6512	70	19	reactive	reactive	JJ
cord-304472-mi5v6512	70	20	individual	individual	JJ
cord-304472-mi5v6512	70	21	memory	memory	NN
cord-304472-mi5v6512	70	22	B	b	NN
cord-304472-mi5v6512	70	23	cells	cell	NNS
cord-304472-mi5v6512	70	24	(	(	-LRB-
cord-304472-mi5v6512	70	25	MBCs	mbc	NNS
cord-304472-mi5v6512	70	26	)	)	-RRB-
cord-304472-mi5v6512	70	27	secreting	secrete	VBG
cord-304472-mi5v6512	70	28	DENV	denv	NN
cord-304472-mi5v6512	70	29	-	-	HYPH
cord-304472-mi5v6512	70	30	specific	specific	JJ
cord-304472-mi5v6512	70	31	antibodies	antibody	NNS
cord-304472-mi5v6512	70	32	in	in	IN
cord-304472-mi5v6512	70	33	a	a	DT
cord-304472-mi5v6512	70	34	polyclonal	polyclonal	JJ
cord-304472-mi5v6512	70	35	mixture	mixture	NN
cord-304472-mi5v6512	70	36	[	[	-LRB-
cord-304472-mi5v6512	70	37	34	34	CD
cord-304472-mi5v6512	70	38	]	]	-RRB-
cord-304472-mi5v6512	70	39	.	.	.
cord-304472-mi5v6512	71	1	Using	use	VBG
cord-304472-mi5v6512	71	2	the	the	DT
cord-304472-mi5v6512	71	3	MCF	MCF	NNP
cord-304472-mi5v6512	71	4	assay	assay	NN
cord-304472-mi5v6512	71	5	,	,	,
cord-304472-mi5v6512	71	6	type	type	NN
cord-304472-mi5v6512	71	7	-	-	HYPH
cord-304472-mi5v6512	71	8	specific	specific	JJ
cord-304472-mi5v6512	71	9	and	and	CC
cord-304472-mi5v6512	71	10	cross	cross	JJ
cord-304472-mi5v6512	71	11	-	-	JJ
cord-304472-mi5v6512	71	12	reactive	reactive	JJ
cord-304472-mi5v6512	71	13	MBC	MBC	NNP
cord-304472-mi5v6512	71	14	responses	response	NNS
cord-304472-mi5v6512	71	15	were	be	VBD
cord-304472-mi5v6512	71	16	investigated	investigate	VBN
cord-304472-mi5v6512	71	17	;	;	:
cord-304472-mi5v6512	71	18	the	the	DT
cord-304472-mi5v6512	71	19	results	result	NNS
cord-304472-mi5v6512	71	20	demonstrate	demonstrate	VBP
cord-304472-mi5v6512	71	21	that	that	IN
cord-304472-mi5v6512	71	22	,	,	,
cord-304472-mi5v6512	71	23	unlike	unlike	IN
cord-304472-mi5v6512	71	24	primary	primary	JJ
cord-304472-mi5v6512	71	25	or	or	CC
cord-304472-mi5v6512	71	26	secondary	secondary	JJ
cord-304472-mi5v6512	71	27	natural	natural	JJ
cord-304472-mi5v6512	71	28	DENV	DENV	NNP
cord-304472-mi5v6512	71	29	infection	infection	NN
cord-304472-mi5v6512	71	30	,	,	,
cord-304472-mi5v6512	71	31	tetravalent	tetravalent	NN
cord-304472-mi5v6512	71	32	vaccination	vaccination	NN
cord-304472-mi5v6512	71	33	elicits	elicit	VBZ
cord-304472-mi5v6512	71	34	tetravalent	tetravalent	NN
cord-304472-mi5v6512	71	35	type	type	NN
cord-304472-mi5v6512	71	36	-	-	HYPH
cord-304472-mi5v6512	71	37	specific	specific	JJ
cord-304472-mi5v6512	71	38	MBCs	mbc	NNS
cord-304472-mi5v6512	71	39	,	,	,
cord-304472-mi5v6512	71	40	and	and	CC
cord-304472-mi5v6512	71	41	thus	thus	RB
cord-304472-mi5v6512	71	42	all	all	DT
cord-304472-mi5v6512	71	43	four	four	CD
cord-304472-mi5v6512	71	44	components	component	NNS
cord-304472-mi5v6512	71	45	of	of	IN
cord-304472-mi5v6512	71	46	TAK-003	tak-003	NN
cord-304472-mi5v6512	71	47	contribute	contribute	VB
cord-304472-mi5v6512	71	48	to	to	IN
cord-304472-mi5v6512	71	49	the	the	DT
cord-304472-mi5v6512	71	50	DENV	DENV	NNP
cord-304472-mi5v6512	71	51	-	-	HYPH
cord-304472-mi5v6512	71	52	specific	specific	JJ
cord-304472-mi5v6512	71	53	MBC	MBC	NNP
cord-304472-mi5v6512	71	54	response	response	NN
cord-304472-mi5v6512	71	55	following	follow	VBG
cord-304472-mi5v6512	71	56	vaccination	vaccination	NN
cord-304472-mi5v6512	71	57	[	[	-LRB-
cord-304472-mi5v6512	71	58	33	33	CD
cord-304472-mi5v6512	71	59	]	]	-RRB-
cord-304472-mi5v6512	71	60	.	.	.
cord-304472-mi5v6512	72	1	The	the	DT
cord-304472-mi5v6512	72	2	Phase	phase	NN
cord-304472-mi5v6512	72	3	2	2	CD
cord-304472-mi5v6512	72	4	trials	trial	NNS
cord-304472-mi5v6512	72	5	on	on	IN
cord-304472-mi5v6512	72	6	immunogenicity	immunogenicity	NN
cord-304472-mi5v6512	72	7	showed	show	VBD
cord-304472-mi5v6512	72	8	that	that	IN
cord-304472-mi5v6512	72	9	geometric	geometric	JJ
cord-304472-mi5v6512	72	10	mean	mean	NN
cord-304472-mi5v6512	72	11	titers	titer	NNS
cord-304472-mi5v6512	72	12	(	(	-LRB-
cord-304472-mi5v6512	72	13	GMTs	gmt	NNS
cord-304472-mi5v6512	72	14	)	)	-RRB-
cord-304472-mi5v6512	72	15	against	against	IN
cord-304472-mi5v6512	72	16	DENV	DENV	NNP
cord-304472-mi5v6512	72	17	1	1	CD
cord-304472-mi5v6512	72	18	,	,	,
cord-304472-mi5v6512	72	19	DENV	DENV	NNP
cord-304472-mi5v6512	72	20	3	3	CD
cord-304472-mi5v6512	72	21	,	,	,
cord-304472-mi5v6512	72	22	and	and	CC
cord-304472-mi5v6512	72	23	DENV	DENV	NNP
cord-304472-mi5v6512	72	24	4	4	CD
cord-304472-mi5v6512	72	25	were	be	VBD
cord-304472-mi5v6512	72	26	lower	low	JJR
cord-304472-mi5v6512	72	27	in	in	IN
cord-304472-mi5v6512	72	28	participants	participant	NNS
cord-304472-mi5v6512	72	29	who	who	WP
cord-304472-mi5v6512	72	30	were	be	VBD
cord-304472-mi5v6512	72	31	seronegative	seronegative	JJ
cord-304472-mi5v6512	72	32	and	and	CC
cord-304472-mi5v6512	72	33	receiving	receive	VBG
cord-304472-mi5v6512	72	34	one	one	CD
cord-304472-mi5v6512	72	35	primary	primary	JJ
cord-304472-mi5v6512	72	36	dose	dose	NN
cord-304472-mi5v6512	72	37	than	than	IN
cord-304472-mi5v6512	72	38	in	in	IN
cord-304472-mi5v6512	72	39	those	those	DT
cord-304472-mi5v6512	72	40	who	who	WP
cord-304472-mi5v6512	72	41	received	receive	VBD
cord-304472-mi5v6512	72	42	the	the	DT
cord-304472-mi5v6512	72	43	two	two	CD
cord-304472-mi5v6512	72	44	-	-	HYPH
cord-304472-mi5v6512	72	45	dose	dose	NN
cord-304472-mi5v6512	72	46	primary	primary	JJ
cord-304472-mi5v6512	72	47	series	series	NN
cord-304472-mi5v6512	72	48	or	or	CC
cord-304472-mi5v6512	72	49	one	one	CD
cord-304472-mi5v6512	72	50	primary	primary	JJ
cord-304472-mi5v6512	72	51	dose	dose	NN
cord-304472-mi5v6512	72	52	plus	plus	CC
cord-304472-mi5v6512	72	53	a	a	DT
cord-304472-mi5v6512	72	54	1-year	1-year	CD
cord-304472-mi5v6512	72	55	booster	booster	NN
cord-304472-mi5v6512	72	56	[	[	-LRB-
cord-304472-mi5v6512	72	57	30	30	CD
cord-304472-mi5v6512	72	58	]	]	-RRB-
cord-304472-mi5v6512	72	59	.	.	.
cord-304472-mi5v6512	73	1	These	these	DT
cord-304472-mi5v6512	73	2	immunogenicity	immunogenicity	NN
cord-304472-mi5v6512	73	3	results	result	NNS
cord-304472-mi5v6512	73	4	suggested	suggest	VBD
cord-304472-mi5v6512	73	5	that	that	IN
cord-304472-mi5v6512	73	6	Phase	phase	NN
cord-304472-mi5v6512	73	7	3	3	CD
cord-304472-mi5v6512	73	8	trials	trial	NNS
cord-304472-mi5v6512	73	9	should	should	MD
cord-304472-mi5v6512	73	10	be	be	VB
cord-304472-mi5v6512	73	11	conducted	conduct	VBN
cord-304472-mi5v6512	73	12	with	with	IN
cord-304472-mi5v6512	73	13	a	a	DT
cord-304472-mi5v6512	73	14	two	two	CD
cord-304472-mi5v6512	73	15	dose	dose	JJ
cord-304472-mi5v6512	73	16	regimen	regimen	NN
cord-304472-mi5v6512	73	17	to	to	TO
cord-304472-mi5v6512	73	18	improve	improve	VB
cord-304472-mi5v6512	73	19	immunogenicity	immunogenicity	NN
cord-304472-mi5v6512	73	20	in	in	IN
cord-304472-mi5v6512	73	21	seronegative	seronegative	JJ
cord-304472-mi5v6512	73	22	individuals	individual	NNS
cord-304472-mi5v6512	73	23	.	.	.
cord-304472-mi5v6512	74	1	At	at	IN
cord-304472-mi5v6512	74	2	Month	month	NN
cord-304472-mi5v6512	74	3	36	36	CD
cord-304472-mi5v6512	74	4	,	,	,
cord-304472-mi5v6512	74	5	seropositivity	seropositivity	NN
cord-304472-mi5v6512	74	6	rates	rate	NNS
cord-304472-mi5v6512	74	7	were	be	VBD
cord-304472-mi5v6512	74	8	97.3	97.3	CD
cord-304472-mi5v6512	74	9	%	%	NN
cord-304472-mi5v6512	74	10	,	,	,
cord-304472-mi5v6512	74	11	98.7	98.7	CD
cord-304472-mi5v6512	74	12	%	%	NN
cord-304472-mi5v6512	74	13	,	,	,
cord-304472-mi5v6512	74	14	88.0	88.0	CD
cord-304472-mi5v6512	74	15	%	%	NN
cord-304472-mi5v6512	74	16	and	and	CC
cord-304472-mi5v6512	74	17	56.0	56.0	CD
cord-304472-mi5v6512	74	18	%	%	NN
cord-304472-mi5v6512	74	19	for	for	IN
cord-304472-mi5v6512	74	20	DENV-1	DENV-1	NNS
cord-304472-mi5v6512	74	21	,	,	,
cord-304472-mi5v6512	74	22	DENV-2	DENV-2	NNP
cord-304472-mi5v6512	74	23	,	,	,
cord-304472-mi5v6512	74	24	DENV-3	denv-3	NN
cord-304472-mi5v6512	74	25	and	and	CC
cord-304472-mi5v6512	74	26	DENV-4	DENV-4	NNP
cord-304472-mi5v6512	74	27	,	,	,
cord-304472-mi5v6512	74	28	respectively	respectively	RB
cord-304472-mi5v6512	74	29	[	[	-LRB-
cord-304472-mi5v6512	74	30	35	35	CD
cord-304472-mi5v6512	74	31	]	]	-RRB-
cord-304472-mi5v6512	74	32	.	.	.
cord-304472-mi5v6512	75	1	A	a	DT
cord-304472-mi5v6512	75	2	Phase	phase	NN
cord-304472-mi5v6512	75	3	3	3	CD
cord-304472-mi5v6512	75	4	trial	trial	NN
cord-304472-mi5v6512	75	5	in	in	IN
cord-304472-mi5v6512	75	6	more	more	JJR
cord-304472-mi5v6512	75	7	than	than	IN
cord-304472-mi5v6512	75	8	20	20	CD
cord-304472-mi5v6512	75	9	000	000	CD
cord-304472-mi5v6512	75	10	healthy	healthy	JJ
cord-304472-mi5v6512	75	11	children	child	NNS
cord-304472-mi5v6512	75	12	and	and	CC
cord-304472-mi5v6512	75	13	adolescents	adolescent	NNS
cord-304472-mi5v6512	75	14	4	4	CD
cord-304472-mi5v6512	75	15	-	-	SYM
cord-304472-mi5v6512	75	16	16	16	CD
cord-304472-mi5v6512	75	17	years	year	NNS
cord-304472-mi5v6512	75	18	of	of	IN
cord-304472-mi5v6512	75	19	age	age	NN
cord-304472-mi5v6512	75	20	to	to	TO
cord-304472-mi5v6512	75	21	receive	receive	VB
cord-304472-mi5v6512	75	22	two	two	CD
cord-304472-mi5v6512	75	23	doses	dose	NNS
cord-304472-mi5v6512	75	24	of	of	IN
cord-304472-mi5v6512	75	25	vaccine	vaccine	NN
cord-304472-mi5v6512	75	26	or	or	CC
cord-304472-mi5v6512	75	27	placebo	placebo	NN
cord-304472-mi5v6512	75	28	is	be	VBZ
cord-304472-mi5v6512	75	29	currently	currently	RB
cord-304472-mi5v6512	75	30	being	be	VBG
cord-304472-mi5v6512	75	31	conducted	conduct	VBN
cord-304472-mi5v6512	75	32	in	in	IN
cord-304472-mi5v6512	75	33	8	8	CD
cord-304472-mi5v6512	75	34	countries	country	NNS
cord-304472-mi5v6512	75	35	in	in	IN
cord-304472-mi5v6512	75	36	Asia	Asia	NNP
cord-304472-mi5v6512	75	37	and	and	CC
cord-304472-mi5v6512	75	38	Latin	Latin	NNP
cord-304472-mi5v6512	75	39	America	America	NNP
cord-304472-mi5v6512	75	40	.	.	.
cord-304472-mi5v6512	76	1	In	in	IN
cord-304472-mi5v6512	76	2	summary	summary	NN
cord-304472-mi5v6512	76	3	,	,	,
cord-304472-mi5v6512	76	4	although	although	IN
cord-304472-mi5v6512	76	5	the	the	DT
cord-304472-mi5v6512	76	6	Takeda	Takeda	NNP
cord-304472-mi5v6512	76	7	vaccine	vaccine	NN
cord-304472-mi5v6512	76	8	appears	appear	VBZ
cord-304472-mi5v6512	76	9	much	much	RB
cord-304472-mi5v6512	76	10	less	less	JJR
cord-304472-mi5v6512	76	11	serostatus	serostatus	NN
cord-304472-mi5v6512	76	12	dependent	dependent	JJ
cord-304472-mi5v6512	76	13	compared	compare	VBN
cord-304472-mi5v6512	76	14	with	with	IN
cord-304472-mi5v6512	77	1	CYD	CYD	NNP
cord-304472-mi5v6512	77	2	-	-	HYPH
cord-304472-mi5v6512	77	3	TDV	TDV	NNP
cord-304472-mi5v6512	77	4	and	and	CC
cord-304472-mi5v6512	77	5	efficacy	efficacy	NN
cord-304472-mi5v6512	77	6	data	datum	NNS
cord-304472-mi5v6512	77	7	look	look	VBP
cord-304472-mi5v6512	77	8	promising	promising	JJ
cord-304472-mi5v6512	77	9	,	,	,
cord-304472-mi5v6512	77	10	some	some	DT
cord-304472-mi5v6512	77	11	complex	complex	JJ
cord-304472-mi5v6512	77	12	nuances	nuance	NNS
cord-304472-mi5v6512	77	13	for	for	IN
cord-304472-mi5v6512	77	14	serotypes	serotypes	NN
cord-304472-mi5v6512	77	15	3	3	CD
cord-304472-mi5v6512	77	16	and	and	CC
cord-304472-mi5v6512	77	17	4	4	CD
cord-304472-mi5v6512	77	18	will	will	MD
cord-304472-mi5v6512	77	19	require	require	VB
cord-304472-mi5v6512	77	20	extended	extended	JJ
cord-304472-mi5v6512	77	21	follow	follow	NN
cord-304472-mi5v6512	77	22	-	-	HYPH
cord-304472-mi5v6512	77	23	up	up	NN
cord-304472-mi5v6512	77	24	,	,	,
cord-304472-mi5v6512	77	25	and	and	CC
cord-304472-mi5v6512	77	26	careful	careful	JJ
cord-304472-mi5v6512	77	27	balancing	balancing	NN
cord-304472-mi5v6512	77	28	by	by	IN
cord-304472-mi5v6512	77	29	regulators	regulator	NNS
cord-304472-mi5v6512	77	30	and	and	CC
cord-304472-mi5v6512	77	31	policy	policy	NN
cord-304472-mi5v6512	77	32	makers	maker	NNS
cord-304472-mi5v6512	77	33	in	in	IN
cord-304472-mi5v6512	77	34	determining	determine	VBG
cord-304472-mi5v6512	77	35	the	the	DT
cord-304472-mi5v6512	77	36	potential	potential	JJ
cord-304472-mi5v6512	77	37	utility	utility	NN
cord-304472-mi5v6512	77	38	and	and	CC
cord-304472-mi5v6512	77	39	safety	safety	NN
cord-304472-mi5v6512	77	40	of	of	IN
cord-304472-mi5v6512	77	41	this	this	DT
cord-304472-mi5v6512	77	42	vaccine	vaccine	NN
cord-304472-mi5v6512	77	43	[	[	-LRB-
cord-304472-mi5v6512	77	44	30	30	CD
cord-304472-mi5v6512	77	45	]	]	-RRB-
cord-304472-mi5v6512	77	46	.	.	.
cord-304472-mi5v6512	78	1	(	(	-LRB-
cord-304472-mi5v6512	78	2	2	2	LS
cord-304472-mi5v6512	78	3	)	)	-RRB-
cord-304472-mi5v6512	79	1	National	National	NNP
cord-304472-mi5v6512	79	2	institute	institute	NNP
cord-304472-mi5v6512	79	3	of	of	IN
cord-304472-mi5v6512	79	4	allergy	allergy	NNP
cord-304472-mi5v6512	79	5	and	and	CC
cord-304472-mi5v6512	79	6	infectious	infectious	JJ
cord-304472-mi5v6512	79	7	diseases	disease	NNS
cord-304472-mi5v6512	80	1	(	(	-LRB-
cord-304472-mi5v6512	80	2	TV003	TV003	NNP
cord-304472-mi5v6512	80	3	/	/	,
cord-304472-mi5v6512	80	4	TV005)/Butantan	TV005)/Butantan	NNP
cord-304472-mi5v6512	81	1	This	this	DT
cord-304472-mi5v6512	81	2	vaccine	vaccine	NN
cord-304472-mi5v6512	81	3	comprises	comprise	VBZ
cord-304472-mi5v6512	81	4	3	3	CD
cord-304472-mi5v6512	81	5	full	full	JJ
cord-304472-mi5v6512	81	6	-	-	HYPH
cord-304472-mi5v6512	81	7	length	length	NN
cord-304472-mi5v6512	81	8	DENV	DENV	NNS
cord-304472-mi5v6512	81	9	attenuated	attenuate	VBN
cord-304472-mi5v6512	81	10	by	by	IN
cord-304472-mi5v6512	81	11	one	one	CD
cord-304472-mi5v6512	81	12	or	or	CC
cord-304472-mi5v6512	81	13	more	more	JJR
cord-304472-mi5v6512	81	14	deletions	deletion	NNS
cord-304472-mi5v6512	81	15	in	in	IN
cord-304472-mi5v6512	81	16	the	the	DT
cord-304472-mi5v6512	81	17	3	3	CD
cord-304472-mi5v6512	81	18	0	0	CD
cord-304472-mi5v6512	81	19	untranslated	untranslated	JJ
cord-304472-mi5v6512	81	20	region	region	NN
cord-304472-mi5v6512	81	21	,	,	,
cord-304472-mi5v6512	81	22	while	while	IN
cord-304472-mi5v6512	81	23	the	the	DT
cord-304472-mi5v6512	81	24	fourth	fourth	JJ
cord-304472-mi5v6512	81	25	component	component	NN
cord-304472-mi5v6512	81	26	is	be	VBZ
cord-304472-mi5v6512	81	27	a	a	DT
cord-304472-mi5v6512	81	28	chimeric	chimeric	JJ
cord-304472-mi5v6512	81	29	virus	virus	NN
cord-304472-mi5v6512	81	30	in	in	IN
cord-304472-mi5v6512	81	31	which	which	WDT
cord-304472-mi5v6512	81	32	the	the	DT
cord-304472-mi5v6512	81	33	prM	prm	JJ
cord-304472-mi5v6512	81	34	and	and	CC
cord-304472-mi5v6512	81	35	E	e	NN
cord-304472-mi5v6512	81	36	proteins	protein	NNS
cord-304472-mi5v6512	81	37	of	of	IN
cord-304472-mi5v6512	81	38	DENV-2	DENV-2	NNP
cord-304472-mi5v6512	81	39	replace	replace	VBP
cord-304472-mi5v6512	81	40	those	those	DT
cord-304472-mi5v6512	81	41	of	of	IN
cord-304472-mi5v6512	81	42	DENV-4	DENV-4	NNP
cord-304472-mi5v6512	81	43	in	in	IN
cord-304472-mi5v6512	81	44	the	the	DT
cord-304472-mi5v6512	81	45	DEN4D30	den4d30	CD
cord-304472-mi5v6512	81	46	background	background	NN
cord-304472-mi5v6512	81	47	[	[	-LRB-
cord-304472-mi5v6512	81	48	38	38	CD
cord-304472-mi5v6512	81	49	]	]	-RRB-
cord-304472-mi5v6512	81	50	.	.	.
cord-304472-mi5v6512	82	1	Thus	thus	RB
cord-304472-mi5v6512	82	2	,	,	,
cord-304472-mi5v6512	82	3	this	this	DT
cord-304472-mi5v6512	82	4	vaccine	vaccine	NN
cord-304472-mi5v6512	82	5	carries	carry	VBZ
cord-304472-mi5v6512	82	6	the	the	DT
cord-304472-mi5v6512	82	7	full	full	JJ
cord-304472-mi5v6512	82	8	-	-	HYPH
cord-304472-mi5v6512	82	9	genomic	genomic	JJ
cord-304472-mi5v6512	82	10	backbone	backbone	NN
cord-304472-mi5v6512	82	11	of	of	IN
cord-304472-mi5v6512	82	12	three	three	CD
cord-304472-mi5v6512	82	13	dengue	dengue	NN
cord-304472-mi5v6512	82	14	serotypes	serotype	NNS
cord-304472-mi5v6512	82	15	,	,	,
cord-304472-mi5v6512	82	16	except	except	IN
cord-304472-mi5v6512	82	17	for	for	IN
cord-304472-mi5v6512	82	18	DENV2	denv2	NN
cord-304472-mi5v6512	82	19	.	.	.
cord-304472-mi5v6512	83	1	The	the	DT
cord-304472-mi5v6512	83	2	capacity	capacity	NN
cord-304472-mi5v6512	83	3	to	to	TO
cord-304472-mi5v6512	83	4	elicit	elicit	VB
cord-304472-mi5v6512	83	5	CD4	CD4	NNP
cord-304472-mi5v6512	83	6	+	+	CC
cord-304472-mi5v6512	83	7	cell	cell	NN
cord-304472-mi5v6512	83	8	responses	response	NNS
cord-304472-mi5v6512	83	9	closely	closely	RB
cord-304472-mi5v6512	83	10	mirrors	mirror	NNS
cord-304472-mi5v6512	83	11	those	those	DT
cord-304472-mi5v6512	83	12	observed	observe	VBN
cord-304472-mi5v6512	83	13	in	in	IN
cord-304472-mi5v6512	83	14	a	a	DT
cord-304472-mi5v6512	83	15	population	population	NN
cord-304472-mi5v6512	83	16	associated	associate	VBN
cord-304472-mi5v6512	83	17	with	with	IN
cord-304472-mi5v6512	83	18	natural	natural	JJ
cord-304472-mi5v6512	83	19	immunity	immunity	NN
cord-304472-mi5v6512	83	20	[	[	-LRB-
cord-304472-mi5v6512	83	21	39	39	CD
cord-304472-mi5v6512	83	22	]	]	-RRB-
cord-304472-mi5v6512	83	23	.	.	.
cord-304472-mi5v6512	84	1	A	a	DT
cord-304472-mi5v6512	84	2	single	single	JJ
cord-304472-mi5v6512	84	3	-	-	HYPH
cord-304472-mi5v6512	84	4	dose	dose	NN
cord-304472-mi5v6512	84	5	induces	induce	VBZ
cord-304472-mi5v6512	84	6	robust	robust	JJ
cord-304472-mi5v6512	84	7	tetravalent	tetravalent	NN
cord-304472-mi5v6512	84	8	antibody	antibody	NN
cord-304472-mi5v6512	84	9	and	and	CC
cord-304472-mi5v6512	84	10	cellular	cellular	JJ
cord-304472-mi5v6512	84	11	T	t	NN
cord-304472-mi5v6512	84	12	cell	cell	NN
cord-304472-mi5v6512	84	13	responses	response	NNS
cord-304472-mi5v6512	84	14	and	and	CC
cord-304472-mi5v6512	84	15	resulted	result	VBD
cord-304472-mi5v6512	84	16	in	in	IN
cord-304472-mi5v6512	84	17	a	a	DT
cord-304472-mi5v6512	84	18	100	100	CD
cord-304472-mi5v6512	84	19	%	%	NN
cord-304472-mi5v6512	84	20	efficacy	efficacy	NN
cord-304472-mi5v6512	84	21	in	in	IN
cord-304472-mi5v6512	84	22	a	a	DT
cord-304472-mi5v6512	84	23	human	human	JJ
cord-304472-mi5v6512	84	24	challenge	challenge	NN
cord-304472-mi5v6512	84	25	study	study	NN
cord-304472-mi5v6512	84	26	[	[	-LRB-
cord-304472-mi5v6512	84	27	40	40	CD
cord-304472-mi5v6512	84	28	]	]	-RRB-
cord-304472-mi5v6512	84	29	.	.	.
cord-304472-mi5v6512	85	1	Developed	develop	VBN
cord-304472-mi5v6512	85	2	by	by	IN
cord-304472-mi5v6512	85	3	the	the	DT
cord-304472-mi5v6512	85	4	U.S.	U.S.	NNP
cord-304472-mi5v6512	85	5	National	National	NNP
cord-304472-mi5v6512	85	6	Institutes	Institutes	NNPS
cord-304472-mi5v6512	85	7	of	of	IN
cord-304472-mi5v6512	85	8	Health	Health	NNP
cord-304472-mi5v6512	85	9	(	(	-LRB-
cord-304472-mi5v6512	85	10	NIH	NIH	NNP
cord-304472-mi5v6512	85	11	/	/	SYM
cord-304472-mi5v6512	85	12	NIAID	NIAID	NNP
cord-304472-mi5v6512	85	13	)	)	-RRB-
cord-304472-mi5v6512	85	14	,	,	,
cord-304472-mi5v6512	85	15	it	-PRON-	PRP
cord-304472-mi5v6512	85	16	is	be	VBZ
cord-304472-mi5v6512	85	17	currently	currently	RB
cord-304472-mi5v6512	85	18	in	in	IN
cord-304472-mi5v6512	85	19	a	a	DT
cord-304472-mi5v6512	85	20	Phase	phase	NN
cord-304472-mi5v6512	85	21	3	3	CD
cord-304472-mi5v6512	85	22	trial	trial	NN
cord-304472-mi5v6512	85	23	in	in	IN
cord-304472-mi5v6512	85	24	Brazil	Brazil	NNP
cord-304472-mi5v6512	85	25	through	through	IN
cord-304472-mi5v6512	85	26	Butantan	Butantan	NNP
cord-304472-mi5v6512	85	27	,	,	,
cord-304472-mi5v6512	85	28	but	but	CC
cord-304472-mi5v6512	85	29	was	be	VBD
cord-304472-mi5v6512	85	30	also	also	RB
cord-304472-mi5v6512	85	31	licensed	license	VBN
cord-304472-mi5v6512	85	32	to	to	IN
cord-304472-mi5v6512	85	33	Merck	Merck	NNP
cord-304472-mi5v6512	85	34	for	for	IN
cord-304472-mi5v6512	85	35	further	further	JJ
cord-304472-mi5v6512	85	36	development	development	NN
cord-304472-mi5v6512	85	37	outside	outside	IN
cord-304472-mi5v6512	85	38	of	of	IN
cord-304472-mi5v6512	85	39	Brazil	Brazil	NNP
cord-304472-mi5v6512	85	40	.	.	.
cord-304472-mi5v6512	86	1	The	the	DT
cord-304472-mi5v6512	86	2	Butantan	Butantan	NNP
cord-304472-mi5v6512	86	3	Institute	Institute	NNP
cord-304472-mi5v6512	86	4	has	have	VBZ
cord-304472-mi5v6512	86	5	Dengue	dengue	NN
cord-304472-mi5v6512	86	6	vaccine	vaccine	NN
cord-304472-mi5v6512	86	7	development	development	NN
cord-304472-mi5v6512	86	8	Wilder	Wilder	NNP
cord-304472-mi5v6512	86	9	-	-	HYPH
cord-304472-mi5v6512	86	10	Smith	Smith	NNP
cord-304472-mi5v6512	86	11	73	73	CD
cord-304472-mi5v6512	86	12	manufactured	manufacture	VBD
cord-304472-mi5v6512	86	13	a	a	DT
cord-304472-mi5v6512	86	14	lyophilized	lyophilized	JJ
cord-304472-mi5v6512	86	15	tetravalent	tetravalent	NN
cord-304472-mi5v6512	86	16	live	live	RB
cord-304472-mi5v6512	86	17	-	-	HYPH
cord-304472-mi5v6512	86	18	attenuated	attenuate	VBN
cord-304472-mi5v6512	86	19	dengue	dengue	NN
cord-304472-mi5v6512	86	20	vaccine	vaccine	NN
cord-304472-mi5v6512	86	21	Butantan	Butantan	NNP
cord-304472-mi5v6512	86	22	-	-	HYPH
cord-304472-mi5v6512	86	23	DV	DV	NNP
cord-304472-mi5v6512	86	24	,	,	,
cord-304472-mi5v6512	86	25	which	which	WDT
cord-304472-mi5v6512	86	26	is	be	VBZ
cord-304472-mi5v6512	86	27	analogous	analogous	JJ
cord-304472-mi5v6512	86	28	to	to	IN
cord-304472-mi5v6512	86	29	the	the	DT
cord-304472-mi5v6512	86	30	US	US	NNP
cord-304472-mi5v6512	86	31	National	National	NNP
cord-304472-mi5v6512	86	32	Institutes	Institutes	NNPS
cord-304472-mi5v6512	86	33	of	of	IN
cord-304472-mi5v6512	86	34	Health	Health	NNP
cord-304472-mi5v6512	86	35	(	(	-LRB-
cord-304472-mi5v6512	86	36	NIH	NIH	NNP
cord-304472-mi5v6512	86	37	)	)	-RRB-
cord-304472-mi5v6512	87	1	TV003	TV003	NNP
cord-304472-mi5v6512	87	2	admixture	admixture	NN
cord-304472-mi5v6512	87	3	[	[	-LRB-
cord-304472-mi5v6512	87	4	30	30	CD
cord-304472-mi5v6512	87	5	]	]	-RRB-
cord-304472-mi5v6512	87	6	.	.	.
cord-304472-mi5v6512	88	1	Seroconversion	seroconversion	NN
cord-304472-mi5v6512	88	2	appears	appear	VBZ
cord-304472-mi5v6512	88	3	to	to	TO
cord-304472-mi5v6512	88	4	be	be	VB
cord-304472-mi5v6512	88	5	high	high	JJ
cord-304472-mi5v6512	88	6	for	for	IN
cord-304472-mi5v6512	88	7	all	all	DT
cord-304472-mi5v6512	88	8	four	four	CD
cord-304472-mi5v6512	88	9	serotypes	serotype	NNS
cord-304472-mi5v6512	88	10	independent	independent	JJ
cord-304472-mi5v6512	88	11	of	of	IN
cord-304472-mi5v6512	88	12	serostatus	serostatus	NNP
cord-304472-mi5v6512	88	13	,	,	,
cord-304472-mi5v6512	88	14	with	with	IN
cord-304472-mi5v6512	88	15	the	the	DT
cord-304472-mi5v6512	88	16	highest	high	JJS
cord-304472-mi5v6512	88	17	for	for	IN
cord-304472-mi5v6512	88	18	DENV	DENV	NNP
cord-304472-mi5v6512	88	19	1	1	CD
cord-304472-mi5v6512	88	20	,	,	,
cord-304472-mi5v6512	88	21	3	3	CD
cord-304472-mi5v6512	88	22	and	and	CC
cord-304472-mi5v6512	88	23	4	4	CD
cord-304472-mi5v6512	88	24	,	,	,
cord-304472-mi5v6512	88	25	and	and	CC
cord-304472-mi5v6512	88	26	the	the	DT
cord-304472-mi5v6512	88	27	lowest	low	JJS
cord-304472-mi5v6512	88	28	for	for	IN
cord-304472-mi5v6512	88	29	DENV	DENV	NNP
cord-304472-mi5v6512	88	30	2	2	CD
cord-304472-mi5v6512	88	31	.	.	.
cord-304472-mi5v6512	89	1	To	to	TO
cord-304472-mi5v6512	89	2	determine	determine	VB
cord-304472-mi5v6512	89	3	the	the	DT
cord-304472-mi5v6512	89	4	ability	ability	NN
cord-304472-mi5v6512	89	5	of	of	IN
cord-304472-mi5v6512	89	6	a	a	DT
cord-304472-mi5v6512	89	7	single	single	JJ
cord-304472-mi5v6512	89	8	dose	dose	NN
cord-304472-mi5v6512	89	9	of	of	IN
cord-304472-mi5v6512	89	10	the	the	DT
cord-304472-mi5v6512	89	11	live	live	JJ
cord-304472-mi5v6512	89	12	attenuated	attenuated	JJ
cord-304472-mi5v6512	89	13	tetravalent	tetravalent	NN
cord-304472-mi5v6512	89	14	dengue	dengue	NN
cord-304472-mi5v6512	89	15	vaccine	vaccine	NN
cord-304472-mi5v6512	89	16	TV003	TV003	NNP
cord-304472-mi5v6512	89	17	to	to	TO
cord-304472-mi5v6512	89	18	induce	induce	VB
cord-304472-mi5v6512	89	19	a	a	DT
cord-304472-mi5v6512	89	20	suitable	suitable	JJ
cord-304472-mi5v6512	89	21	neutralizing	neutralize	VBG
cord-304472-mi5v6512	89	22	antibody	antibody	NN
cord-304472-mi5v6512	89	23	response	response	NN
cord-304472-mi5v6512	89	24	,	,	,
cord-304472-mi5v6512	89	25	a	a	DT
cord-304472-mi5v6512	89	26	placebo	placebo	NN
cord-304472-mi5v6512	89	27	-	-	HYPH
cord-304472-mi5v6512	89	28	controlled	control	VBN
cord-304472-mi5v6512	89	29	clinical	clinical	JJ
cord-304472-mi5v6512	89	30	trial	trial	NN
cord-304472-mi5v6512	89	31	was	be	VBD
cord-304472-mi5v6512	89	32	performed	perform	VBN
cord-304472-mi5v6512	89	33	in	in	IN
cord-304472-mi5v6512	89	34	48	48	CD
cord-304472-mi5v6512	89	35	healthy	healthy	JJ
cord-304472-mi5v6512	89	36	adults	adult	NNS
cord-304472-mi5v6512	89	37	who	who	WP
cord-304472-mi5v6512	89	38	received	receive	VBD
cord-304472-mi5v6512	89	39	2	2	CD
cord-304472-mi5v6512	89	40	doses	dose	NNS
cord-304472-mi5v6512	89	41	of	of	IN
cord-304472-mi5v6512	89	42	vaccine	vaccine	NN
cord-304472-mi5v6512	89	43	or	or	CC
cord-304472-mi5v6512	89	44	placebo	placebo	NN
cord-304472-mi5v6512	89	45	administered	administer	VBN
cord-304472-mi5v6512	89	46	12	12	CD
cord-304472-mi5v6512	89	47	months	month	NNS
cord-304472-mi5v6512	89	48	apart	apart	RB
cord-304472-mi5v6512	89	49	.	.	.
cord-304472-mi5v6512	90	1	Evaluation	evaluation	NN
cord-304472-mi5v6512	90	2	of	of	IN
cord-304472-mi5v6512	90	3	safety	safety	NN
cord-304472-mi5v6512	90	4	,	,	,
cord-304472-mi5v6512	90	5	vaccine	vaccine	NN
cord-304472-mi5v6512	90	6	viremia	viremia	NN
cord-304472-mi5v6512	90	7	,	,	,
cord-304472-mi5v6512	90	8	and	and	CC
cord-304472-mi5v6512	90	9	neutralizing	neutralize	VBG
cord-304472-mi5v6512	90	10	antibody	antibody	NN
cord-304472-mi5v6512	90	11	response	response	NN
cord-304472-mi5v6512	90	12	indicated	indicate	VBD
cord-304472-mi5v6512	90	13	that	that	IN
cord-304472-mi5v6512	90	14	a	a	DT
cord-304472-mi5v6512	90	15	single	single	JJ
cord-304472-mi5v6512	90	16	dose	dose	NN
cord-304472-mi5v6512	90	17	is	be	VBZ
cord-304472-mi5v6512	90	18	sufficient	sufficient	JJ
cord-304472-mi5v6512	90	19	[	[	-LRB-
cord-304472-mi5v6512	90	20	41	41	CD
cord-304472-mi5v6512	90	21	]	]	-RRB-
cord-304472-mi5v6512	90	22	.	.	.
cord-304472-mi5v6512	91	1	Thus	thus	RB
cord-304472-mi5v6512	91	2	,	,	,
cord-304472-mi5v6512	91	3	this	this	DT
cord-304472-mi5v6512	91	4	vaccine	vaccine	NN
cord-304472-mi5v6512	91	5	has	have	VBZ
cord-304472-mi5v6512	91	6	gone	go	VBN
cord-304472-mi5v6512	91	7	into	into	IN
cord-304472-mi5v6512	91	8	Phase	phase	NN
cord-304472-mi5v6512	91	9	3	3	CD
cord-304472-mi5v6512	91	10	trial	trial	NN
cord-304472-mi5v6512	91	11	with	with	IN
cord-304472-mi5v6512	91	12	a	a	DT
cord-304472-mi5v6512	91	13	single	single	JJ
cord-304472-mi5v6512	91	14	dose	dose	NN
cord-304472-mi5v6512	91	15	(	(	-LRB-
cord-304472-mi5v6512	91	16	in	in	IN
cord-304472-mi5v6512	91	17	contrast	contrast	NN
cord-304472-mi5v6512	91	18	to	to	IN
cord-304472-mi5v6512	91	19	TAK-003	tak-003	NN
cord-304472-mi5v6512	91	20	with	with	IN
cord-304472-mi5v6512	91	21	2	2	CD
cord-304472-mi5v6512	91	22	doses	dose	NNS
cord-304472-mi5v6512	91	23	,	,	,
cord-304472-mi5v6512	91	24	and	and	CC
cord-304472-mi5v6512	91	25	CYD	CYD	NNP
cord-304472-mi5v6512	91	26	-	-	HYPH
cord-304472-mi5v6512	91	27	TDV	TDV	NNP
cord-304472-mi5v6512	91	28	with	with	IN
cord-304472-mi5v6512	91	29	3	3	CD
cord-304472-mi5v6512	91	30	doses	dose	NNS
cord-304472-mi5v6512	91	31	)	)	-RRB-
cord-304472-mi5v6512	91	32	.	.	.
cord-304472-mi5v6512	92	1	The	the	DT
cord-304472-mi5v6512	92	2	Phase	phase	NN
cord-304472-mi5v6512	92	3	3	3	CD
cord-304472-mi5v6512	92	4	results	result	NNS
cord-304472-mi5v6512	92	5	remain	remain	VBP
cord-304472-mi5v6512	92	6	unpublished	unpublished	JJ
cord-304472-mi5v6512	92	7	to	to	IN
cord-304472-mi5v6512	92	8	date	date	NN
cord-304472-mi5v6512	92	9	,	,	,
cord-304472-mi5v6512	92	10	without	without	IN
cord-304472-mi5v6512	92	11	known	know	VBN
cord-304472-mi5v6512	92	12	interim	interim	JJ
cord-304472-mi5v6512	92	13	analyses	analysis	NNS
cord-304472-mi5v6512	92	14	.	.	.
cord-304472-mi5v6512	93	1	Given	give	VBN
cord-304472-mi5v6512	93	2	that	that	IN
cord-304472-mi5v6512	93	3	many	many	JJ
cord-304472-mi5v6512	93	4	endemic	endemic	JJ
cord-304472-mi5v6512	93	5	countries	country	NNS
cord-304472-mi5v6512	93	6	are	be	VBP
cord-304472-mi5v6512	93	7	popular	popular	JJ
cord-304472-mi5v6512	93	8	tourist	tourist	NN
cord-304472-mi5v6512	93	9	destinations	destination	NNS
cord-304472-mi5v6512	93	10	,	,	,
cord-304472-mi5v6512	93	11	international	international	JJ
cord-304472-mi5v6512	93	12	travelers	traveler	NNS
cord-304472-mi5v6512	93	13	are	be	VBP
cord-304472-mi5v6512	93	14	increasingly	increasingly	RB
cord-304472-mi5v6512	93	15	at	at	IN
cord-304472-mi5v6512	93	16	risk	risk	NN
cord-304472-mi5v6512	93	17	of	of	IN
cord-304472-mi5v6512	93	18	dengue	dengue	NN
cord-304472-mi5v6512	93	19	[	[	-LRB-
cord-304472-mi5v6512	93	20	5	5	CD
cord-304472-mi5v6512	93	21	,	,	,
cord-304472-mi5v6512	93	22	8	8	CD
cord-304472-mi5v6512	93	23	,	,	,
cord-304472-mi5v6512	93	24	[	[	-LRB-
cord-304472-mi5v6512	93	25	10	10	CD
cord-304472-mi5v6512	93	26	]	]	-RRB-
cord-304472-mi5v6512	93	27	[	[	-LRB-
cord-304472-mi5v6512	93	28	11	11	CD
cord-304472-mi5v6512	93	29	]	]	-RRB-
cord-304472-mi5v6512	93	30	[	[	-LRB-
cord-304472-mi5v6512	93	31	12	12	CD
cord-304472-mi5v6512	93	32	]	]	-RRB-
cord-304472-mi5v6512	93	33	42	42	CD
cord-304472-mi5v6512	93	34	]	]	-RRB-
cord-304472-mi5v6512	93	35	,	,	,
cord-304472-mi5v6512	93	36	with	with	IN
cord-304472-mi5v6512	93	37	attack	attack	NN
cord-304472-mi5v6512	93	38	rates	rate	NNS
cord-304472-mi5v6512	93	39	reported	report	VBN
cord-304472-mi5v6512	93	40	as	as	RB
cord-304472-mi5v6512	93	41	high	high	JJ
cord-304472-mi5v6512	93	42	as	as	IN
cord-304472-mi5v6512	93	43	5.51	5.51	CD
cord-304472-mi5v6512	93	44	cases	case	NNS
cord-304472-mi5v6512	93	45	per	per	IN
cord-304472-mi5v6512	93	46	1000	1000	CD
cord-304472-mi5v6512	93	47	travel	travel	NN
cord-304472-mi5v6512	93	48	-	-	HYPH
cord-304472-mi5v6512	93	49	months	month	NNS
cord-304472-mi5v6512	93	50	[	[	-LRB-
cord-304472-mi5v6512	93	51	43	43	CD
cord-304472-mi5v6512	93	52	]	]	-RRB-
cord-304472-mi5v6512	93	53	.	.	.
cord-304472-mi5v6512	94	1	Dengue	dengue	NN
cord-304472-mi5v6512	94	2	is	be	VBZ
cord-304472-mi5v6512	94	3	a	a	DT
cord-304472-mi5v6512	94	4	frequent	frequent	JJ
cord-304472-mi5v6512	94	5	problem	problem	NN
cord-304472-mi5v6512	94	6	in	in	IN
cord-304472-mi5v6512	94	7	travelers	traveler	NNS
cord-304472-mi5v6512	94	8	[	[	-LRB-
cord-304472-mi5v6512	94	9	44.45	44.45	CD
cord-304472-mi5v6512	94	10	]	]	-RRB-
cord-304472-mi5v6512	94	11	,	,	,
cord-304472-mi5v6512	94	12	more	more	RBR
cord-304472-mi5v6512	94	13	frequent	frequent	JJ
cord-304472-mi5v6512	94	14	than	than	IN
cord-304472-mi5v6512	94	15	'	'	``
cord-304472-mi5v6512	94	16	traditional	traditional	JJ
cord-304472-mi5v6512	94	17	'	'	''
cord-304472-mi5v6512	94	18	travel	travel	NN
cord-304472-mi5v6512	94	19	-	-	HYPH
cord-304472-mi5v6512	94	20	associated	associate	VBN
cord-304472-mi5v6512	94	21	infectious	infectious	JJ
cord-304472-mi5v6512	94	22	diseases	disease	NNS
cord-304472-mi5v6512	94	23	such	such	JJ
cord-304472-mi5v6512	94	24	as	as	IN
cord-304472-mi5v6512	94	25	typhoid	typhoid	NN
cord-304472-mi5v6512	94	26	fever	fever	NN
cord-304472-mi5v6512	94	27	[	[	-LRB-
cord-304472-mi5v6512	94	28	46	46	CD
cord-304472-mi5v6512	94	29	]	]	-RRB-
cord-304472-mi5v6512	94	30	,	,	,
cord-304472-mi5v6512	94	31	rabies	rabie	NNS
cord-304472-mi5v6512	94	32	[	[	-LRB-
cord-304472-mi5v6512	94	33	47	47	CD
cord-304472-mi5v6512	94	34	]	]	-RRB-
cord-304472-mi5v6512	94	35	,	,	,
cord-304472-mi5v6512	94	36	and	and	CC
cord-304472-mi5v6512	94	37	yellow	yellow	JJ
cord-304472-mi5v6512	94	38	fever	fever	NN
cord-304472-mi5v6512	94	39	[	[	-LRB-
cord-304472-mi5v6512	94	40	48	48	CD
cord-304472-mi5v6512	94	41	,	,	,
cord-304472-mi5v6512	94	42	49	49	CD
cord-304472-mi5v6512	94	43	]	]	-RRB-
cord-304472-mi5v6512	94	44	.	.	.
cord-304472-mi5v6512	95	1	GeoSentinel	GeoSentinel	NNP
cord-304472-mi5v6512	95	2	is	be	VBZ
cord-304472-mi5v6512	95	3	an	an	DT
cord-304472-mi5v6512	95	4	international	international	JJ
cord-304472-mi5v6512	95	5	network	network	NN
cord-304472-mi5v6512	95	6	of	of	IN
cord-304472-mi5v6512	95	7	travel	travel	NN
cord-304472-mi5v6512	95	8	medicine	medicine	NN
cord-304472-mi5v6512	95	9	providers	provider	NNS
cord-304472-mi5v6512	95	10	to	to	TO
cord-304472-mi5v6512	95	11	monitor	monitor	VB
cord-304472-mi5v6512	95	12	trends	trend	NNS
cord-304472-mi5v6512	95	13	in	in	IN
cord-304472-mi5v6512	95	14	travel	travel	NN
cord-304472-mi5v6512	95	15	-	-	HYPH
cord-304472-mi5v6512	95	16	associated	associate	VBN
cord-304472-mi5v6512	95	17	diseases	disease	NNS
cord-304472-mi5v6512	95	18	[	[	-LRB-
cord-304472-mi5v6512	95	19	50	50	CD
cord-304472-mi5v6512	95	20	]	]	-RRB-
cord-304472-mi5v6512	95	21	[	[	-LRB-
cord-304472-mi5v6512	95	22	51	51	CD
cord-304472-mi5v6512	95	23	]	]	-RRB-
cord-304472-mi5v6512	95	24	[	[	-LRB-
cord-304472-mi5v6512	95	25	52	52	CD
cord-304472-mi5v6512	95	26	]	]	-RRB-
cord-304472-mi5v6512	95	27	which	which	WDT
cord-304472-mi5v6512	95	28	has	have	VBZ
cord-304472-mi5v6512	95	29	reported	report	VBN
cord-304472-mi5v6512	95	30	a	a	DT
cord-304472-mi5v6512	95	31	substantial	substantial	JJ
cord-304472-mi5v6512	95	32	increase	increase	NN
cord-304472-mi5v6512	95	33	of	of	IN
cord-304472-mi5v6512	95	34	dengue	dengue	NN
cord-304472-mi5v6512	95	35	over	over	IN
cord-304472-mi5v6512	95	36	the	the	DT
cord-304472-mi5v6512	95	37	past	past	JJ
cord-304472-mi5v6512	95	38	decade	decade	NN
cord-304472-mi5v6512	95	39	[	[	-LRB-
cord-304472-mi5v6512	95	40	53	53	CD
cord-304472-mi5v6512	95	41	]	]	-RRB-
cord-304472-mi5v6512	95	42	.	.	.
cord-304472-mi5v6512	96	1	Dengue	dengue	NN
cord-304472-mi5v6512	96	2	can	can	MD
cord-304472-mi5v6512	96	3	affect	affect	VB
cord-304472-mi5v6512	96	4	tourist	tourist	NN
cord-304472-mi5v6512	96	5	travelers	traveler	NNS
cord-304472-mi5v6512	96	6	,	,	,
cord-304472-mi5v6512	96	7	business	business	NN
cord-304472-mi5v6512	96	8	travelers	traveler	NNS
cord-304472-mi5v6512	96	9	and	and	CC
cord-304472-mi5v6512	96	10	expatriates	expatriate	NNS
cord-304472-mi5v6512	96	11	[	[	-LRB-
cord-304472-mi5v6512	96	12	12	12	CD
cord-304472-mi5v6512	96	13	,	,	,
cord-304472-mi5v6512	96	14	52	52	CD
cord-304472-mi5v6512	96	15	]	]	-RRB-
cord-304472-mi5v6512	96	16	,	,	,
cord-304472-mi5v6512	96	17	migrants	migrant	NNS
cord-304472-mi5v6512	96	18	including	include	VBG
cord-304472-mi5v6512	96	19	those	those	DT
cord-304472-mi5v6512	96	20	visiting	visit	VBG
cord-304472-mi5v6512	96	21	friends	friend	NNS
cord-304472-mi5v6512	96	22	and	and	CC
cord-304472-mi5v6512	96	23	relatives	relative	NNS
cord-304472-mi5v6512	96	24	(	(	-LRB-
cord-304472-mi5v6512	96	25	VFR	VFR	NNP
cord-304472-mi5v6512	96	26	)	)	-RRB-
cord-304472-mi5v6512	96	27	[	[	-LRB-
cord-304472-mi5v6512	96	28	54	54	CD
cord-304472-mi5v6512	96	29	]	]	-RRB-
cord-304472-mi5v6512	96	30	,	,	,
cord-304472-mi5v6512	96	31	and	and	CC
cord-304472-mi5v6512	96	32	pilgrims	pilgrim	NNS
cord-304472-mi5v6512	96	33	[	[	-LRB-
cord-304472-mi5v6512	96	34	55	55	CD
cord-304472-mi5v6512	96	35	]	]	-RRB-
cord-304472-mi5v6512	96	36	;	;	:
cord-304472-mi5v6512	96	37	both	both	CC
cord-304472-mi5v6512	96	38	in	in	IN
cord-304472-mi5v6512	96	39	adult	adult	NN
cord-304472-mi5v6512	96	40	and	and	CC
cord-304472-mi5v6512	96	41	pediatric	pediatric	JJ
cord-304472-mi5v6512	96	42	travelers	traveler	NNS
cord-304472-mi5v6512	96	43	[	[	-LRB-
cord-304472-mi5v6512	96	44	11	11	CD
cord-304472-mi5v6512	96	45	,	,	,
cord-304472-mi5v6512	96	46	42	42	CD
cord-304472-mi5v6512	96	47	,	,	,
cord-304472-mi5v6512	96	48	56	56	CD
cord-304472-mi5v6512	96	49	]	]	-RRB-
cord-304472-mi5v6512	96	50	.	.	.
cord-304472-mi5v6512	97	1	Interruption	interruption	NN
cord-304472-mi5v6512	97	2	of	of	IN
cord-304472-mi5v6512	97	3	travel	travel	NN
cord-304472-mi5v6512	97	4	,	,	,
cord-304472-mi5v6512	97	5	hospitalization	hospitalization	NN
cord-304472-mi5v6512	97	6	during	during	IN
cord-304472-mi5v6512	97	7	or	or	CC
cord-304472-mi5v6512	97	8	after	after	IN
cord-304472-mi5v6512	97	9	travel	travel	NN
cord-304472-mi5v6512	97	10	,	,	,
cord-304472-mi5v6512	97	11	and	and	CC
cord-304472-mi5v6512	97	12	out	out	RB
cord-304472-mi5v6512	97	13	-	-	HYPH
cord-304472-mi5v6512	97	14	of	of	IN
cord-304472-mi5v6512	97	15	-	-	HYPH
cord-304472-mi5v6512	97	16	pocket	pocket	NN
cord-304472-mi5v6512	97	17	expenses	expense	NNS
cord-304472-mi5v6512	97	18	can	can	MD
cord-304472-mi5v6512	97	19	ensue	ensue	VB
cord-304472-mi5v6512	97	20	[	[	-LRB-
cord-304472-mi5v6512	97	21	9	9	CD
cord-304472-mi5v6512	97	22	]	]	-RRB-
cord-304472-mi5v6512	97	23	.	.	.
cord-304472-mi5v6512	98	1	Dengue	dengue	NN
cord-304472-mi5v6512	98	2	is	be	VBZ
cord-304472-mi5v6512	98	3	now	now	RB
cord-304472-mi5v6512	98	4	much	much	RB
cord-304472-mi5v6512	98	5	more	more	RBR
cord-304472-mi5v6512	98	6	frequent	frequent	JJ
cord-304472-mi5v6512	98	7	than	than	IN
cord-304472-mi5v6512	98	8	many	many	JJ
cord-304472-mi5v6512	98	9	of	of	IN
cord-304472-mi5v6512	98	10	the	the	DT
cord-304472-mi5v6512	98	11	other	other	JJ
cord-304472-mi5v6512	98	12	travel	travel	NN
cord-304472-mi5v6512	98	13	-	-	HYPH
cord-304472-mi5v6512	98	14	associated	associate	VBN
cord-304472-mi5v6512	98	15	vaccine	vaccine	NN
cord-304472-mi5v6512	98	16	preventable	preventable	JJ
cord-304472-mi5v6512	98	17	diseases	disease	NNS
cord-304472-mi5v6512	98	18	such	such	JJ
cord-304472-mi5v6512	98	19	as	as	IN
cord-304472-mi5v6512	98	20	rabies	rabies	NN
cord-304472-mi5v6512	98	21	,	,	,
cord-304472-mi5v6512	98	22	hepatitis	hepatitis	NNP
cord-304472-mi5v6512	98	23	A	A	NNP
cord-304472-mi5v6512	98	24	[	[	-LRB-
cord-304472-mi5v6512	98	25	57	57	CD
cord-304472-mi5v6512	98	26	]	]	-RRB-
cord-304472-mi5v6512	98	27	,	,	,
cord-304472-mi5v6512	98	28	yellow	yellow	JJ
cord-304472-mi5v6512	98	29	fever	fever	NN
cord-304472-mi5v6512	98	30	or	or	CC
cord-304472-mi5v6512	98	31	Japanese	japanese	JJ
cord-304472-mi5v6512	98	32	encephalitis	encephalitis	JJ
cord-304472-mi5v6512	98	33	[	[	-LRB-
cord-304472-mi5v6512	98	34	58	58	CD
cord-304472-mi5v6512	98	35	,	,	,
cord-304472-mi5v6512	98	36	59	59	CD
cord-304472-mi5v6512	98	37	]	]	-RRB-
cord-304472-mi5v6512	98	38	;	;	:
cord-304472-mi5v6512	98	39	thus	thus	RB
cord-304472-mi5v6512	98	40	,	,	,
cord-304472-mi5v6512	98	41	vaccination	vaccination	NN
cord-304472-mi5v6512	98	42	against	against	IN
cord-304472-mi5v6512	98	43	dengue	dengue	NN
cord-304472-mi5v6512	98	44	would	would	MD
cord-304472-mi5v6512	98	45	be	be	VB
cord-304472-mi5v6512	98	46	an	an	DT
cord-304472-mi5v6512	98	47	indication	indication	NN
cord-304472-mi5v6512	98	48	in	in	IN
cord-304472-mi5v6512	98	49	the	the	DT
cord-304472-mi5v6512	98	50	travel	travel	NN
cord-304472-mi5v6512	98	51	medicine	medicine	NN
cord-304472-mi5v6512	98	52	context	context	NN
cord-304472-mi5v6512	98	53	.	.	.
cord-304472-mi5v6512	99	1	The	the	DT
cord-304472-mi5v6512	99	2	limitation	limitation	NN
cord-304472-mi5v6512	99	3	of	of	IN
cord-304472-mi5v6512	99	4	the	the	DT
cord-304472-mi5v6512	99	5	currently	currently	RB
cord-304472-mi5v6512	99	6	only	only	RB
cord-304472-mi5v6512	99	7	licensed	license	VBN
cord-304472-mi5v6512	99	8	dengue	dengue	NN
cord-304472-mi5v6512	99	9	vaccine	vaccine	NN
cord-304472-mi5v6512	99	10	,	,	,
cord-304472-mi5v6512	99	11	CYD	CYD	NNP
cord-304472-mi5v6512	99	12	-	-	HYPH
cord-304472-mi5v6512	99	13	TDV	TDV	NNP
cord-304472-mi5v6512	99	14	,	,	,
cord-304472-mi5v6512	99	15	is	be	VBZ
cord-304472-mi5v6512	99	16	that	that	IN
cord-304472-mi5v6512	99	17	it	-PRON-	PRP
cord-304472-mi5v6512	99	18	should	should	MD
cord-304472-mi5v6512	99	19	only	only	RB
cord-304472-mi5v6512	99	20	be	be	VB
cord-304472-mi5v6512	99	21	used	use	VBN
cord-304472-mi5v6512	99	22	in	in	IN
cord-304472-mi5v6512	99	23	seropositive	seropositive	JJ
cord-304472-mi5v6512	99	24	travelers	traveler	NNS
cord-304472-mi5v6512	99	25	[	[	-LRB-
cord-304472-mi5v6512	99	26	27	27	CD
cord-304472-mi5v6512	99	27	]	]	-RRB-
cord-304472-mi5v6512	99	28	.	.	.
cord-304472-mi5v6512	100	1	However	however	RB
cord-304472-mi5v6512	100	2	,	,	,
cord-304472-mi5v6512	100	3	most	most	JJS
cord-304472-mi5v6512	100	4	travelers	traveler	NNS
cord-304472-mi5v6512	100	5	are	be	VBP
cord-304472-mi5v6512	100	6	seronegative	seronegative	JJ
cord-304472-mi5v6512	100	7	.	.	.
cord-304472-mi5v6512	101	1	Furthermore	furthermore	RB
cord-304472-mi5v6512	101	2	,	,	,
cord-304472-mi5v6512	101	3	the	the	DT
cord-304472-mi5v6512	101	4	dosing	dosing	NN
cord-304472-mi5v6512	101	5	schedule	schedule	NN
cord-304472-mi5v6512	101	6	of	of	IN
cord-304472-mi5v6512	101	7	3	3	CD
cord-304472-mi5v6512	101	8	doses	dose	NNS
cord-304472-mi5v6512	101	9	6	6	CD
cord-304472-mi5v6512	101	10	months	month	NNS
cord-304472-mi5v6512	101	11	apart	apart	RB
cord-304472-mi5v6512	101	12	for	for	IN
cord-304472-mi5v6512	101	13	CYD	CYD	NNP
cord-304472-mi5v6512	101	14	-	-	HYPH
cord-304472-mi5v6512	101	15	TDV	TDV	NNP
cord-304472-mi5v6512	101	16	renders	render	VBZ
cord-304472-mi5v6512	101	17	the	the	DT
cord-304472-mi5v6512	101	18	use	use	NN
cord-304472-mi5v6512	101	19	of	of	IN
cord-304472-mi5v6512	101	20	such	such	PDT
cord-304472-mi5v6512	101	21	a	a	DT
cord-304472-mi5v6512	101	22	vaccine	vaccine	NN
cord-304472-mi5v6512	101	23	difficult	difficult	JJ
cord-304472-mi5v6512	101	24	in	in	IN
cord-304472-mi5v6512	101	25	the	the	DT
cord-304472-mi5v6512	101	26	travel	travel	NN
cord-304472-mi5v6512	101	27	medicine	medicine	NN
cord-304472-mi5v6512	101	28	setting	setting	NN
cord-304472-mi5v6512	101	29	.	.	.
cord-304472-mi5v6512	102	1	A	a	DT
cord-304472-mi5v6512	102	2	safe	safe	JJ
cord-304472-mi5v6512	102	3	and	and	CC
cord-304472-mi5v6512	102	4	efficacious	efficacious	JJ
cord-304472-mi5v6512	102	5	vaccine	vaccine	NN
cord-304472-mi5v6512	102	6	that	that	WDT
cord-304472-mi5v6512	102	7	can	can	MD
cord-304472-mi5v6512	102	8	be	be	VB
cord-304472-mi5v6512	102	9	used	use	VBN
cord-304472-mi5v6512	102	10	regardless	regardless	RB
cord-304472-mi5v6512	102	11	of	of	IN
cord-304472-mi5v6512	102	12	serostatus	serostatus	NN
cord-304472-mi5v6512	102	13	is	be	VBZ
cord-304472-mi5v6512	102	14	needed	need	VBN
cord-304472-mi5v6512	102	15	for	for	IN
cord-304472-mi5v6512	102	16	travelers	traveler	NNS
cord-304472-mi5v6512	102	17	[	[	-LRB-
cord-304472-mi5v6512	102	18	60	60	CD
cord-304472-mi5v6512	102	19	]	]	-RRB-
cord-304472-mi5v6512	102	20	.	.	.
cord-304472-mi5v6512	103	1	Until	until	IN
cord-304472-mi5v6512	103	2	a	a	DT
cord-304472-mi5v6512	103	3	vaccine	vaccine	NN
cord-304472-mi5v6512	103	4	becomes	become	VBZ
cord-304472-mi5v6512	103	5	available	available	JJ
cord-304472-mi5v6512	103	6	that	that	WDT
cord-304472-mi5v6512	103	7	would	would	MD
cord-304472-mi5v6512	103	8	benefit	benefit	VB
cord-304472-mi5v6512	103	9	all	all	DT
cord-304472-mi5v6512	103	10	travelers	traveler	NNS
cord-304472-mi5v6512	103	11	to	to	IN
cord-304472-mi5v6512	103	12	dengue	dengue	VB
cord-304472-mi5v6512	103	13	endemic	endemic	JJ
cord-304472-mi5v6512	103	14	countries	country	NNS
cord-304472-mi5v6512	103	15	,	,	,
cord-304472-mi5v6512	103	16	travelers	traveler	NNS
cord-304472-mi5v6512	103	17	should	should	MD
cord-304472-mi5v6512	103	18	be	be	VB
cord-304472-mi5v6512	103	19	advised	advise	VBN
cord-304472-mi5v6512	103	20	to	to	TO
cord-304472-mi5v6512	103	21	take	take	VB
cord-304472-mi5v6512	103	22	day	day	NN
cord-304472-mi5v6512	103	23	-	-	HYPH
cord-304472-mi5v6512	103	24	time	time	NN
cord-304472-mi5v6512	103	25	personal	personal	JJ
cord-304472-mi5v6512	103	26	protective	protective	JJ
cord-304472-mi5v6512	103	27	measures	measure	NNS
cord-304472-mi5v6512	103	28	against	against	IN
cord-304472-mi5v6512	103	29	mosquito	mosquito	NN
cord-304472-mi5v6512	103	30	bites	bite	NNS
cord-304472-mi5v6512	103	31	[	[	-LRB-
cord-304472-mi5v6512	103	32	61	61	CD
cord-304472-mi5v6512	103	33	]	]	-RRB-
cord-304472-mi5v6512	103	34	and	and	CC
cord-304472-mi5v6512	103	35	consider	consider	VB
cord-304472-mi5v6512	103	36	Dengvaxia	Dengvaxia	NNP
cord-304472-mi5v6512	103	37	if	if	IN
cord-304472-mi5v6512	103	38	they	-PRON-	PRP
cord-304472-mi5v6512	103	39	are	be	VBP
cord-304472-mi5v6512	103	40	seropositive	seropositive	JJ
cord-304472-mi5v6512	103	41	[	[	-LRB-
cord-304472-mi5v6512	103	42	28	28	CD
cord-304472-mi5v6512	103	43	]	]	-RRB-
cord-304472-mi5v6512	103	44	.	.	.
cord-304472-mi5v6512	104	1	Pre	pre	JJ
cord-304472-mi5v6512	104	2	-	-	JJ
cord-304472-mi5v6512	104	3	travel	travel	JJ
cord-304472-mi5v6512	104	4	advice	advice	NN
cord-304472-mi5v6512	104	5	for	for	IN
cord-304472-mi5v6512	104	6	all	all	DT
cord-304472-mi5v6512	104	7	travellers	traveller	NNS
cord-304472-mi5v6512	105	1	to	to	IN
cord-304472-mi5v6512	105	2	dengue	dengue	VB
cord-304472-mi5v6512	105	3	endemic	endemic	JJ
cord-304472-mi5v6512	105	4	countries	country	NNS
cord-304472-mi5v6512	105	5	need	need	VBP
cord-304472-mi5v6512	105	6	to	to	TO
cord-304472-mi5v6512	105	7	include	include	VB
cord-304472-mi5v6512	105	8	advice	advice	NN
cord-304472-mi5v6512	105	9	on	on	IN
cord-304472-mi5v6512	105	10	the	the	DT
cord-304472-mi5v6512	105	11	dengue	dengue	NN
cord-304472-mi5v6512	105	12	risk	risk	NN
cord-304472-mi5v6512	105	13	[	[	-LRB-
cord-304472-mi5v6512	105	14	5	5	CD
cord-304472-mi5v6512	105	15	,	,	,
cord-304472-mi5v6512	105	16	62	62	CD
cord-304472-mi5v6512	105	17	]	]	-RRB-
cord-304472-mi5v6512	105	18	.	.	.
cord-304472-mi5v6512	106	1	While	while	IN
cord-304472-mi5v6512	106	2	dengue	dengue	NN
cord-304472-mi5v6512	106	3	-	-	HYPH
cord-304472-mi5v6512	106	4	primed	prime	VBN
cord-304472-mi5v6512	106	5	individuals	individual	NNS
cord-304472-mi5v6512	106	6	can	can	MD
cord-304472-mi5v6512	106	7	already	already	RB
cord-304472-mi5v6512	106	8	benefit	benefit	VB
cord-304472-mi5v6512	106	9	from	from	IN
cord-304472-mi5v6512	106	10	vaccination	vaccination	NN
cord-304472-mi5v6512	106	11	against	against	IN
cord-304472-mi5v6512	106	12	all	all	DT
cord-304472-mi5v6512	106	13	four	four	CD
cord-304472-mi5v6512	106	14	serotypes	serotype	NNS
cord-304472-mi5v6512	106	15	with	with	IN
cord-304472-mi5v6512	106	16	the	the	DT
cord-304472-mi5v6512	106	17	first	first	JJ
cord-304472-mi5v6512	106	18	licensed	licensed	JJ
cord-304472-mi5v6512	106	19	dengue	dengue	NN
cord-304472-mi5v6512	106	20	vaccine	vaccine	NN
cord-304472-mi5v6512	106	21	CYD	CYD	NNP
cord-304472-mi5v6512	106	22	-	-	HYPH
cord-304472-mi5v6512	106	23	TDV	TDV	NNP
cord-304472-mi5v6512	106	24	,	,	,
cord-304472-mi5v6512	106	25	the	the	DT
cord-304472-mi5v6512	106	26	need	need	NN
cord-304472-mi5v6512	106	27	for	for	IN
cord-304472-mi5v6512	106	28	dengue	dengue	NN
cord-304472-mi5v6512	106	29	-	-	HYPH
cord-304472-mi5v6512	106	30	naive	naive	JJ
cord-304472-mi5v6512	106	31	population	population	NN
cord-304472-mi5v6512	106	32	has	have	VBZ
cord-304472-mi5v6512	106	33	not	not	RB
cord-304472-mi5v6512	106	34	yet	yet	RB
cord-304472-mi5v6512	106	35	been	be	VBN
cord-304472-mi5v6512	106	36	met	meet	VBN
cord-304472-mi5v6512	106	37	.	.	.
cord-304472-mi5v6512	107	1	Would	Would	MD
cord-304472-mi5v6512	107	2	sequential	sequential	JJ
cord-304472-mi5v6512	107	3	immunization	immunization	NN
cord-304472-mi5v6512	107	4	induce	induce	VB
cord-304472-mi5v6512	107	5	stronger	strong	JJR
cord-304472-mi5v6512	107	6	and	and	CC
cord-304472-mi5v6512	107	7	broader	broad	JJR
cord-304472-mi5v6512	107	8	immunity	immunity	NN
cord-304472-mi5v6512	107	9	against	against	IN
cord-304472-mi5v6512	107	10	four	four	CD
cord-304472-mi5v6512	107	11	DENV	DENV	NNP
cord-304472-mi5v6512	107	12	serotypes	serotype	NNS
cord-304472-mi5v6512	107	13	than	than	IN
cord-304472-mi5v6512	107	14	tetravalent	tetravalent	NN
cord-304472-mi5v6512	107	15	-	-	HYPH
cord-304472-mi5v6512	107	16	formulated	formulate	VBN
cord-304472-mi5v6512	107	17	immunization	immunization	NN
cord-304472-mi5v6512	107	18	and	and	CC
cord-304472-mi5v6512	107	19	overcome	overcome	VB
cord-304472-mi5v6512	107	20	the	the	DT
cord-304472-mi5v6512	107	21	viral	viral	JJ
cord-304472-mi5v6512	107	22	interference	interference	NN
cord-304472-mi5v6512	107	23	we	-PRON-	PRP
cord-304472-mi5v6512	107	24	have	have	VBP
cord-304472-mi5v6512	107	25	seen	see	VBN
cord-304472-mi5v6512	107	26	to	to	IN
cord-304472-mi5v6512	107	27	date	date	NN
cord-304472-mi5v6512	107	28	for	for	IN
cord-304472-mi5v6512	107	29	the	the	DT
cord-304472-mi5v6512	107	30	live	live	JJ
cord-304472-mi5v6512	107	31	attenuated	attenuated	JJ
cord-304472-mi5v6512	107	32	dengue	dengue	NN
cord-304472-mi5v6512	107	33	vaccine	vaccine	NN
cord-304472-mi5v6512	107	34	formulations	formulation	NNS
cord-304472-mi5v6512	107	35	?	?	.
cord-304472-mi5v6512	108	1	In	in	IN
cord-304472-mi5v6512	108	2	a	a	DT
cord-304472-mi5v6512	108	3	study	study	NN
cord-304472-mi5v6512	108	4	in	in	IN
cord-304472-mi5v6512	108	5	Singapore	Singapore	NNP
cord-304472-mi5v6512	108	6	mice	mouse	NNS
cord-304472-mi5v6512	108	7	were	be	VBD
cord-304472-mi5v6512	108	8	immunized	immunize	VBN
cord-304472-mi5v6512	108	9	with	with	IN
cord-304472-mi5v6512	108	10	four	four	CD
cord-304472-mi5v6512	108	11	DNA	dna	NN
cord-304472-mi5v6512	108	12	plasmids	plasmid	NNS
cord-304472-mi5v6512	108	13	,	,	,
cord-304472-mi5v6512	108	14	each	each	DT
cord-304472-mi5v6512	108	15	encoding	encode	VBG
cord-304472-mi5v6512	108	16	the	the	DT
cord-304472-mi5v6512	108	17	pre	pre	NN
cord-304472-mi5v6512	108	18	-	-	NN
cord-304472-mi5v6512	108	19	membrane	membrane	NN
cord-304472-mi5v6512	108	20	and	and	CC
cord-304472-mi5v6512	108	21	envelope	envelope	NN
cord-304472-mi5v6512	108	22	from	from	IN
cord-304472-mi5v6512	108	23	one	one	CD
cord-304472-mi5v6512	108	24	DENV	DENV	NNP
cord-304472-mi5v6512	108	25	serotype	serotype	NN
cord-304472-mi5v6512	108	26	,	,	,
cord-304472-mi5v6512	108	27	either	either	CC
cord-304472-mi5v6512	108	28	sequentially	sequentially	RB
cord-304472-mi5v6512	108	29	or	or	CC
cord-304472-mi5v6512	108	30	simultaneously	simultaneously	RB
cord-304472-mi5v6512	108	31	.	.	.
cord-304472-mi5v6512	109	1	The	the	DT
cord-304472-mi5v6512	109	2	sequential	sequential	JJ
cord-304472-mi5v6512	109	3	immunization	immunization	NN
cord-304472-mi5v6512	109	4	induced	induce	VBN
cord-304472-mi5v6512	109	5	significantly	significantly	RB
cord-304472-mi5v6512	109	6	higher	high	JJR
cord-304472-mi5v6512	109	7	levels	level	NNS
cord-304472-mi5v6512	109	8	of	of	IN
cord-304472-mi5v6512	109	9	interferon	interferon	NN
cord-304472-mi5v6512	109	10	(	(	-LRB-
cord-304472-mi5v6512	109	11	IFN)g	IFN)g	NNP
cord-304472-mi5v6512	109	12	-	-	HYPH
cord-304472-mi5v6512	109	13	expressing	express	VBG
cord-304472-mi5v6512	109	14	or	or	CC
cord-304472-mi5v6512	109	15	tumor	tumor	NN
cord-304472-mi5v6512	109	16	necrosis	necrosis	NN
cord-304472-mi5v6512	109	17	factor	factor	NN
cord-304472-mi5v6512	109	18	(	(	-LRB-
cord-304472-mi5v6512	109	19	TNF)a	TNF)a	NNP
cord-304472-mi5v6512	109	20	-	-	HYPH
cord-304472-mi5v6512	109	21	expressing	express	VBG
cord-304472-mi5v6512	109	22	CD4	CD4	NNP
cord-304472-mi5v6512	109	23	+	+	CC
cord-304472-mi5v6512	109	24	and	and	CC
cord-304472-mi5v6512	109	25	CD8	CD8	NNP
cord-304472-mi5v6512	109	26	+	+	CC
cord-304472-mi5v6512	109	27	T	T	NNP
cord-304472-mi5v6512	109	28	cells	cell	NNS
cord-304472-mi5v6512	109	29	to	to	IN
cord-304472-mi5v6512	109	30	both	both	DT
cord-304472-mi5v6512	109	31	serotype	serotype	NN
cord-304472-mi5v6512	109	32	-	-	HYPH
cord-304472-mi5v6512	109	33	specific	specific	JJ
cord-304472-mi5v6512	109	34	and	and	CC
cord-304472-mi5v6512	109	35	conserved	conserved	JJ
cord-304472-mi5v6512	109	36	epitopes	epitope	NNS
cord-304472-mi5v6512	109	37	than	than	IN
cord-304472-mi5v6512	109	38	tetravalent	tetravalent	NN
cord-304472-mi5v6512	109	39	immunization	immunization	NN
cord-304472-mi5v6512	109	40	[	[	-LRB-
cord-304472-mi5v6512	109	41	63	63	CD
cord-304472-mi5v6512	109	42	]	]	-RRB-
cord-304472-mi5v6512	109	43	.	.	.
cord-304472-mi5v6512	110	1	Moreover	moreover	RB
cord-304472-mi5v6512	110	2	,	,	,
cord-304472-mi5v6512	110	3	sequential	sequential	JJ
cord-304472-mi5v6512	110	4	immunization	immunization	NN
cord-304472-mi5v6512	110	5	induced	induce	VBN
cord-304472-mi5v6512	110	6	higher	high	JJR
cord-304472-mi5v6512	110	7	levels	level	NNS
cord-304472-mi5v6512	110	8	of	of	IN
cord-304472-mi5v6512	110	9	neutralizing	neutralize	VBG
cord-304472-mi5v6512	110	10	antibodies	antibody	NNS
cord-304472-mi5v6512	110	11	to	to	IN
cord-304472-mi5v6512	110	12	all	all	DT
cord-304472-mi5v6512	110	13	four	four	CD
cord-304472-mi5v6512	110	14	DENV	DENV	NNP
cord-304472-mi5v6512	110	15	serotypes	serotype	NNS
cord-304472-mi5v6512	110	16	than	than	IN
cord-304472-mi5v6512	110	17	tetravalent	tetravalent	NN
cord-304472-mi5v6512	110	18	vaccination	vaccination	NN
cord-304472-mi5v6512	110	19	.	.	.
cord-304472-mi5v6512	111	1	In	in	IN
cord-304472-mi5v6512	111	2	these	these	DT
cord-304472-mi5v6512	111	3	animal	animal	NN
cord-304472-mi5v6512	111	4	data	datum	NNS
cord-304472-mi5v6512	111	5	,	,	,
cord-304472-mi5v6512	111	6	sequential	sequential	JJ
cord-304472-mi5v6512	111	7	immunization	immunization	NN
cord-304472-mi5v6512	111	8	resulted	result	VBD
cord-304472-mi5v6512	111	9	in	in	IN
cord-304472-mi5v6512	111	10	more	more	RBR
cord-304472-mi5v6512	111	11	diversified	diversified	JJ
cord-304472-mi5v6512	111	12	immunoglobulin	immunoglobulin	NN
cord-304472-mi5v6512	111	13	repertoire	repertoire	NN
cord-304472-mi5v6512	111	14	,	,	,
cord-304472-mi5v6512	111	15	and	and	CC
cord-304472-mi5v6512	111	16	suggests	suggest	VBZ
cord-304472-mi5v6512	111	17	that	that	IN
cord-304472-mi5v6512	111	18	sequential	sequential	JJ
cord-304472-mi5v6512	111	19	immunization	immunization	NN
cord-304472-mi5v6512	111	20	offers	offer	VBZ
cord-304472-mi5v6512	111	21	an	an	DT
cord-304472-mi5v6512	111	22	alternative	alternative	JJ
cord-304472-mi5v6512	111	23	approach	approach	NN
cord-304472-mi5v6512	111	24	to	to	TO
cord-304472-mi5v6512	111	25	potentially	potentially	RB
cord-304472-mi5v6512	111	26	overcome	overcome	VB
cord-304472-mi5v6512	111	27	the	the	DT
cord-304472-mi5v6512	111	28	current	current	JJ
cord-304472-mi5v6512	111	29	challenges	challenge	NNS
cord-304472-mi5v6512	111	30	encountered	encounter	VBN
cord-304472-mi5v6512	111	31	with	with	IN
cord-304472-mi5v6512	111	32	tetravalent	tetravalent	NN
cord-304472-mi5v6512	111	33	-	-	HYPH
cord-304472-mi5v6512	111	34	formulated	formulate	VBN
cord-304472-mi5v6512	111	35	dengue	dengue	NN
cord-304472-mi5v6512	111	36	vaccines	vaccine	NNS
cord-304472-mi5v6512	111	37	.	.	.
cord-304472-mi5v6512	112	1	Another	another	DT
cord-304472-mi5v6512	112	2	strategy	strategy	NN
cord-304472-mi5v6512	112	3	to	to	TO
cord-304472-mi5v6512	112	4	overcome	overcome	VB
cord-304472-mi5v6512	112	5	viral	viral	JJ
cord-304472-mi5v6512	112	6	interference	interference	NN
cord-304472-mi5v6512	112	7	for	for	IN
cord-304472-mi5v6512	112	8	tetravalent	tetravalent	NN
cord-304472-mi5v6512	112	9	dengue	dengue	NN
cord-304472-mi5v6512	112	10	vaccines	vaccine	NNS
cord-304472-mi5v6512	112	11	would	would	MD
cord-304472-mi5v6512	112	12	be	be	VB
cord-304472-mi5v6512	112	13	to	to	TO
cord-304472-mi5v6512	112	14	use	use	VB
cord-304472-mi5v6512	112	15	a	a	DT
cord-304472-mi5v6512	112	16	heterologous	heterologous	JJ
cord-304472-mi5v6512	112	17	prime	prime	JJ
cord-304472-mi5v6512	112	18	-	-	HYPH
cord-304472-mi5v6512	112	19	boost	boost	NN
cord-304472-mi5v6512	112	20	strategy	strategy	NN
cord-304472-mi5v6512	112	21	.	.	.
cord-304472-mi5v6512	113	1	While	while	IN
cord-304472-mi5v6512	113	2	TAK-003	tak-003	DT
cord-304472-mi5v6512	113	3	vaccine	vaccine	NN
cord-304472-mi5v6512	113	4	induces	induce	VBZ
cord-304472-mi5v6512	113	5	high	high	JJ
cord-304472-mi5v6512	113	6	protection	protection	NN
cord-304472-mi5v6512	113	7	against	against	IN
cord-304472-mi5v6512	113	8	DENV2	denv2	NN
cord-304472-mi5v6512	113	9	and	and	CC
cord-304472-mi5v6512	113	10	to	to	IN
cord-304472-mi5v6512	113	11	a	a	DT
cord-304472-mi5v6512	113	12	lesser	less	JJR
cord-304472-mi5v6512	113	13	extent	extent	NN
cord-304472-mi5v6512	113	14	against	against	IN
cord-304472-mi5v6512	113	15	DENV1	DENV1	NNS
cord-304472-mi5v6512	113	16	in	in	IN
cord-304472-mi5v6512	113	17	both	both	DT
cord-304472-mi5v6512	113	18	dengue	dengue	NN
cord-304472-mi5v6512	113	19	-	-	HYPH
cord-304472-mi5v6512	113	20	seropositive	seropositive	JJ
cord-304472-mi5v6512	113	21	and	and	CC
cord-304472-mi5v6512	113	22	-seronegative	-seronegative	JJ
cord-304472-mi5v6512	113	23	individuals	individual	NNS
cord-304472-mi5v6512	113	24	,	,	,
cord-304472-mi5v6512	113	25	CYD	CYD	NNP
cord-304472-mi5v6512	113	26	-	-	HYPH
cord-304472-mi5v6512	113	27	TDV	TDV	NNP
cord-304472-mi5v6512	113	28	induces	induce	VBZ
cord-304472-mi5v6512	113	29	a	a	DT
cord-304472-mi5v6512	113	30	high	high	JJ
cord-304472-mi5v6512	113	31	protection	protection	NN
cord-304472-mi5v6512	113	32	against	against	IN
cord-304472-mi5v6512	113	33	DENV3	DENV3	NNS
cord-304472-mi5v6512	113	34	and	and	CC
cord-304472-mi5v6512	113	35	4	4	CD
cord-304472-mi5v6512	113	36	but	but	CC
cord-304472-mi5v6512	113	37	to	to	IN
cord-304472-mi5v6512	113	38	a	a	DT
cord-304472-mi5v6512	113	39	lesser	less	JJR
cord-304472-mi5v6512	113	40	extent	extent	NN
cord-304472-mi5v6512	113	41	against	against	IN
cord-304472-mi5v6512	113	42	DENV1	DENV1	NNS
cord-304472-mi5v6512	113	43	and	and	CC
cord-304472-mi5v6512	113	44	2	2	CD
cord-304472-mi5v6512	113	45	.	.	.
cord-304472-mi5v6512	114	1	Furthermore	furthermore	RB
cord-304472-mi5v6512	114	2	,	,	,
cord-304472-mi5v6512	114	3	while	while	IN
cord-304472-mi5v6512	114	4	TAK-003	tak-003	DT
cord-304472-mi5v6512	114	5	vaccine	vaccine	NN
cord-304472-mi5v6512	114	6	performance	performance	NN
cord-304472-mi5v6512	114	7	seems	seem	VBZ
cord-304472-mi5v6512	114	8	to	to	TO
cord-304472-mi5v6512	114	9	be	be	VB
cord-304472-mi5v6512	114	10	less	less	JJR
cord-304472-mi5v6512	114	11	serostatus	serostatus	NN
cord-304472-mi5v6512	114	12	dependent	dependent	JJ
cord-304472-mi5v6512	114	13	,	,	,
cord-304472-mi5v6512	114	14	an	an	DT
cord-304472-mi5v6512	114	15	inconclusive	inconclusive	JJ
cord-304472-mi5v6512	114	16	relative	relative	JJ
cord-304472-mi5v6512	114	17	risk	risk	NN
cord-304472-mi5v6512	114	18	>	>	XX
cord-304472-mi5v6512	115	1	1	1	CD
cord-304472-mi5v6512	115	2	has	have	VBZ
cord-304472-mi5v6512	115	3	been	be	VBN
cord-304472-mi5v6512	115	4	observed	observe	VBN
cord-304472-mi5v6512	115	5	for	for	IN
cord-304472-mi5v6512	115	6	DENV3	DENV3	NNS
cord-304472-mi5v6512	115	7	in	in	IN
cord-304472-mi5v6512	115	8	seronegative	seronegative	JJ
cord-304472-mi5v6512	115	9	vaccinees	vaccinee	NNS
cord-304472-mi5v6512	115	10	and	and	CC
cord-304472-mi5v6512	115	11	no	no	DT
cord-304472-mi5v6512	115	12	conclusion	conclusion	NN
cord-304472-mi5v6512	115	13	could	could	MD
cord-304472-mi5v6512	115	14	be	be	VB
cord-304472-mi5v6512	115	15	drawn	draw	VBN
cord-304472-mi5v6512	115	16	regarding	regard	VBG
cord-304472-mi5v6512	115	17	DENV4	DENV4	NNPS
cord-304472-mi5v6512	115	18	[	[	-LRB-
cord-304472-mi5v6512	115	19	30	30	CD
cord-304472-mi5v6512	115	20	]	]	-RRB-
cord-304472-mi5v6512	115	21	.	.	.
cord-304472-mi5v6512	116	1	So	so	RB
cord-304472-mi5v6512	116	2	what	what	WP
cord-304472-mi5v6512	116	3	about	about	IN
cord-304472-mi5v6512	116	4	combining	combine	VBG
cord-304472-mi5v6512	116	5	both	both	DT
cord-304472-mi5v6512	116	6	vaccines	vaccine	NNS
cord-304472-mi5v6512	116	7	in	in	IN
cord-304472-mi5v6512	116	8	a	a	DT
cord-304472-mi5v6512	116	9	heterologous	heterologous	JJ
cord-304472-mi5v6512	116	10	prime	prime	JJ
cord-304472-mi5v6512	116	11	-	-	HYPH
cord-304472-mi5v6512	116	12	boost	boost	NN
cord-304472-mi5v6512	116	13	regimen	regimen	NN
cord-304472-mi5v6512	116	14	,	,	,
cord-304472-mi5v6512	116	15	leveraging	leverage	VBG
cord-304472-mi5v6512	116	16	upon	upon	IN
cord-304472-mi5v6512	116	17	the	the	DT
cord-304472-mi5v6512	116	18	benefits	benefit	NNS
cord-304472-mi5v6512	116	19	of	of	IN
cord-304472-mi5v6512	116	20	each	each	DT
cord-304472-mi5v6512	116	21	vaccine	vaccine	NN
cord-304472-mi5v6512	116	22	and	and	CC
cord-304472-mi5v6512	116	23	thereby	thereby	RB
cord-304472-mi5v6512	116	24	minimizing	minimize	VBG
cord-304472-mi5v6512	116	25	safety	safety	NN
cord-304472-mi5v6512	116	26	concerns	concern	NNS
cord-304472-mi5v6512	116	27	?	?	.
cord-304472-mi5v6512	117	1	Priming	prime	VBG
cord-304472-mi5v6512	117	2	with	with	IN
cord-304472-mi5v6512	117	3	TAK-003	tak-003	NN
cord-304472-mi5v6512	117	4	followed	follow	VBN
cord-304472-mi5v6512	117	5	by	by	IN
cord-304472-mi5v6512	117	6	a	a	DT
cord-304472-mi5v6512	117	7	CYD	CYD	NNP
cord-304472-mi5v6512	117	8	-	-	HYPH
cord-304472-mi5v6512	117	9	TDV	TDV	NNP
cord-304472-mi5v6512	117	10	boost	boost	NN
cord-304472-mi5v6512	117	11	would	would	MD
cord-304472-mi5v6512	117	12	initially	initially	RB
cord-304472-mi5v6512	117	13	ensure	ensure	VB
cord-304472-mi5v6512	117	14	strong	strong	JJ
cord-304472-mi5v6512	117	15	humoral	humoral	JJ
cord-304472-mi5v6512	117	16	and	and	CC
cord-304472-mi5v6512	117	17	cellular	cellular	JJ
cord-304472-mi5v6512	117	18	responses	response	NNS
cord-304472-mi5v6512	117	19	against	against	IN
cord-304472-mi5v6512	117	20	DENV2the	denv2the	DT
cord-304472-mi5v6512	117	21	weakest	weak	JJS
cord-304472-mi5v6512	117	22	CYD	CYD	NNP
cord-304472-mi5v6512	117	23	-	-	HYPH
cord-304472-mi5v6512	117	24	TDV	TDV	NNP
cord-304472-mi5v6512	117	25	serotype	serotype	NN
cord-304472-mi5v6512	117	26	-	-	:
cord-304472-mi5v6512	117	27	,	,	,
cord-304472-mi5v6512	117	28	and	and	CC
cord-304472-mi5v6512	117	29	then	then	RB
cord-304472-mi5v6512	117	30	eventually	eventually	RB
cord-304472-mi5v6512	117	31	strengthen	strengthen	VB
cord-304472-mi5v6512	117	32	responses	response	NNS
cord-304472-mi5v6512	117	33	against	against	IN
cord-304472-mi5v6512	117	34	the	the	DT
cord-304472-mi5v6512	117	35	other	other	JJ
cord-304472-mi5v6512	117	36	serotypes	serotype	NNS
cord-304472-mi5v6512	117	37	,	,	,
cord-304472-mi5v6512	117	38	in	in	IN
cord-304472-mi5v6512	117	39	particular	particular	JJ
cord-304472-mi5v6512	117	40	DENV4	denv4	XX
cord-304472-mi5v6512	117	41	-the	-the	DT
cord-304472-mi5v6512	117	42	dominant	dominant	JJ
cord-304472-mi5v6512	117	43	CYD	CYD	NNP
cord-304472-mi5v6512	117	44	-	-	HYPH
cord-304472-mi5v6512	117	45	TDV	TDV	NNP
cord-304472-mi5v6512	117	46	and	and	CC
cord-304472-mi5v6512	117	47	weakest	weak	JJS
cord-304472-mi5v6512	117	48	TAK-003	tak-003	NN
cord-304472-mi5v6512	117	49	serotype	serotype	NN
cord-304472-mi5v6512	117	50	[	[	-LRB-
cord-304472-mi5v6512	117	51	64	64	CD
cord-304472-mi5v6512	117	52	]	]	-RRB-
cord-304472-mi5v6512	117	53	.	.	.
cord-304472-mi5v6512	118	1	Heterologous	Heterologous	NNP
cord-304472-mi5v6512	118	2	CYD	CYD	NNP
cord-304472-mi5v6512	118	3	-	-	HYPH
cord-304472-mi5v6512	118	4	TDV	TDV	NNP
cord-304472-mi5v6512	118	5	boost	boost	NN
cord-304472-mi5v6512	118	6	may	may	MD
cord-304472-mi5v6512	118	7	also	also	RB
cord-304472-mi5v6512	118	8	likely	likely	RB
cord-304472-mi5v6512	118	9	induce	induce	VB
cord-304472-mi5v6512	118	10	broader	broad	JJR
cord-304472-mi5v6512	118	11	cross	cross	JJ
cord-304472-mi5v6512	118	12	-	-	JJ
cord-304472-mi5v6512	118	13	reactive	reactive	JJ
cord-304472-mi5v6512	118	14	immune	immune	JJ
cord-304472-mi5v6512	118	15	responses	response	NNS
cord-304472-mi5v6512	118	16	at	at	IN
cord-304472-mi5v6512	118	17	both	both	CC
cord-304472-mi5v6512	118	18	humoral	humoral	JJ
cord-304472-mi5v6512	118	19	and	and	CC
cord-304472-mi5v6512	118	20	cellular	cellular	JJ
cord-304472-mi5v6512	118	21	levels	level	NNS
cord-304472-mi5v6512	118	22	.	.	.
cord-304472-mi5v6512	119	1	Moreover	moreover	RB
cord-304472-mi5v6512	119	2	,	,	,
cord-304472-mi5v6512	119	3	CYD	CYD	NNP
cord-304472-mi5v6512	119	4	-	-	HYPH
cord-304472-mi5v6512	119	5	TDV	TDV	NNP
cord-304472-mi5v6512	119	6	possesses	possess	VBZ
cord-304472-mi5v6512	119	7	an	an	DT
cord-304472-mi5v6512	119	8	YF-17D	YF-17D	NNP
cord-304472-mi5v6512	119	9	backbone	backbone	NN
cord-304472-mi5v6512	119	10	,	,	,
cord-304472-mi5v6512	119	11	decreasing	decrease	VBG
cord-304472-mi5v6512	119	12	the	the	DT
cord-304472-mi5v6512	119	13	risk	risk	NN
cord-304472-mi5v6512	119	14	of	of	IN
cord-304472-mi5v6512	119	15	being	be	VBG
cord-304472-mi5v6512	119	16	negatively	negatively	RB
cord-304472-mi5v6512	119	17	impacted	impact	VBN
cord-304472-mi5v6512	119	18	by	by	IN
cord-304472-mi5v6512	119	19	initial	initial	JJ
cord-304472-mi5v6512	119	20	TAK-003-induced	TAK-003-induced	NNP
cord-304472-mi5v6512	119	21	DENV2-specific	DENV2-specific	NNP
cord-304472-mi5v6512	119	22	cellular	cellular	JJ
cord-304472-mi5v6512	119	23	responses	response	NNS
cord-304472-mi5v6512	119	24	.	.	.
cord-304472-mi5v6512	120	1	A	a	DT
cord-304472-mi5v6512	120	2	DENV	DENV	NNP
cord-304472-mi5v6512	120	3	1	1	CD
cord-304472-mi5v6512	120	4	-	-	SYM
cord-304472-mi5v6512	120	5	2	2	CD
cord-304472-mi5v6512	120	6	dominant	dominant	JJ
cord-304472-mi5v6512	120	7	vaccine	vaccine	NN
cord-304472-mi5v6512	120	8	followed	follow	VBN
cord-304472-mi5v6512	120	9	by	by	IN
cord-304472-mi5v6512	120	10	a	a	DT
cord-304472-mi5v6512	120	11	DENV3	denv3	NN
cord-304472-mi5v6512	120	12	-	-	SYM
cord-304472-mi5v6512	120	13	4	4	CD
cord-304472-mi5v6512	120	14	dominant	dominant	JJ
cord-304472-mi5v6512	120	15	vaccine	vaccine	NN
cord-304472-mi5v6512	120	16	may	may	MD
cord-304472-mi5v6512	120	17	also	also	RB
cord-304472-mi5v6512	120	18	better	well	RBR
cord-304472-mi5v6512	120	19	reflect	reflect	VB
cord-304472-mi5v6512	120	20	the	the	DT
cord-304472-mi5v6512	120	21	theoretical	theoretical	JJ
cord-304472-mi5v6512	120	22	advantages	advantage	NNS
cord-304472-mi5v6512	120	23	of	of	IN
cord-304472-mi5v6512	120	24	sequential	sequential	JJ
cord-304472-mi5v6512	120	25	infections	infection	NNS
cord-304472-mi5v6512	120	26	as	as	IN
cord-304472-mi5v6512	120	27	outlined	outline	VBN
cord-304472-mi5v6512	120	28	above	above	RB
cord-304472-mi5v6512	120	29	.	.	.
cord-304472-mi5v6512	121	1	It	-PRON-	PRP
cord-304472-mi5v6512	121	2	is	be	VBZ
cord-304472-mi5v6512	121	3	likely	likely	JJ
cord-304472-mi5v6512	121	4	that	that	IN
cord-304472-mi5v6512	121	5	Takeda	Takeda	NNP
cord-304472-mi5v6512	121	6	will	will	MD
cord-304472-mi5v6512	121	7	only	only	RB
cord-304472-mi5v6512	121	8	investigate	investigate	VB
cord-304472-mi5v6512	121	9	such	such	PDT
cord-304472-mi5v6512	121	10	a	a	DT
cord-304472-mi5v6512	121	11	prime	prime	JJ
cord-304472-mi5v6512	121	12	-	-	HYPH
cord-304472-mi5v6512	121	13	boost	boost	NN
cord-304472-mi5v6512	121	14	strategy	strategy	NN
cord-304472-mi5v6512	121	15	after	after	IN
cord-304472-mi5v6512	121	16	their	-PRON-	PRP$
cord-304472-mi5v6512	121	17	vaccine	vaccine	NN
cord-304472-mi5v6512	121	18	has	have	VBZ
cord-304472-mi5v6512	121	19	been	be	VBN
cord-304472-mi5v6512	121	20	licensed	license	VBN
cord-304472-mi5v6512	121	21	.	.	.
cord-304472-mi5v6512	122	1	Combining	combine	VBG
cord-304472-mi5v6512	122	2	vaccine	vaccine	NN
cord-304472-mi5v6512	122	3	platforms	platform	NNS
cord-304472-mi5v6512	122	4	developed	develop	VBN
cord-304472-mi5v6512	122	5	by	by	IN
cord-304472-mi5v6512	122	6	competing	compete	VBG
cord-304472-mi5v6512	122	7	companies	company	NNS
cord-304472-mi5v6512	122	8	may	may	MD
cord-304472-mi5v6512	122	9	pose	pose	VB
cord-304472-mi5v6512	122	10	challenges	challenge	NNS
cord-304472-mi5v6512	122	11	,	,	,
cord-304472-mi5v6512	122	12	but	but	CC
cord-304472-mi5v6512	122	13	these	these	DT
cord-304472-mi5v6512	122	14	can	can	MD
cord-304472-mi5v6512	122	15	be	be	VB
cord-304472-mi5v6512	122	16	overcome	overcome	VBN
cord-304472-mi5v6512	122	17	.	.	.
cord-304472-mi5v6512	123	1	Next	next	JJ
cord-304472-mi5v6512	123	2	-	-	HYPH
cord-304472-mi5v6512	123	3	generation	generation	NN
cord-304472-mi5v6512	123	4	dengue	dengue	NN
cord-304472-mi5v6512	123	5	vaccines	vaccine	NNS
cord-304472-mi5v6512	123	6	in	in	IN
cord-304472-mi5v6512	123	7	development	development	NN
cord-304472-mi5v6512	123	8	include	include	VBP
cord-304472-mi5v6512	123	9	DNA	DNA	NNP
cord-304472-mi5v6512	123	10	,	,	,
cord-304472-mi5v6512	123	11	subunit	subunit	NN
cord-304472-mi5v6512	123	12	,	,	,
cord-304472-mi5v6512	123	13	virus	virus	NN
cord-304472-mi5v6512	123	14	-	-	HYPH
cord-304472-mi5v6512	123	15	like	like	JJ
cord-304472-mi5v6512	123	16	particles	particle	NNS
cord-304472-mi5v6512	123	17	(	(	-LRB-
cord-304472-mi5v6512	123	18	VLP	VLP	NNP
cord-304472-mi5v6512	123	19	)	)	-RRB-
cord-304472-mi5v6512	123	20	and	and	CC
cord-304472-mi5v6512	123	21	viral	viral	JJ
cord-304472-mi5v6512	123	22	vector	vector	NN
cord-304472-mi5v6512	123	23	vaccines	vaccine	NNS
cord-304472-mi5v6512	123	24	[	[	-LRB-
cord-304472-mi5v6512	123	25	65	65	CD
cord-304472-mi5v6512	123	26	]	]	-RRB-
cord-304472-mi5v6512	123	27	.	.	.
cord-304472-mi5v6512	124	1	Two	two	CD
cord-304472-mi5v6512	124	2	phase	phase	NN
cord-304472-mi5v6512	124	3	I	-PRON-	PRP
cord-304472-mi5v6512	124	4	clinical	clinical	JJ
cord-304472-mi5v6512	124	5	trials	trial	NNS
cord-304472-mi5v6512	124	6	were	be	VBD
cord-304472-mi5v6512	124	7	conducted	conduct	VBN
cord-304472-mi5v6512	124	8	to	to	TO
cord-304472-mi5v6512	124	9	evaluate	evaluate	VB
cord-304472-mi5v6512	124	10	the	the	DT
cord-304472-mi5v6512	124	11	safety	safety	NN
cord-304472-mi5v6512	124	12	and	and	CC
cord-304472-mi5v6512	124	13	efficacy	efficacy	NN
cord-304472-mi5v6512	124	14	of	of	IN
cord-304472-mi5v6512	124	15	the	the	DT
cord-304472-mi5v6512	124	16	tetravalent	tetravalent	NN
cord-304472-mi5v6512	124	17	formulation	formulation	NN
cord-304472-mi5v6512	124	18	purified	purify	VBN
cord-304472-mi5v6512	124	19	inactivated	inactivated	JJ
cord-304472-mi5v6512	124	20	vaccine	vaccine	NN
cord-304472-mi5v6512	124	21	combined	combine	VBN
cord-304472-mi5v6512	124	22	with	with	IN
cord-304472-mi5v6512	124	23	different	different	JJ
cord-304472-mi5v6512	124	24	adjuvants	adjuvant	NNS
cord-304472-mi5v6512	124	25	(	(	-LRB-
cord-304472-mi5v6512	124	26	e.g.	e.g.	IN
cord-304472-mi5v6512	124	27	aluminium	aluminium	NN
cord-304472-mi5v6512	124	28	hydroxide	hydroxide	NN
cord-304472-mi5v6512	124	29	,	,	,
cord-304472-mi5v6512	124	30	AS01E	as01e	NN
cord-304472-mi5v6512	124	31	or	or	CC
cord-304472-mi5v6512	124	32	AS03B	as03b	LS
cord-304472-mi5v6512	124	33	)	)	-RRB-
cord-304472-mi5v6512	124	34	[	[	-LRB-
cord-304472-mi5v6512	124	35	66	66	CD
cord-304472-mi5v6512	124	36	,	,	,
cord-304472-mi5v6512	124	37	67	67	CD
cord-304472-mi5v6512	124	38	]	]	-RRB-
cord-304472-mi5v6512	124	39	.	.	.
cord-304472-mi5v6512	125	1	All	all	DT
cord-304472-mi5v6512	125	2	formulations	formulation	NNS
cord-304472-mi5v6512	125	3	were	be	VBD
cord-304472-mi5v6512	125	4	well	well	RB
cord-304472-mi5v6512	125	5	tolerated	tolerate	VBN
cord-304472-mi5v6512	125	6	and	and	CC
cord-304472-mi5v6512	125	7	induced	induce	VBD
cord-304472-mi5v6512	125	8	a	a	DT
cord-304472-mi5v6512	125	9	balanced	balanced	JJ
cord-304472-mi5v6512	125	10	immune	immune	JJ
cord-304472-mi5v6512	125	11	response	response	NN
cord-304472-mi5v6512	125	12	against	against	IN
cord-304472-mi5v6512	125	13	all	all	DT
cord-304472-mi5v6512	125	14	four	four	CD
cord-304472-mi5v6512	125	15	serotypes	serotype	NNS
cord-304472-mi5v6512	125	16	,	,	,
cord-304472-mi5v6512	125	17	with	with	IN
cord-304472-mi5v6512	125	18	the	the	DT
cord-304472-mi5v6512	125	19	highest	high	JJS
cord-304472-mi5v6512	125	20	mean	mean	JJ
cord-304472-mi5v6512	125	21	antibody	antibody	NN
cord-304472-mi5v6512	125	22	titers	titer	NNS
cord-304472-mi5v6512	125	23	reached	reach	VBD
cord-304472-mi5v6512	125	24	with	with	IN
cord-304472-mi5v6512	125	25	AS01E	as01e	NN
cord-304472-mi5v6512	125	26	and	and	CC
cord-304472-mi5v6512	125	27	AS03B.	AS03B.	NNP
cord-304472-mi5v6512	125	28	A	a	DT
cord-304472-mi5v6512	125	29	phase	phase	NN
cord-304472-mi5v6512	125	30	2	2	CD
cord-304472-mi5v6512	125	31	trial	trial	NN
cord-304472-mi5v6512	125	32	is	be	VBZ
cord-304472-mi5v6512	125	33	currently	currently	RB
cord-304472-mi5v6512	125	34	evaluating	evaluate	VBG
cord-304472-mi5v6512	125	35	a	a	DT
cord-304472-mi5v6512	125	36	tetravalent	tetravalent	NN
cord-304472-mi5v6512	125	37	purified	purify	VBN
cord-304472-mi5v6512	125	38	inactivated	inactivate	VBN
cord-304472-mi5v6512	125	39	dengue	dengue	NN
cord-304472-mi5v6512	125	40	vaccine	vaccine	NN
cord-304472-mi5v6512	125	41	with	with	IN
cord-304472-mi5v6512	125	42	AS03B	as03b	NN
cord-304472-mi5v6512	125	43	to	to	TO
cord-304472-mi5v6512	125	44	determine	determine	VB
cord-304472-mi5v6512	125	45	the	the	DT
cord-304472-mi5v6512	125	46	most	most	RBS
cord-304472-mi5v6512	125	47	effective	effective	JJ
cord-304472-mi5v6512	125	48	injection	injection	NN
cord-304472-mi5v6512	125	49	schedule	schedule	NN
cord-304472-mi5v6512	125	50	(	(	-LRB-
cord-304472-mi5v6512	125	51	0	0	CD
cord-304472-mi5v6512	125	52	-	-	SYM
cord-304472-mi5v6512	125	53	1	1	CD
cord-304472-mi5v6512	125	54	,	,	,
cord-304472-mi5v6512	125	55	0	0	CD
cord-304472-mi5v6512	125	56	-	-	HYPH
cord-304472-mi5v6512	125	57	1	1	CD
cord-304472-mi5v6512	125	58	-	-	SYM
cord-304472-mi5v6512	125	59	6	6	CD
cord-304472-mi5v6512	125	60	,	,	,
cord-304472-mi5v6512	125	61	or	or	CC
cord-304472-mi5v6512	125	62	0	0	CD
cord-304472-mi5v6512	125	63	-	-	SYM
cord-304472-mi5v6512	125	64	3	3	CD
cord-304472-mi5v6512	125	65	months	month	NNS
cord-304472-mi5v6512	125	66	)	)	-RRB-
cord-304472-mi5v6512	126	1	(	(	-LRB-
cord-304472-mi5v6512	126	2	NCT02421367	nct02421367	NN
cord-304472-mi5v6512	126	3	)	)	-RRB-
cord-304472-mi5v6512	127	1	The	the	DT
cord-304472-mi5v6512	127	2	emergence	emergence	NN
cord-304472-mi5v6512	127	3	of	of	IN
cord-304472-mi5v6512	127	4	Zika	Zika	NNP
cord-304472-mi5v6512	127	5	virus	virus	NN
cord-304472-mi5v6512	127	6	as	as	IN
cord-304472-mi5v6512	127	7	a	a	DT
cord-304472-mi5v6512	127	8	public	public	JJ
cord-304472-mi5v6512	127	9	health	health	NN
cord-304472-mi5v6512	127	10	problem	problem	NN
cord-304472-mi5v6512	127	11	of	of	IN
cord-304472-mi5v6512	127	12	international	international	JJ
cord-304472-mi5v6512	127	13	concern	concern	NN
cord-304472-mi5v6512	127	14	in	in	IN
cord-304472-mi5v6512	127	15	early	early	JJ
cord-304472-mi5v6512	127	16	2016	2016	CD
cord-304472-mi5v6512	127	17	,	,	,
cord-304472-mi5v6512	127	18	a	a	DT
cord-304472-mi5v6512	127	19	vector	vector	NN
cord-304472-mi5v6512	127	20	-	-	HYPH
cord-304472-mi5v6512	127	21	borne	bear	VBN
cord-304472-mi5v6512	127	22	virus	virus	NN
cord-304472-mi5v6512	127	23	with	with	IN
cord-304472-mi5v6512	127	24	close	close	JJ
cord-304472-mi5v6512	127	25	genetic	genetic	JJ
cord-304472-mi5v6512	127	26	similarity	similarity	NN
cord-304472-mi5v6512	127	27	to	to	IN
cord-304472-mi5v6512	127	28	dengue	dengue	NN
cord-304472-mi5v6512	127	29	viruses	virus	NNS
cord-304472-mi5v6512	127	30	,	,	,
cord-304472-mi5v6512	127	31	was	be	VBD
cord-304472-mi5v6512	127	32	the	the	DT
cord-304472-mi5v6512	127	33	first	first	JJ
cord-304472-mi5v6512	127	34	challenge	challenge	NN
cord-304472-mi5v6512	127	35	to	to	IN
cord-304472-mi5v6512	127	36	dengue	dengue	NN
cord-304472-mi5v6512	127	37	vaccine	vaccine	NN
cord-304472-mi5v6512	127	38	development	development	NN
cord-304472-mi5v6512	127	39	,	,	,
cord-304472-mi5v6512	127	40	followed	follow	VBN
cord-304472-mi5v6512	127	41	by	by	IN
cord-304472-mi5v6512	127	42	the	the	DT
cord-304472-mi5v6512	127	43	emergence	emergence	NN
cord-304472-mi5v6512	127	44	of	of	IN
cord-304472-mi5v6512	127	45	another	another	DT
cord-304472-mi5v6512	127	46	virus	virus	NN
cord-304472-mi5v6512	127	47	by	by	IN
cord-304472-mi5v6512	127	48	late	late	JJ
cord-304472-mi5v6512	127	49	2019	2019	CD
cord-304472-mi5v6512	127	50	,	,	,
cord-304472-mi5v6512	127	51	not	not	RB
cord-304472-mi5v6512	127	52	related	relate	VBN
cord-304472-mi5v6512	127	53	to	to	IN
cord-304472-mi5v6512	127	54	dengue	dengue	NN
cord-304472-mi5v6512	127	55	,	,	.
cord-304472-mi5v6512	128	1	SARS	SARS	NNP
cord-304472-mi5v6512	128	2	-	-	HYPH
cord-304472-mi5v6512	128	3	CoV-2	CoV-2	NNP
cord-304472-mi5v6512	128	4	causing	cause	VBG
cord-304472-mi5v6512	128	5	coronavirus	coronavirus	NN
cord-304472-mi5v6512	128	6	related	relate	VBN
cord-304472-mi5v6512	128	7	disease	disease	NN
cord-304472-mi5v6512	128	8	(	(	-LRB-
cord-304472-mi5v6512	128	9	COVID-19	COVID-19	NNP
cord-304472-mi5v6512	128	10	)	)	-RRB-
cord-304472-mi5v6512	128	11	.	.	.
cord-304472-mi5v6512	129	1	Although	although	IN
cord-304472-mi5v6512	129	2	dengue	dengue	NN
cord-304472-mi5v6512	129	3	virus	virus	NN
cord-304472-mi5v6512	129	4	is	be	VBZ
cord-304472-mi5v6512	129	5	not	not	RB
cord-304472-mi5v6512	129	6	associated	associate	VBN
cord-304472-mi5v6512	129	7	with	with	IN
cord-304472-mi5v6512	129	8	severe	severe	JJ
cord-304472-mi5v6512	129	9	pregnancy	pregnancy	NN
cord-304472-mi5v6512	129	10	outcomes	outcome	NNS
cord-304472-mi5v6512	129	11	as	as	IN
cord-304472-mi5v6512	129	12	Zika	Zika	NNP
cord-304472-mi5v6512	129	13	[	[	-LRB-
cord-304472-mi5v6512	129	14	68	68	CD
cord-304472-mi5v6512	129	15	]	]	-RRB-
cord-304472-mi5v6512	129	16	,	,	,
cord-304472-mi5v6512	129	17	not	not	RB
cord-304472-mi5v6512	129	18	thought	think	VBN
cord-304472-mi5v6512	129	19	to	to	TO
cord-304472-mi5v6512	129	20	be	be	VB
cord-304472-mi5v6512	129	21	sexually	sexually	RB
cord-304472-mi5v6512	129	22	transmitted	transmit	VBN
cord-304472-mi5v6512	129	23	[	[	-LRB-
cord-304472-mi5v6512	129	24	69	69	CD
cord-304472-mi5v6512	129	25	,	,	,
cord-304472-mi5v6512	129	26	70	70	CD
cord-304472-mi5v6512	129	27	]	]	-RRB-
cord-304472-mi5v6512	129	28	and	and	CC
cord-304472-mi5v6512	129	29	not	not	RB
cord-304472-mi5v6512	129	30	as	as	RB
cord-304472-mi5v6512	129	31	strongly	strongly	RB
cord-304472-mi5v6512	129	32	associated	associate	VBN
cord-304472-mi5v6512	129	33	with	with	IN
cord-304472-mi5v6512	129	34	neurological	neurological	JJ
cord-304472-mi5v6512	129	35	complications	complication	NNS
cord-304472-mi5v6512	129	36	such	such	JJ
cord-304472-mi5v6512	129	37	as	as	IN
cord-304472-mi5v6512	129	38	Guillain	Guillain	NNP
cord-304472-mi5v6512	129	39	-	-	HYPH
cord-304472-mi5v6512	129	40	Barre	Barre	NNP
cord-304472-mi5v6512	129	41	Syndrome	Syndrome	NNP
cord-304472-mi5v6512	129	42	[	[	-LRB-
cord-304472-mi5v6512	129	43	71	71	CD
cord-304472-mi5v6512	129	44	]	]	-RRB-
cord-304472-mi5v6512	129	45	,	,	.
cord-304472-mi5v6512	130	1	the	the	DT
cord-304472-mi5v6512	130	2	emergence	emergence	NN
cord-304472-mi5v6512	130	3	of	of	IN
cord-304472-mi5v6512	130	4	Zika	Zika	NNP
cord-304472-mi5v6512	130	5	has	have	VBZ
cord-304472-mi5v6512	130	6	complicated	complicate	VBN
cord-304472-mi5v6512	130	7	dengue	dengue	NN
cord-304472-mi5v6512	130	8	vaccine	vaccine	NN
cord-304472-mi5v6512	130	9	development	development	NN
cord-304472-mi5v6512	130	10	because	because	IN
cord-304472-mi5v6512	130	11	of	of	IN
cord-304472-mi5v6512	130	12	the	the	DT
cord-304472-mi5v6512	130	13	potential	potential	JJ
cord-304472-mi5v6512	130	14	immunological	immunological	JJ
cord-304472-mi5v6512	130	15	interaction	interaction	NN
cord-304472-mi5v6512	130	16	between	between	IN
cord-304472-mi5v6512	130	17	these	these	DT
cord-304472-mi5v6512	130	18	closely	closely	RB
cord-304472-mi5v6512	130	19	related	related	JJ
cord-304472-mi5v6512	130	20	viruses	virus	NNS
cord-304472-mi5v6512	130	21	.	.	.
cord-304472-mi5v6512	131	1	By	by	IN
cord-304472-mi5v6512	131	2	acquiring	acquire	VBG
cord-304472-mi5v6512	131	3	cytotoxic	cytotoxic	JJ
cord-304472-mi5v6512	131	4	T	t	NN
cord-304472-mi5v6512	131	5	-	-	HYPH
cord-304472-mi5v6512	131	6	cell	cell	NN
cord-304472-mi5v6512	131	7	epitope	epitope	NN
cord-304472-mi5v6512	131	8	-	-	HYPH
cord-304472-mi5v6512	131	9	rich	rich	JJ
cord-304472-mi5v6512	131	10	regions	region	NNS
cord-304472-mi5v6512	131	11	from	from	IN
cord-304472-mi5v6512	131	12	Culex	Culex	NNP
cord-304472-mi5v6512	131	13	-	-	HYPH
cord-304472-mi5v6512	131	14	borne	bear	VBN
cord-304472-mi5v6512	131	15	flaviviruses	flavivirus	NNS
cord-304472-mi5v6512	131	16	,	,	,
cord-304472-mi5v6512	131	17	ZIKV	ZIKV	NNP
cord-304472-mi5v6512	131	18	evaded	evade	VBD
cord-304472-mi5v6512	131	19	DENV	DENV	NNP
cord-304472-mi5v6512	131	20	-	-	HYPH
cord-304472-mi5v6512	131	21	generated	generate	VBN
cord-304472-mi5v6512	131	22	T	t	NN
cord-304472-mi5v6512	131	23	-	-	HYPH
cord-304472-mi5v6512	131	24	cell	cell	NN
cord-304472-mi5v6512	131	25	immune	immune	JJ
cord-304472-mi5v6512	131	26	cross	cross	NN
cord-304472-mi5v6512	131	27	-	-	NN
cord-304472-mi5v6512	131	28	protection	protection	JJ
cord-304472-mi5v6512	131	29	[	[	-LRB-
cord-304472-mi5v6512	131	30	72	72	CD
cord-304472-mi5v6512	131	31	]	]	-RRB-
cord-304472-mi5v6512	131	32	.	.	.
cord-304472-mi5v6512	132	1	Interestingly	interestingly	RB
cord-304472-mi5v6512	132	2	,	,	,
cord-304472-mi5v6512	132	3	pre	pre	JJ
cord-304472-mi5v6512	132	4	-	-	JJ
cord-304472-mi5v6512	132	5	existing	existing	JJ
cord-304472-mi5v6512	132	6	dengue	dengue	NN
cord-304472-mi5v6512	132	7	immunity	immunity	NN
cord-304472-mi5v6512	132	8	has	have	VBZ
cord-304472-mi5v6512	132	9	minimal	minimal	JJ
cord-304472-mi5v6512	132	10	impact	impact	NN
cord-304472-mi5v6512	132	11	on	on	IN
cord-304472-mi5v6512	132	12	the	the	DT
cord-304472-mi5v6512	132	13	innate	innate	JJ
cord-304472-mi5v6512	132	14	immune	immune	JJ
cord-304472-mi5v6512	132	15	response	response	NN
cord-304472-mi5v6512	132	16	to	to	IN
cord-304472-mi5v6512	132	17	Zika	Zika	NNP
cord-304472-mi5v6512	132	18	[	[	-LRB-
cord-304472-mi5v6512	132	19	73	73	CD
cord-304472-mi5v6512	132	20	]	]	-RRB-
cord-304472-mi5v6512	132	21	.	.	.
cord-304472-mi5v6512	133	1	Primary	primary	JJ
cord-304472-mi5v6512	133	2	and	and	CC
cord-304472-mi5v6512	133	3	secondary	secondary	JJ
cord-304472-mi5v6512	133	4	DENV	DENV	NNP
cord-304472-mi5v6512	133	5	elicit	elicit	VBP
cord-304472-mi5v6512	133	6	similar	similar	JJ
cord-304472-mi5v6512	133	7	memory	memory	NN
cord-304472-mi5v6512	133	8	B	b	NN
cord-304472-mi5v6512	133	9	-	-	HYPH
cord-304472-mi5v6512	133	10	Cell	cell	NN
cord-304472-mi5v6512	133	11	responses	response	NNS
cord-304472-mi5v6512	133	12	,	,	,
cord-304472-mi5v6512	133	13	but	but	CC
cord-304472-mi5v6512	133	14	breadth	breadth	NN
cord-304472-mi5v6512	133	15	to	to	IN
cord-304472-mi5v6512	133	16	other	other	JJ
cord-304472-mi5v6512	133	17	serotypes	serotype	NNS
cord-304472-mi5v6512	133	18	and	and	CC
cord-304472-mi5v6512	133	19	cross	cross	NN
cord-304472-mi5v6512	133	20	-	-	NN
cord-304472-mi5v6512	133	21	reactivity	reactivity	NN
cord-304472-mi5v6512	133	22	to	to	IN
cord-304472-mi5v6512	133	23	Zika	Zika	NNP
cord-304472-mi5v6512	133	24	virus	virus	NN
cord-304472-mi5v6512	133	25	is	be	VBZ
cord-304472-mi5v6512	133	26	higher	high	JJR
cord-304472-mi5v6512	133	27	in	in	IN
cord-304472-mi5v6512	133	28	secondary	secondary	JJ
cord-304472-mi5v6512	133	29	dengue	dengue	NN
cord-304472-mi5v6512	133	30	[	[	-LRB-
cord-304472-mi5v6512	133	31	74	74	CD
cord-304472-mi5v6512	133	32	]	]	-RRB-
cord-304472-mi5v6512	133	33	.	.	.
cord-304472-mi5v6512	134	1	Immunity	immunity	NN
cord-304472-mi5v6512	134	2	to	to	IN
cord-304472-mi5v6512	134	3	DENV	DENV	NNP
cord-304472-mi5v6512	134	4	only	only	RB
cord-304472-mi5v6512	134	5	modestly	modestly	RB
cord-304472-mi5v6512	134	6	shapes	shape	VBZ
cord-304472-mi5v6512	134	7	breadth	breadth	NN
cord-304472-mi5v6512	134	8	and	and	CC
cord-304472-mi5v6512	134	9	magnitude	magnitude	NN
cord-304472-mi5v6512	134	10	of	of	IN
cord-304472-mi5v6512	134	11	enduring	endure	VBG
cord-304472-mi5v6512	134	12	ZIKV	ZIKV	NNP
cord-304472-mi5v6512	134	13	antibody	antibody	NN
cord-304472-mi5v6512	134	14	responses	response	NNS
cord-304472-mi5v6512	134	15	[	[	-LRB-
cord-304472-mi5v6512	134	16	75	75	CD
cord-304472-mi5v6512	134	17	]	]	-RRB-
cord-304472-mi5v6512	134	18	.	.	.
cord-304472-mi5v6512	135	1	While	while	IN
cord-304472-mi5v6512	135	2	the	the	DT
cord-304472-mi5v6512	135	3	evidence	evidence	NN
cord-304472-mi5v6512	135	4	is	be	VBZ
cord-304472-mi5v6512	135	5	mounting	mount	VBG
cord-304472-mi5v6512	135	6	that	that	IN
cord-304472-mi5v6512	135	7	preexisting	preexist	VBG
cord-304472-mi5v6512	135	8	high	high	JJ
cord-304472-mi5v6512	135	9	antibody	antibody	NN
cord-304472-mi5v6512	135	10	titers	titer	NNS
cord-304472-mi5v6512	135	11	to	to	IN
cord-304472-mi5v6512	135	12	dengue	dengue	NN
cord-304472-mi5v6512	135	13	virus	virus	NN
cord-304472-mi5v6512	135	14	were	be	VBD
cord-304472-mi5v6512	135	15	associated	associate	VBN
cord-304472-mi5v6512	135	16	with	with	IN
cord-304472-mi5v6512	135	17	reduced	reduced	JJ
cord-304472-mi5v6512	135	18	risk	risk	NN
cord-304472-mi5v6512	135	19	of	of	IN
cord-304472-mi5v6512	135	20	ZIKV	ZIKV	NNP
cord-304472-mi5v6512	135	21	infection	infection	NN
cord-304472-mi5v6512	135	22	and	and	CC
cord-304472-mi5v6512	135	23	symptoms	symptom	NNS
cord-304472-mi5v6512	135	24	[	[	-LRB-
cord-304472-mi5v6512	135	25	76	76	CD
cord-304472-mi5v6512	135	26	]	]	-RRB-
cord-304472-mi5v6512	135	27	,	,	,
cord-304472-mi5v6512	135	28	there	there	EX
cord-304472-mi5v6512	135	29	is	be	VBZ
cord-304472-mi5v6512	135	30	still	still	RB
cord-304472-mi5v6512	135	31	lack	lack	NN
cord-304472-mi5v6512	135	32	of	of	IN
cord-304472-mi5v6512	135	33	data	datum	NNS
cord-304472-mi5v6512	135	34	on	on	IN
cord-304472-mi5v6512	135	35	whether	whether	IN
cord-304472-mi5v6512	135	36	pre	pre	JJ
cord-304472-mi5v6512	135	37	-	-	JJ
cord-304472-mi5v6512	135	38	existing	existing	JJ
cord-304472-mi5v6512	135	39	immunity	immunity	NN
cord-304472-mi5v6512	135	40	to	to	IN
cord-304472-mi5v6512	135	41	Zika	Zika	NNP
cord-304472-mi5v6512	135	42	protects	protect	VBZ
cord-304472-mi5v6512	135	43	against	against	IN
cord-304472-mi5v6512	135	44	or	or	CC
cord-304472-mi5v6512	135	45	enhances	enhance	VBZ
cord-304472-mi5v6512	135	46	a	a	DT
cord-304472-mi5v6512	135	47	subsequent	subsequent	JJ
cord-304472-mi5v6512	135	48	dengue	dengue	NN
cord-304472-mi5v6512	135	49	infection	infection	NN
cord-304472-mi5v6512	135	50	.	.	.
cord-304472-mi5v6512	136	1	These	these	DT
cord-304472-mi5v6512	136	2	are	be	VBP
cord-304472-mi5v6512	136	3	data	datum	NNS
cord-304472-mi5v6512	136	4	gaps	gap	NNS
cord-304472-mi5v6512	136	5	that	that	WDT
cord-304472-mi5v6512	136	6	need	need	VBP
cord-304472-mi5v6512	136	7	to	to	TO
cord-304472-mi5v6512	136	8	be	be	VB
cord-304472-mi5v6512	136	9	addressed	address	VBN
cord-304472-mi5v6512	136	10	for	for	IN
cord-304472-mi5v6512	136	11	dengue	dengue	NN
cord-304472-mi5v6512	136	12	vaccine	vaccine	NN
cord-304472-mi5v6512	136	13	development	development	NN
cord-304472-mi5v6512	136	14	.	.	.
cord-304472-mi5v6512	137	1	Clearly	clearly	RB
cord-304472-mi5v6512	137	2	,	,	,
cord-304472-mi5v6512	137	3	the	the	DT
cord-304472-mi5v6512	137	4	presence	presence	NN
cord-304472-mi5v6512	137	5	of	of	IN
cord-304472-mi5v6512	137	6	co	co	JJ
cord-304472-mi5v6512	137	7	-	-	JJ
cord-304472-mi5v6512	137	8	circulating	circulating	JJ
cord-304472-mi5v6512	137	9	arboviruses	arbovirus	NNS
cord-304472-mi5v6512	137	10	such	such	JJ
cord-304472-mi5v6512	137	11	as	as	IN
cord-304472-mi5v6512	137	12	dengue	dengue	NN
cord-304472-mi5v6512	137	13	and	and	CC
cord-304472-mi5v6512	137	14	Zika	Zika	NNP
cord-304472-mi5v6512	137	15	increases	increase	VBZ
cord-304472-mi5v6512	137	16	the	the	DT
cord-304472-mi5v6512	137	17	chance	chance	NN
cord-304472-mi5v6512	137	18	of	of	IN
cord-304472-mi5v6512	137	19	co	co	NN
cord-304472-mi5v6512	137	20	-	-	NN
cord-304472-mi5v6512	137	21	infection	infection	NN
cord-304472-mi5v6512	137	22	and	and	CC
cord-304472-mi5v6512	137	23	demonstrates	demonstrate	VBZ
cord-304472-mi5v6512	137	24	the	the	DT
cord-304472-mi5v6512	137	25	importance	importance	NN
cord-304472-mi5v6512	137	26	of	of	IN
cord-304472-mi5v6512	137	27	the	the	DT
cord-304472-mi5v6512	137	28	differential	differential	JJ
cord-304472-mi5v6512	137	29	diagnosis	diagnosis	NN
cord-304472-mi5v6512	137	30	,	,	,
cord-304472-mi5v6512	137	31	especially	especially	RB
cord-304472-mi5v6512	137	32	during	during	IN
cord-304472-mi5v6512	137	33	periods	period	NNS
cord-304472-mi5v6512	137	34	of	of	IN
cord-304472-mi5v6512	137	35	arboviral	arboviral	JJ
cord-304472-mi5v6512	137	36	outbreaks	outbreak	NNS
cord-304472-mi5v6512	137	37	[	[	-LRB-
cord-304472-mi5v6512	137	38	77	77	CD
cord-304472-mi5v6512	137	39	]	]	-RRB-
cord-304472-mi5v6512	137	40	,	,	,
cord-304472-mi5v6512	137	41	and	and	CC
cord-304472-mi5v6512	137	42	this	this	DT
cord-304472-mi5v6512	137	43	needs	need	VBZ
cord-304472-mi5v6512	137	44	to	to	TO
cord-304472-mi5v6512	137	45	be	be	VB
cord-304472-mi5v6512	137	46	taken	take	VBN
cord-304472-mi5v6512	137	47	into	into	IN
cord-304472-mi5v6512	137	48	consideration	consideration	NN
cord-304472-mi5v6512	137	49	for	for	IN
cord-304472-mi5v6512	137	50	clinical	clinical	JJ
cord-304472-mi5v6512	137	51	trial	trial	NN
cord-304472-mi5v6512	137	52	design	design	NN
cord-304472-mi5v6512	137	53	.	.	.
cord-304472-mi5v6512	138	1	The	the	DT
cord-304472-mi5v6512	138	2	current	current	JJ
cord-304472-mi5v6512	138	3	COVID-19	covid-19	JJ
cord-304472-mi5v6512	138	4	pandemic	pandemic	NN
cord-304472-mi5v6512	138	5	has	have	VBZ
cord-304472-mi5v6512	138	6	placed	place	VBN
cord-304472-mi5v6512	138	7	immense	immense	JJ
cord-304472-mi5v6512	138	8	pressure	pressure	NN
cord-304472-mi5v6512	138	9	on	on	IN
cord-304472-mi5v6512	138	10	health	health	NN
cord-304472-mi5v6512	138	11	care	care	NN
cord-304472-mi5v6512	138	12	and	and	CC
cord-304472-mi5v6512	138	13	public	public	JJ
cord-304472-mi5v6512	138	14	health	health	NN
cord-304472-mi5v6512	138	15	systems	system	NNS
cord-304472-mi5v6512	138	16	worldwide	worldwide	RB
cord-304472-mi5v6512	138	17	.	.	.
cord-304472-mi5v6512	139	1	COVID-19	COVID-19	NNP
cord-304472-mi5v6512	139	2	and	and	CC
cord-304472-mi5v6512	139	3	dengue	dengue	NN
cord-304472-mi5v6512	139	4	co	co	NNS
cord-304472-mi5v6512	139	5	-	-	NNS
cord-304472-mi5v6512	139	6	infections	infection	NNS
cord-304472-mi5v6512	139	7	have	have	VBP
cord-304472-mi5v6512	139	8	been	be	VBN
cord-304472-mi5v6512	139	9	reported	report	VBN
cord-304472-mi5v6512	139	10	[	[	-LRB-
cord-304472-mi5v6512	139	11	78	78	CD
cord-304472-mi5v6512	139	12	]	]	-RRB-
cord-304472-mi5v6512	139	13	.	.	.
cord-304472-mi5v6512	140	1	The	the	DT
cord-304472-mi5v6512	140	2	response	response	NN
cord-304472-mi5v6512	140	3	to	to	IN
cord-304472-mi5v6512	140	4	this	this	DT
cord-304472-mi5v6512	140	5	pandemic	pandemic	NN
cord-304472-mi5v6512	140	6	unfortunately	unfortunately	RB
cord-304472-mi5v6512	140	7	has	have	VBZ
cord-304472-mi5v6512	140	8	diverted	divert	VBN
cord-304472-mi5v6512	140	9	resources	resource	NNS
cord-304472-mi5v6512	140	10	and	and	CC
cord-304472-mi5v6512	140	11	finances	finance	NNS
cord-304472-mi5v6512	140	12	;	;	:
cord-304472-mi5v6512	140	13	and	and	CC
cord-304472-mi5v6512	140	14	pushed	push	VBD
cord-304472-mi5v6512	140	15	dengue	dengue	NN
cord-304472-mi5v6512	140	16	vaccine	vaccine	NN
cord-304472-mi5v6512	140	17	development	development	NN
cord-304472-mi5v6512	140	18	out	out	IN
cord-304472-mi5v6512	140	19	of	of	IN
cord-304472-mi5v6512	140	20	the	the	DT
cord-304472-mi5v6512	140	21	international	international	JJ
cord-304472-mi5v6512	140	22	spotlight	spotlight	NN
cord-304472-mi5v6512	140	23	.	.	.
cord-304472-mi5v6512	141	1	A	a	DT
cord-304472-mi5v6512	141	2	resurgence	resurgence	NN
cord-304472-mi5v6512	141	3	of	of	IN
cord-304472-mi5v6512	141	4	dengue	dengue	NN
cord-304472-mi5v6512	141	5	is	be	VBZ
cord-304472-mi5v6512	141	6	a	a	DT
cord-304472-mi5v6512	141	7	real	real	JJ
cord-304472-mi5v6512	141	8	threat	threat	NN
cord-304472-mi5v6512	141	9	during	during	IN
cord-304472-mi5v6512	141	10	the	the	DT
cord-304472-mi5v6512	141	11	COVID-19	covid-19	JJ
cord-304472-mi5v6512	141	12	pandemic	pandemic	NN
cord-304472-mi5v6512	141	13	because	because	IN
cord-304472-mi5v6512	141	14	the	the	DT
cord-304472-mi5v6512	141	15	high	high	JJ
cord-304472-mi5v6512	141	16	burden	burden	NN
cord-304472-mi5v6512	141	17	of	of	IN
cord-304472-mi5v6512	141	18	dengue	dengue	NN
cord-304472-mi5v6512	141	19	related	relate	VBN
cord-304472-mi5v6512	141	20	hospitalizations	hospitalization	NNS
cord-304472-mi5v6512	141	21	will	will	MD
cord-304472-mi5v6512	141	22	further	further	RB
cord-304472-mi5v6512	141	23	overwhelm	overwhelm	VB
cord-304472-mi5v6512	141	24	already	already	RB
cord-304472-mi5v6512	141	25	overwhelmed	overwhelm	VBN
cord-304472-mi5v6512	141	26	healthcare	healthcare	NN
cord-304472-mi5v6512	141	27	systems	system	NNS
cord-304472-mi5v6512	141	28	[	[	-LRB-
cord-304472-mi5v6512	141	29	79	79	CD
cord-304472-mi5v6512	141	30	]	]	-RRB-
cord-304472-mi5v6512	141	31	.	.	.
cord-304472-mi5v6512	142	1	The	the	DT
cord-304472-mi5v6512	142	2	COVID-19	covid-19	CD
cord-304472-mi5v6512	142	3	pandemic	pandemic	NN
cord-304472-mi5v6512	142	4	therefore	therefore	RB
cord-304472-mi5v6512	142	5	provides	provide	VBZ
cord-304472-mi5v6512	142	6	even	even	RB
cord-304472-mi5v6512	142	7	more	more	JJR
cord-304472-mi5v6512	142	8	impetus	impetus	NN
cord-304472-mi5v6512	142	9	to	to	TO
cord-304472-mi5v6512	142	10	develop	develop	VB
cord-304472-mi5v6512	142	11	,	,	,
cord-304472-mi5v6512	142	12	license	license	VB
cord-304472-mi5v6512	142	13	and	and	CC
cord-304472-mi5v6512	142	14	roll	roll	VB
cord-304472-mi5v6512	142	15	out	out	RP
cord-304472-mi5v6512	142	16	dengue	dengue	NN
cord-304472-mi5v6512	142	17	vaccines	vaccine	NNS
cord-304472-mi5v6512	142	18	for	for	IN
cord-304472-mi5v6512	142	19	broader	broad	JJR
cord-304472-mi5v6512	142	20	use	use	NN
cord-304472-mi5v6512	142	21	.	.	.
cord-304472-mi5v6512	143	1	The	the	DT
cord-304472-mi5v6512	143	2	first	first	JJ
cord-304472-mi5v6512	143	3	licensed	licensed	JJ
cord-304472-mi5v6512	143	4	dengue	dengue	NN
cord-304472-mi5v6512	143	5	vaccine	vaccine	NN
cord-304472-mi5v6512	143	6	led	lead	VBD
cord-304472-mi5v6512	143	7	to	to	IN
cord-304472-mi5v6512	143	8	considerable	considerable	JJ
cord-304472-mi5v6512	143	9	controversy	controversy	NN
cord-304472-mi5v6512	143	10	,	,	,
cord-304472-mi5v6512	143	11	and	and	CC
cord-304472-mi5v6512	143	12	to	to	IN
cord-304472-mi5v6512	143	13	date	date	NN
cord-304472-mi5v6512	143	14	,	,	,
cord-304472-mi5v6512	143	15	no	no	DT
cord-304472-mi5v6512	143	16	dengue	dengue	NN
cord-304472-mi5v6512	143	17	vaccine	vaccine	NN
cord-304472-mi5v6512	143	18	is	be	VBZ
cord-304472-mi5v6512	143	19	in	in	IN
cord-304472-mi5v6512	143	20	widespread	widespread	JJ
cord-304472-mi5v6512	143	21	use	use	NN
cord-304472-mi5v6512	143	22	.	.	.
cord-304472-mi5v6512	144	1	All	all	DT
cord-304472-mi5v6512	144	2	three	three	CD
cord-304472-mi5v6512	144	3	leading	lead	VBG
cord-304472-mi5v6512	144	4	dengue	dengue	NN
cord-304472-mi5v6512	144	5	vaccine	vaccine	NN
cord-304472-mi5v6512	144	6	candidates	candidate	NNS
cord-304472-mi5v6512	144	7	are	be	VBP
cord-304472-mi5v6512	144	8	live	live	RB
cord-304472-mi5v6512	144	9	-	-	HYPH
cord-304472-mi5v6512	144	10	attenuated	attenuate	VBN
cord-304472-mi5v6512	144	11	vaccines	vaccine	NNS
cord-304472-mi5v6512	144	12	,	,	,
cord-304472-mi5v6512	144	13	with	with	IN
cord-304472-mi5v6512	144	14	the	the	DT
cord-304472-mi5v6512	144	15	main	main	JJ
cord-304472-mi5v6512	144	16	difference	difference	NN
cord-304472-mi5v6512	144	17	between	between	IN
cord-304472-mi5v6512	144	18	them	-PRON-	PRP
cord-304472-mi5v6512	144	19	being	be	VBG
cord-304472-mi5v6512	144	20	the	the	DT
cord-304472-mi5v6512	144	21	type	type	NN
cord-304472-mi5v6512	144	22	of	of	IN
cord-304472-mi5v6512	144	23	backbone	backbone	NN
cord-304472-mi5v6512	144	24	and	and	CC
cord-304472-mi5v6512	144	25	the	the	DT
cord-304472-mi5v6512	144	26	extent	extent	NN
cord-304472-mi5v6512	144	27	of	of	IN
cord-304472-mi5v6512	144	28	chimerization	chimerization	NN
cord-304472-mi5v6512	144	29	.	.	.
cord-304472-mi5v6512	145	1	While	while	IN
cord-304472-mi5v6512	145	2	CYD	CYD	NNP
cord-304472-mi5v6512	145	3	-	-	HYPH
cord-304472-mi5v6512	145	4	TDV	TDV	NNP
cord-304472-mi5v6512	145	5	(	(	-LRB-
cord-304472-mi5v6512	145	6	the	the	DT
cord-304472-mi5v6512	145	7	first	first	JJ
cord-304472-mi5v6512	145	8	licensed	licensed	JJ
cord-304472-mi5v6512	145	9	dengue	dengue	NN
cord-304472-mi5v6512	145	10	vaccine	vaccine	NN
cord-304472-mi5v6512	145	11	)	)	-RRB-
cord-304472-mi5v6512	145	12	does	do	VBZ
cord-304472-mi5v6512	145	13	not	not	RB
cord-304472-mi5v6512	145	14	include	include	VB
cord-304472-mi5v6512	145	15	non	non	JJ
cord-304472-mi5v6512	145	16	-	-	JJ
cord-304472-mi5v6512	145	17	structural	structural	JJ
cord-304472-mi5v6512	145	18	proteins	protein	NNS
cord-304472-mi5v6512	145	19	of	of	IN
cord-304472-mi5v6512	145	20	dengue	dengue	NN
cord-304472-mi5v6512	145	21	,	,	,
cord-304472-mi5v6512	145	22	TAK-003	tak-003	NN
cord-304472-mi5v6512	145	23	contains	contain	VBZ
cord-304472-mi5v6512	145	24	the	the	DT
cord-304472-mi5v6512	145	25	dengue	dengue	NN
cord-304472-mi5v6512	145	26	virus	virus	NN
cord-304472-mi5v6512	145	27	serotype	serotype	NN
cord-304472-mi5v6512	145	28	2	2	CD
cord-304472-mi5v6512	145	29	backbone	backbone	NN
cord-304472-mi5v6512	145	30	,	,	,
cord-304472-mi5v6512	145	31	and	and	CC
cord-304472-mi5v6512	145	32	the	the	DT
cord-304472-mi5v6512	145	33	Butantan	Butantan	NNP
cord-304472-mi5v6512	145	34	/	/	SYM
cord-304472-mi5v6512	145	35	Merck	Merck	NNP
cord-304472-mi5v6512	145	36	vaccine	vaccine	NN
cord-304472-mi5v6512	145	37	contains	contain	VBZ
cord-304472-mi5v6512	145	38	three	three	CD
cord-304472-mi5v6512	145	39	full	full	JJ
cord-304472-mi5v6512	145	40	-	-	HYPH
cord-304472-mi5v6512	145	41	genomes	genome	NNS
cord-304472-mi5v6512	145	42	of	of	IN
cord-304472-mi5v6512	145	43	the	the	DT
cord-304472-mi5v6512	145	44	four	four	CD
cord-304472-mi5v6512	145	45	dengue	dengue	NN
cord-304472-mi5v6512	145	46	virus	virus	NN
cord-304472-mi5v6512	145	47	serotypes	serotype	NNS
cord-304472-mi5v6512	145	48	.	.	.
cord-304472-mi5v6512	146	1	The	the	DT
cord-304472-mi5v6512	146	2	four	four	CD
cord-304472-mi5v6512	146	3	genetically	genetically	RB
cord-304472-mi5v6512	146	4	succinct	succinct	JJ
cord-304472-mi5v6512	146	5	but	but	CC
cord-304472-mi5v6512	146	6	still	still	RB
cord-304472-mi5v6512	146	7	closely	closely	RB
cord-304472-mi5v6512	146	8	related	related	JJ
cord-304472-mi5v6512	146	9	dengue	dengue	NN
cord-304472-mi5v6512	146	10	serotypes	serotype	NNS
cord-304472-mi5v6512	146	11	are	be	VBP
cord-304472-mi5v6512	146	12	known	know	VBN
cord-304472-mi5v6512	146	13	to	to	TO
cord-304472-mi5v6512	146	14	interact	interact	VB
cord-304472-mi5v6512	146	15	immunologically	immunologically	RB
cord-304472-mi5v6512	146	16	with	with	IN
cord-304472-mi5v6512	146	17	potential	potential	NN
cord-304472-mi5v6512	146	18	for	for	IN
cord-304472-mi5v6512	146	19	disease	disease	NN
cord-304472-mi5v6512	146	20	enhancement	enhancement	NN
cord-304472-mi5v6512	146	21	.	.	.
cord-304472-mi5v6512	147	1	While	while	IN
cord-304472-mi5v6512	147	2	dengueprimed	dengueprime	VBN
cord-304472-mi5v6512	147	3	individuals	individual	NNS
cord-304472-mi5v6512	147	4	can	can	MD
cord-304472-mi5v6512	147	5	already	already	RB
cord-304472-mi5v6512	147	6	benefit	benefit	VB
cord-304472-mi5v6512	147	7	from	from	IN
cord-304472-mi5v6512	147	8	vaccination	vaccination	NN
cord-304472-mi5v6512	147	9	against	against	IN
cord-304472-mi5v6512	147	10	all	all	DT
cord-304472-mi5v6512	147	11	four	four	CD
cord-304472-mi5v6512	147	12	serotypes	serotype	NNS
cord-304472-mi5v6512	147	13	with	with	IN
cord-304472-mi5v6512	147	14	the	the	DT
cord-304472-mi5v6512	147	15	first	first	JJ
cord-304472-mi5v6512	147	16	licensed	licensed	JJ
cord-304472-mi5v6512	147	17	dengue	dengue	NN
cord-304472-mi5v6512	147	18	vaccine	vaccine	NN
cord-304472-mi5v6512	147	19	CYD	CYD	NNP
cord-304472-mi5v6512	147	20	-	-	HYPH
cord-304472-mi5v6512	147	21	TDV	TDV	NNP
cord-304472-mi5v6512	147	22	,	,	,
cord-304472-mi5v6512	147	23	the	the	DT
cord-304472-mi5v6512	147	24	need	need	NN
cord-304472-mi5v6512	147	25	for	for	IN
cord-304472-mi5v6512	147	26	dengue	dengue	NN
cord-304472-mi5v6512	147	27	-	-	HYPH
cord-304472-mi5v6512	147	28	naive	naive	JJ
cord-304472-mi5v6512	147	29	population	population	NN
cord-304472-mi5v6512	147	30	has	have	VBZ
cord-304472-mi5v6512	147	31	not	not	RB
cord-304472-mi5v6512	147	32	yet	yet	RB
cord-304472-mi5v6512	147	33	been	be	VBN
cord-304472-mi5v6512	147	34	met	meet	VBN
cord-304472-mi5v6512	147	35	.	.	.
cord-304472-mi5v6512	148	1	To	to	TO
cord-304472-mi5v6512	148	2	improve	improve	VB
cord-304472-mi5v6512	148	3	tetravalent	tetravalent	NN
cord-304472-mi5v6512	148	4	protection	protection	NN
cord-304472-mi5v6512	148	5	,	,	,
cord-304472-mi5v6512	148	6	sequential	sequential	JJ
cord-304472-mi5v6512	148	7	vaccination	vaccination	NN
cord-304472-mi5v6512	148	8	should	should	MD
cord-304472-mi5v6512	148	9	be	be	VB
cord-304472-mi5v6512	148	10	considered	consider	VBN
cord-304472-mi5v6512	148	11	in	in	IN
cord-304472-mi5v6512	148	12	addition	addition	NN
cord-304472-mi5v6512	148	13	to	to	IN
cord-304472-mi5v6512	148	14	a	a	DT
cord-304472-mi5v6512	148	15	heterologous	heterologous	JJ
cord-304472-mi5v6512	148	16	prime	prime	JJ
cord-304472-mi5v6512	148	17	-	-	HYPH
cord-304472-mi5v6512	148	18	boost	boost	NN
cord-304472-mi5v6512	148	19	approach	approach	NN
cord-304472-mi5v6512	148	20	.	.	.
cord-304472-mi5v6512	149	1	The	the	DT
cord-304472-mi5v6512	149	2	ideal	ideal	JJ
cord-304472-mi5v6512	149	3	properties	property	NNS
cord-304472-mi5v6512	149	4	of	of	IN
cord-304472-mi5v6512	149	5	a	a	DT
cord-304472-mi5v6512	149	6	dengue	dengue	NN
cord-304472-mi5v6512	149	7	vaccine	vaccine	NN
cord-304472-mi5v6512	149	8	should	should	MD
cord-304472-mi5v6512	149	9	include	include	VB
cord-304472-mi5v6512	149	10	the	the	DT
cord-304472-mi5v6512	149	11	ability	ability	NN
cord-304472-mi5v6512	149	12	to	to	TO
cord-304472-mi5v6512	149	13	induce	induce	VB
cord-304472-mi5v6512	149	14	long	long	RB
cord-304472-mi5v6512	149	15	-	-	HYPH
cord-304472-mi5v6512	149	16	lasting	last	VBG
cord-304472-mi5v6512	149	17	homotypic	homotypic	JJ
cord-304472-mi5v6512	149	18	immune	immune	JJ
cord-304472-mi5v6512	149	19	responses	response	NNS
cord-304472-mi5v6512	149	20	to	to	IN
cord-304472-mi5v6512	149	21	all	all	DT
cord-304472-mi5v6512	149	22	four	four	CD
cord-304472-mi5v6512	149	23	serotypes	serotype	NNS
cord-304472-mi5v6512	149	24	in	in	IN
cord-304472-mi5v6512	149	25	all	all	DT
cord-304472-mi5v6512	149	26	age	age	NN
cord-304472-mi5v6512	149	27	groups	group	NNS
cord-304472-mi5v6512	149	28	,	,	,
cord-304472-mi5v6512	149	29	regardless	regardless	RB
cord-304472-mi5v6512	149	30	of	of	IN
cord-304472-mi5v6512	149	31	dengue	dengue	NN
cord-304472-mi5v6512	149	32	serostatus	serostatus	NN
cord-304472-mi5v6512	149	33	.	.	.
cord-304472-mi5v6512	150	1	The	the	DT
cord-304472-mi5v6512	150	2	vaccine	vaccine	NN
cord-304472-mi5v6512	150	3	should	should	MD
cord-304472-mi5v6512	150	4	have	have	VB
cord-304472-mi5v6512	150	5	a	a	DT
cord-304472-mi5v6512	150	6	schedule	schedule	NN
cord-304472-mi5v6512	150	7	ideally	ideally	RB
cord-304472-mi5v6512	150	8	with	with	IN
cord-304472-mi5v6512	150	9	2	2	CD
cord-304472-mi5v6512	150	10	or	or	CC
cord-304472-mi5v6512	150	11	fewer	few	JJR
cord-304472-mi5v6512	150	12	doses	dose	NNS
cord-304472-mi5v6512	150	13	,	,	,
cord-304472-mi5v6512	150	14	should	should	MD
cord-304472-mi5v6512	150	15	be	be	VB
cord-304472-mi5v6512	150	16	able	able	JJ
cord-304472-mi5v6512	150	17	to	to	TO
cord-304472-mi5v6512	150	18	prevent	prevent	VB
cord-304472-mi5v6512	150	19	dengue	dengue	NN
cord-304472-mi5v6512	150	20	outbreaks	outbreak	NNS
cord-304472-mi5v6512	150	21	if	if	IN
cord-304472-mi5v6512	150	22	used	use	VBN
cord-304472-mi5v6512	150	23	early	early	RB
cord-304472-mi5v6512	150	24	at	at	IN
cord-304472-mi5v6512	150	25	the	the	DT
cord-304472-mi5v6512	150	26	onset	onset	NN
cord-304472-mi5v6512	150	27	of	of	IN
cord-304472-mi5v6512	150	28	the	the	DT
cord-304472-mi5v6512	150	29	outbreak	outbreak	NN
cord-304472-mi5v6512	150	30	,	,	,
cord-304472-mi5v6512	150	31	and	and	CC
cord-304472-mi5v6512	150	32	should	should	MD
cord-304472-mi5v6512	150	33	serve	serve	VB
cord-304472-mi5v6512	150	34	as	as	IN
cord-304472-mi5v6512	150	35	prophylaxis	prophylaxis	NN
cord-304472-mi5v6512	150	36	in	in	IN
cord-304472-mi5v6512	150	37	large	large	JJ
cord-304472-mi5v6512	150	38	populations	population	NNS
cord-304472-mi5v6512	150	39	to	to	TO
cord-304472-mi5v6512	150	40	effectively	effectively	RB
cord-304472-mi5v6512	150	41	prevent	prevent	VB
cord-304472-mi5v6512	150	42	epidemics	epidemic	NNS
cord-304472-mi5v6512	150	43	in	in	IN
cord-304472-mi5v6512	150	44	the	the	DT
cord-304472-mi5v6512	150	45	long	long	JJ
cord-304472-mi5v6512	150	46	term	term	NN
cord-304472-mi5v6512	150	47	.	.	.
cord-304472-mi5v6512	151	1	AWS	AWS	NNP
cord-304472-mi5v6512	151	2	wrote	write	VBD
cord-304472-mi5v6512	151	3	the	the	DT
cord-304472-mi5v6512	151	4	review	review	NN
cord-304472-mi5v6512	151	5	.	.	.
cord-304472-mi5v6512	152	1	None	none	NN
cord-304472-mi5v6512	152	2	.	.	.
cord-304472-mi5v6512	153	1	Severe	severe	JJ
cord-304472-mi5v6512	153	2	dengue	dengue	NN
cord-304472-mi5v6512	153	3	in	in	IN
cord-304472-mi5v6512	153	4	travellers	traveller	NNS
cord-304472-mi5v6512	153	5	:	:	:
cord-304472-mi5v6512	153	6	pathogenesis	pathogenesis	NN
cord-304472-mi5v6512	153	7	,	,	,
cord-304472-mi5v6512	153	8	risk	risk	NN
cord-304472-mi5v6512	153	9	and	and	CC
cord-304472-mi5v6512	153	10	clinical	clinical	JJ
cord-304472-mi5v6512	153	11	management	management	NN
cord-304472-mi5v6512	153	12	Dengue	dengue	NN
cord-304472-mi5v6512	153	13	infection	infection	NN
cord-304472-mi5v6512	153	14	in	in	IN
cord-304472-mi5v6512	153	15	international	international	JJ
cord-304472-mi5v6512	153	16	travellers	traveller	NNS
cord-304472-mi5v6512	153	17	visiting	visit	VBG
cord-304472-mi5v6512	153	18	Bali	Bali	NNP
cord-304472-mi5v6512	153	19	,	,	,
cord-304472-mi5v6512	153	20	Indonesia	Indonesia	NNP
cord-304472-mi5v6512	153	21	Imported	import	VBN
cord-304472-mi5v6512	153	22	dengue	dengue	NN
cord-304472-mi5v6512	153	23	fever	fever	NN
cord-304472-mi5v6512	153	24	in	in	IN
cord-304472-mi5v6512	153	25	East	East	NNP
cord-304472-mi5v6512	153	26	London	London	NNP
cord-304472-mi5v6512	153	27	:	:	:
cord-304472-mi5v6512	153	28	a	a	DT
cord-304472-mi5v6512	153	29	6-year	6-year	JJ
cord-304472-mi5v6512	153	30	retrospective	retrospective	JJ
cord-304472-mi5v6512	153	31	observational	observational	JJ
cord-304472-mi5v6512	153	32	study	study	NN
cord-304472-mi5v6512	153	33	Dengue	dengue	NN
cord-304472-mi5v6512	153	34	fever	fever	NN
cord-304472-mi5v6512	153	35	among	among	IN
cord-304472-mi5v6512	153	36	Israeli	israeli	JJ
cord-304472-mi5v6512	153	37	expatriates	expatriate	NNS
cord-304472-mi5v6512	153	38	in	in	IN
cord-304472-mi5v6512	153	39	Delhi	Delhi	NNP
cord-304472-mi5v6512	153	40	,	,	,
cord-304472-mi5v6512	153	41	2015	2015	CD
cord-304472-mi5v6512	154	1	:	:	:
cord-304472-mi5v6512	154	2	implications	implication	NNS
cord-304472-mi5v6512	154	3	for	for	IN
cord-304472-mi5v6512	154	4	dengue	dengue	NN
cord-304472-mi5v6512	154	5	incidence	incidence	NN
cord-304472-mi5v6512	154	6	in	in	IN
cord-304472-mi5v6512	154	7	Delhi	Delhi	NNP
cord-304472-mi5v6512	154	8	,	,	,
cord-304472-mi5v6512	154	9	India	India	NNP
cord-304472-mi5v6512	154	10	Risk	Risk	NNP
cord-304472-mi5v6512	154	11	of	of	IN
cord-304472-mi5v6512	154	12	severe	severe	JJ
cord-304472-mi5v6512	154	13	dengue	dengue	NN
cord-304472-mi5v6512	154	14	is	be	VBZ
cord-304472-mi5v6512	154	15	higher	high	JJR
cord-304472-mi5v6512	154	16	in	in	IN
cord-304472-mi5v6512	154	17	patients	patient	NNS
cord-304472-mi5v6512	154	18	with	with	IN
cord-304472-mi5v6512	154	19	sickle	sickle	NN
cord-304472-mi5v6512	154	20	cell	cell	NN
cord-304472-mi5v6512	154	21	disease	disease	NN
cord-304472-mi5v6512	154	22	:	:	:
cord-304472-mi5v6512	154	23	a	a	DT
cord-304472-mi5v6512	154	24	scoping	scoping	NN
cord-304472-mi5v6512	154	25	review	review	NN
cord-304472-mi5v6512	154	26	Efficacy	Efficacy	NNP
cord-304472-mi5v6512	154	27	and	and	CC
cord-304472-mi5v6512	154	28	long	long	JJ
cord-304472-mi5v6512	154	29	-	-	HYPH
cord-304472-mi5v6512	154	30	term	term	NN
cord-304472-mi5v6512	154	31	safety	safety	NN
cord-304472-mi5v6512	154	32	of	of	IN
cord-304472-mi5v6512	154	33	a	a	DT
cord-304472-mi5v6512	154	34	dengue	dengue	NN
cord-304472-mi5v6512	154	35	vaccine	vaccine	NN
cord-304472-mi5v6512	154	36	in	in	IN
cord-304472-mi5v6512	154	37	regions	region	NNS
cord-304472-mi5v6512	154	38	of	of	IN
cord-304472-mi5v6512	154	39	endemic	endemic	JJ
cord-304472-mi5v6512	154	40	disease	disease	NN
cord-304472-mi5v6512	154	41	Effect	effect	NN
cord-304472-mi5v6512	154	42	of	of	IN
cord-304472-mi5v6512	154	43	dengue	dengue	NN
cord-304472-mi5v6512	154	44	serostatus	serostatus	NN
cord-304472-mi5v6512	154	45	on	on	IN
cord-304472-mi5v6512	154	46	dengue	dengue	NN
cord-304472-mi5v6512	154	47	vaccine	vaccine	NN
cord-304472-mi5v6512	154	48	safety	safety	NN
cord-304472-mi5v6512	154	49	and	and	CC
cord-304472-mi5v6512	154	50	efficacy	efficacy	NN
cord-304472-mi5v6512	154	51	Long	long	JJ
cord-304472-mi5v6512	154	52	-	-	HYPH
cord-304472-mi5v6512	154	53	term	term	NN
cord-304472-mi5v6512	154	54	follow	follow	NN
cord-304472-mi5v6512	154	55	-	-	HYPH
cord-304472-mi5v6512	154	56	up	up	NN
cord-304472-mi5v6512	154	57	of	of	IN
cord-304472-mi5v6512	154	58	all	all	DT
cord-304472-mi5v6512	154	59	Phase	phase	NN
cord-304472-mi5v6512	154	60	3	3	CD
cord-304472-mi5v6512	154	61	trial	trial	NN
cord-304472-mi5v6512	154	62	data	datum	NNS
cord-304472-mi5v6512	154	63	globally	globally	RB
cord-304472-mi5v6512	154	64	including	include	VBG
cord-304472-mi5v6512	154	65	benefit	benefit	NN
cord-304472-mi5v6512	154	66	risk	risk	NN
cord-304472-mi5v6512	154	67	assessment	assessment	NN
cord-304472-mi5v6512	154	68	based	base	VBN
cord-304472-mi5v6512	154	69	on	on	IN
cord-304472-mi5v6512	154	70	stratification	stratification	NN
cord-304472-mi5v6512	154	71	based	base	VBN
cord-304472-mi5v6512	154	72	on	on	IN
cord-304472-mi5v6512	154	73	baseline	baseline	JJ
cord-304472-mi5v6512	154	74	serostatus	serostatus	NN
cord-304472-mi5v6512	154	75	Deliberations	deliberation	NNS
cord-304472-mi5v6512	154	76	of	of	IN
cord-304472-mi5v6512	154	77	the	the	DT
cord-304472-mi5v6512	154	78	strategic	strategic	JJ
cord-304472-mi5v6512	154	79	advisory	advisory	JJ
cord-304472-mi5v6512	154	80	group	group	NN
cord-304472-mi5v6512	154	81	of	of	IN
cord-304472-mi5v6512	154	82	experts	expert	NNS
cord-304472-mi5v6512	154	83	on	on	IN
cord-304472-mi5v6512	154	84	immunization	immunization	NN
cord-304472-mi5v6512	154	85	on	on	IN
cord-304472-mi5v6512	154	86	the	the	DT
cord-304472-mi5v6512	154	87	use	use	NN
cord-304472-mi5v6512	154	88	of	of	IN
cord-304472-mi5v6512	155	1	CYD	CYD	NNP
cord-304472-mi5v6512	155	2	-	-	HYPH
cord-304472-mi5v6512	155	3	TDV	TDV	NNP
cord-304472-mi5v6512	155	4	dengue	dengue	NN
cord-304472-mi5v6512	155	5	vaccine	vaccine	NN
cord-304472-mi5v6512	155	6	Dengue	Dengue	NNP
cord-304472-mi5v6512	155	7	virus	virus	NN
cord-304472-mi5v6512	155	8	NS1	ns1	NN
cord-304472-mi5v6512	155	9	protein	protein	NN
cord-304472-mi5v6512	155	10	activates	activate	VBZ
cord-304472-mi5v6512	155	11	cells	cell	NNS
cord-304472-mi5v6512	155	12	via	via	IN
cord-304472-mi5v6512	155	13	Toll	toll	NN
cord-304472-mi5v6512	155	14	-	-	HYPH
cord-304472-mi5v6512	155	15	like	like	JJ
cord-304472-mi5v6512	155	16	receptor	receptor	NN
cord-304472-mi5v6512	155	17	4	4	CD
cord-304472-mi5v6512	155	18	and	and	CC
cord-304472-mi5v6512	155	19	disrupts	disrupt	VBZ
cord-304472-mi5v6512	155	20	endothelial	endothelial	JJ
cord-304472-mi5v6512	155	21	cell	cell	NN
cord-304472-mi5v6512	155	22	monolayer	monolayer	NN
cord-304472-mi5v6512	155	23	integrity	integrity	NN
cord-304472-mi5v6512	155	24	Dengue	dengue	NN
cord-304472-mi5v6512	155	25	virus	virus	NN
cord-304472-mi5v6512	155	26	NS1	NS1	VBZ
cord-304472-mi5v6512	155	27	triggers	trigger	VBZ
cord-304472-mi5v6512	155	28	endothelial	endothelial	JJ
cord-304472-mi5v6512	155	29	permeability	permeability	NN
cord-304472-mi5v6512	155	30	and	and	CC
cord-304472-mi5v6512	155	31	vascular	vascular	JJ
cord-304472-mi5v6512	155	32	leak	leak	NN
cord-304472-mi5v6512	155	33	that	that	WDT
cord-304472-mi5v6512	155	34	is	be	VBZ
cord-304472-mi5v6512	155	35	prevented	prevent	VBN
cord-304472-mi5v6512	155	36	by	by	IN
cord-304472-mi5v6512	155	37	NS1	NS1	NNS
cord-304472-mi5v6512	155	38	vaccination	vaccination	NN
cord-304472-mi5v6512	155	39	Dengue	dengue	NN
cord-304472-mi5v6512	155	40	virus	virus	NN
cord-304472-mi5v6512	155	41	NS1	ns1	CD
cord-304472-mi5v6512	155	42	cytokine	cytokine	JJ
cord-304472-mi5v6512	155	43	-	-	HYPH
cord-304472-mi5v6512	155	44	independent	independent	JJ
cord-304472-mi5v6512	155	45	vascular	vascular	JJ
cord-304472-mi5v6512	155	46	leak	leak	NN
cord-304472-mi5v6512	155	47	is	be	VBZ
cord-304472-mi5v6512	155	48	dependent	dependent	JJ
cord-304472-mi5v6512	155	49	on	on	IN
cord-304472-mi5v6512	155	50	endothelial	endothelial	JJ
cord-304472-mi5v6512	155	51	glycocalyx	glycocalyx	NN
cord-304472-mi5v6512	155	52	components	component	NNS
cord-304472-mi5v6512	155	53	Dengue	Dengue	NNP
cord-304472-mi5v6512	155	54	virus	virus	NN
cord-304472-mi5v6512	155	55	NS1	ns1	NN
cord-304472-mi5v6512	155	56	disrupts	disrupt	VBZ
cord-304472-mi5v6512	155	57	the	the	DT
cord-304472-mi5v6512	155	58	endothelial	endothelial	JJ
cord-304472-mi5v6512	155	59	glycocalyx	glycocalyx	NN
cord-304472-mi5v6512	155	60	,	,	,
cord-304472-mi5v6512	155	61	leading	lead	VBG
cord-304472-mi5v6512	155	62	to	to	IN
cord-304472-mi5v6512	155	63	hyperpermeability	hyperpermeability	NN
cord-304472-mi5v6512	155	64	Dengue	Dengue	NNP
cord-304472-mi5v6512	155	65	vaccine	vaccine	NN
cord-304472-mi5v6512	155	66	:	:	:
cord-304472-mi5v6512	155	67	WHO	who	WP
cord-304472-mi5v6512	155	68	position	position	VBP
cord-304472-mi5v6512	155	69	paper	paper	NN
cord-304472-mi5v6512	155	70	Dengue	dengue	NN
cord-304472-mi5v6512	155	71	prevaccination	prevaccination	NN
cord-304472-mi5v6512	155	72	serology	serology	NN
cord-304472-mi5v6512	155	73	screening	screening	NN
cord-304472-mi5v6512	155	74	for	for	IN
cord-304472-mi5v6512	155	75	the	the	DT
cord-304472-mi5v6512	155	76	use	use	NN
cord-304472-mi5v6512	155	77	of	of	IN
cord-304472-mi5v6512	155	78	Dengvaxia(R	dengvaxia(r	NN
cord-304472-mi5v6512	155	79	)	)	-RRB-
cord-304472-mi5v6512	155	80	CYD	CYD	NNP
cord-304472-mi5v6512	155	81	-	-	HYPH
cord-304472-mi5v6512	155	82	TDV	TDV	NNP
cord-304472-mi5v6512	155	83	dengue	dengue	NN
cord-304472-mi5v6512	155	84	vaccine	vaccine	NN
cord-304472-mi5v6512	155	85	performance	performance	NN
cord-304472-mi5v6512	155	86	by	by	IN
cord-304472-mi5v6512	155	87	baseline	baseline	JJ
cord-304472-mi5v6512	155	88	immune	immune	NN
cord-304472-mi5v6512	155	89	profile	profile	NN
cord-304472-mi5v6512	155	90	(	(	-LRB-
cord-304472-mi5v6512	155	91	monotypic/	monotypic/	CD
cord-304472-mi5v6512	155	92	multitypic	multitypic	JJ
cord-304472-mi5v6512	155	93	)	)	-RRB-
cord-304472-mi5v6512	155	94	in	in	IN
cord-304472-mi5v6512	155	95	dengue	dengue	NN
cord-304472-mi5v6512	155	96	seropositive	seropositive	JJ
cord-304472-mi5v6512	155	97	individuals	individual	NNS
cord-304472-mi5v6512	155	98	.	.	.
cord-304472-mi5v6512	156	1	Clin	Clin	NNP
cord-304472-mi5v6512	156	2	Infect	infect	NN
cord-304472-mi5v6512	156	3	Dis	Dis	NNP
cord-304472-mi5v6512	156	4	2020	2020	CD
cord-304472-mi5v6512	156	5	.	.	.
cord-304472-mi5v6512	157	1	Evaluation	evaluation	NN
cord-304472-mi5v6512	157	2	of	of	IN
cord-304472-mi5v6512	157	3	several	several	JJ
cord-304472-mi5v6512	157	4	ELISA	ELISA	NNP
cord-304472-mi5v6512	157	5	and	and	CC
cord-304472-mi5v6512	157	6	rapid	rapid	JJ
cord-304472-mi5v6512	157	7	diagnostic	diagnostic	JJ
cord-304472-mi5v6512	157	8	assays	assay	NNS
cord-304472-mi5v6512	157	9	for	for	IN
cord-304472-mi5v6512	157	10	determining	determine	VBG
cord-304472-mi5v6512	157	11	prior	prior	JJ
cord-304472-mi5v6512	157	12	dengue	dengue	NN
cord-304472-mi5v6512	157	13	infection	infection	NN
cord-304472-mi5v6512	157	14	Evaluation	Evaluation	NNP
cord-304472-mi5v6512	157	15	of	of	IN
cord-304472-mi5v6512	157	16	rapid	rapid	JJ
cord-304472-mi5v6512	157	17	diagnostic	diagnostic	JJ
cord-304472-mi5v6512	157	18	tests	test	NNS
cord-304472-mi5v6512	157	19	and	and	CC
cord-304472-mi5v6512	157	20	conventional	conventional	JJ
cord-304472-mi5v6512	157	21	enzymelinked	enzymelinked	JJ
cord-304472-mi5v6512	157	22	immunosorbent	immunosorbent	JJ
cord-304472-mi5v6512	157	23	assays	assay	NNS
cord-304472-mi5v6512	157	24	to	to	TO
cord-304472-mi5v6512	157	25	determine	determine	VB
cord-304472-mi5v6512	157	26	prior	prior	JJ
cord-304472-mi5v6512	157	27	dengue	dengue	NN
cord-304472-mi5v6512	157	28	infection	infection	NN
cord-304472-mi5v6512	157	29	Pre	pre	JJ
cord-304472-mi5v6512	157	30	-	-	JJ
cord-304472-mi5v6512	157	31	vaccination	vaccination	JJ
cord-304472-mi5v6512	157	32	screening	screening	NN
cord-304472-mi5v6512	157	33	strategies	strategy	NNS
cord-304472-mi5v6512	157	34	for	for	IN
cord-304472-mi5v6512	157	35	the	the	DT
cord-304472-mi5v6512	157	36	use	use	NN
cord-304472-mi5v6512	157	37	of	of	IN
cord-304472-mi5v6512	157	38	the	the	DT
cord-304472-mi5v6512	157	39	CYD	CYD	NNP
cord-304472-mi5v6512	157	40	-	-	HYPH
cord-304472-mi5v6512	157	41	TDV	TDV	NNP
cord-304472-mi5v6512	157	42	dengue	dengue	NN
cord-304472-mi5v6512	157	43	vaccine	vaccine	NN
cord-304472-mi5v6512	157	44	:	:	:
cord-304472-mi5v6512	158	1	a	a	DT
cord-304472-mi5v6512	158	2	meeting	meeting	NN
cord-304472-mi5v6512	158	3	report	report	NN
cord-304472-mi5v6512	158	4	Use	Use	NNP
cord-304472-mi5v6512	158	5	of	of	IN
cord-304472-mi5v6512	158	6	pre	pre	JJ
cord-304472-mi5v6512	158	7	-	-	JJ
cord-304472-mi5v6512	158	8	travel	travel	JJ
cord-304472-mi5v6512	158	9	vaccine	vaccine	NN
cord-304472-mi5v6512	158	10	-	-	HYPH
cord-304472-mi5v6512	158	11	preventable	preventable	JJ
cord-304472-mi5v6512	158	12	disease	disease	NN
cord-304472-mi5v6512	158	13	serology	serology	NN
cord-304472-mi5v6512	158	14	as	as	IN
cord-304472-mi5v6512	158	15	a	a	DT
cord-304472-mi5v6512	158	16	screening	screening	NN
cord-304472-mi5v6512	158	17	tool	tool	NN
cord-304472-mi5v6512	158	18	to	to	TO
cord-304472-mi5v6512	158	19	identify	identify	VB
cord-304472-mi5v6512	158	20	patients	patient	NNS
cord-304472-mi5v6512	158	21	in	in	IN
cord-304472-mi5v6512	158	22	need	need	NN
cord-304472-mi5v6512	158	23	of	of	IN
cord-304472-mi5v6512	158	24	pre	pre	JJ
cord-304472-mi5v6512	158	25	-	-	JJ
cord-304472-mi5v6512	158	26	travel	travel	JJ
cord-304472-mi5v6512	158	27	vaccination	vaccination	NN
cord-304472-mi5v6512	158	28	:	:	:
cord-304472-mi5v6512	158	29	a	a	DT
cord-304472-mi5v6512	158	30	retrospective	retrospective	JJ
cord-304472-mi5v6512	158	31	audit	audit	NN
cord-304472-mi5v6512	158	32	A	a	NN
cord-304472-mi5v6512	158	33	:	:	:
cord-304472-mi5v6512	158	34	Serostatus	serostatus	NN
cord-304472-mi5v6512	158	35	-	-	HYPH
cord-304472-mi5v6512	158	36	dependent	dependent	JJ
cord-304472-mi5v6512	158	37	performance	performance	NN
cord-304472-mi5v6512	158	38	of	of	IN
cord-304472-mi5v6512	158	39	the	the	DT
cord-304472-mi5v6512	158	40	first	first	JJ
cord-304472-mi5v6512	158	41	licensed	licensed	JJ
cord-304472-mi5v6512	158	42	dengue	dengue	NN
cord-304472-mi5v6512	158	43	vaccine	vaccine	NN
cord-304472-mi5v6512	158	44	:	:	:
cord-304472-mi5v6512	158	45	implications	implication	NNS
cord-304472-mi5v6512	158	46	for	for	IN
cord-304472-mi5v6512	158	47	travellers	traveller	NNS
cord-304472-mi5v6512	158	48	Timing	Timing	NNP
cord-304472-mi5v6512	158	49	of	of	IN
cord-304472-mi5v6512	158	50	administration	administration	NN
cord-304472-mi5v6512	158	51	of	of	IN
cord-304472-mi5v6512	158	52	dengue	dengue	NNP
cord-304472-mi5v6512	158	53	vaccine	vaccine	NN
cord-304472-mi5v6512	158	54	in	in	IN
cord-304472-mi5v6512	158	55	travellers	traveller	NNS
cord-304472-mi5v6512	158	56	with	with	IN
cord-304472-mi5v6512	158	57	a	a	DT
cord-304472-mi5v6512	158	58	recent	recent	JJ
cord-304472-mi5v6512	158	59	confirmed	confirm	VBN
cord-304472-mi5v6512	158	60	dengue	dengue	NN
cord-304472-mi5v6512	158	61	infection	infection	NN
cord-304472-mi5v6512	158	62	Clinical	clinical	JJ
cord-304472-mi5v6512	158	63	development	development	NN
cord-304472-mi5v6512	158	64	and	and	CC
cord-304472-mi5v6512	158	65	regulatory	regulatory	JJ
cord-304472-mi5v6512	158	66	points	point	NNS
cord-304472-mi5v6512	158	67	for	for	IN
cord-304472-mi5v6512	158	68	consideration	consideration	NN
cord-304472-mi5v6512	158	69	for	for	IN
cord-304472-mi5v6512	158	70	second	second	JJ
cord-304472-mi5v6512	158	71	-	-	HYPH
cord-304472-mi5v6512	158	72	generation	generation	NN
cord-304472-mi5v6512	158	73	live	live	VBP
cord-304472-mi5v6512	158	74	attenuated	attenuated	JJ
cord-304472-mi5v6512	158	75	dengue	dengue	NN
cord-304472-mi5v6512	158	76	vaccines	vaccine	VBZ
cord-304472-mi5v6512	158	77	A	a	DT
cord-304472-mi5v6512	159	1	:	:	:
cord-304472-mi5v6512	159	2	Evaluation	evaluation	NN
cord-304472-mi5v6512	159	3	of	of	IN
cord-304472-mi5v6512	159	4	a	a	DT
cord-304472-mi5v6512	159	5	tetravalent	tetravalent	NN
cord-304472-mi5v6512	159	6	dengue	dengue	NN
cord-304472-mi5v6512	159	7	vaccine	vaccine	NN
cord-304472-mi5v6512	159	8	by	by	IN
cord-304472-mi5v6512	159	9	serostatus	serostatus	NN
cord-304472-mi5v6512	159	10	and	and	CC
cord-304472-mi5v6512	159	11	serotype	serotype	NN
cord-304472-mi5v6512	159	12	A	a	DT
cord-304472-mi5v6512	159	13	recombinant	recombinant	JJ
cord-304472-mi5v6512	159	14	,	,	,
cord-304472-mi5v6512	159	15	chimeric	chimeric	JJ
cord-304472-mi5v6512	159	16	tetravalent	tetravalent	NN
cord-304472-mi5v6512	159	17	dengue	dengue	NN
cord-304472-mi5v6512	159	18	vaccine	vaccine	NN
cord-304472-mi5v6512	159	19	candidate	candidate	NN
cord-304472-mi5v6512	159	20	based	base	VBN
cord-304472-mi5v6512	159	21	on	on	IN
cord-304472-mi5v6512	159	22	a	a	DT
cord-304472-mi5v6512	159	23	dengue	dengue	NN
cord-304472-mi5v6512	159	24	virus	virus	NN
cord-304472-mi5v6512	159	25	serotype	serotype	NN
cord-304472-mi5v6512	159	26	2	2	CD
cord-304472-mi5v6512	159	27	backbone	backbone	NN
cord-304472-mi5v6512	159	28	Immunogenicity	Immunogenicity	NNP
cord-304472-mi5v6512	159	29	and	and	CC
cord-304472-mi5v6512	159	30	safety	safety	NN
cord-304472-mi5v6512	159	31	of	of	IN
cord-304472-mi5v6512	159	32	one	one	CD
cord-304472-mi5v6512	159	33	versus	versus	IN
cord-304472-mi5v6512	159	34	two	two	CD
cord-304472-mi5v6512	159	35	doses	dose	NNS
cord-304472-mi5v6512	159	36	of	of	IN
cord-304472-mi5v6512	159	37	tetravalent	tetravalent	NNP
cord-304472-mi5v6512	159	38	dengue	dengue	NN
cord-304472-mi5v6512	159	39	vaccine	vaccine	NN
cord-304472-mi5v6512	159	40	in	in	IN
cord-304472-mi5v6512	159	41	healthy	healthy	JJ
cord-304472-mi5v6512	159	42	children	child	NNS
cord-304472-mi5v6512	159	43	aged	age	VBN
cord-304472-mi5v6512	159	44	2	2	CD
cord-304472-mi5v6512	159	45	-	-	SYM
cord-304472-mi5v6512	159	46	17	17	CD
cord-304472-mi5v6512	159	47	years	year	NNS
cord-304472-mi5v6512	159	48	in	in	IN
cord-304472-mi5v6512	159	49	Asia	Asia	NNP
cord-304472-mi5v6512	159	50	and	and	CC
cord-304472-mi5v6512	159	51	Latin	Latin	NNP
cord-304472-mi5v6512	159	52	America	America	NNP
cord-304472-mi5v6512	159	53	:	:	:
cord-304472-mi5v6512	159	54	18-month	18-month	JJ
cord-304472-mi5v6512	159	55	interim	interim	JJ
cord-304472-mi5v6512	159	56	data	datum	NNS
cord-304472-mi5v6512	159	57	from	from	IN
cord-304472-mi5v6512	159	58	a	a	DT
cord-304472-mi5v6512	159	59	phase	phase	NN
cord-304472-mi5v6512	159	60	2	2	CD
cord-304472-mi5v6512	159	61	,	,	,
cord-304472-mi5v6512	159	62	randomised	randomised	JJ
cord-304472-mi5v6512	159	63	,	,	,
cord-304472-mi5v6512	159	64	placebo	placebo	NN
cord-304472-mi5v6512	159	65	-	-	HYPH
cord-304472-mi5v6512	159	66	controlled	control	VBN
cord-304472-mi5v6512	159	67	study	study	NN
cord-304472-mi5v6512	159	68	Immunogenicity	Immunogenicity	NNP
cord-304472-mi5v6512	159	69	and	and	CC
cord-304472-mi5v6512	159	70	safety	safety	NN
cord-304472-mi5v6512	159	71	of	of	IN
cord-304472-mi5v6512	159	72	lyophilized	lyophilized	JJ
cord-304472-mi5v6512	159	73	and	and	CC
cord-304472-mi5v6512	159	74	liquid	liquid	JJ
cord-304472-mi5v6512	159	75	dengue	dengue	NN
cord-304472-mi5v6512	159	76	tetravalent	tetravalent	NN
cord-304472-mi5v6512	159	77	vaccine	vaccine	NN
cord-304472-mi5v6512	159	78	candidate	candidate	NN
cord-304472-mi5v6512	159	79	formulations	formulation	NNS
cord-304472-mi5v6512	159	80	in	in	IN
cord-304472-mi5v6512	159	81	healthy	healthy	JJ
cord-304472-mi5v6512	159	82	adults	adult	NNS
cord-304472-mi5v6512	159	83	:	:	:
cord-304472-mi5v6512	159	84	a	a	DT
cord-304472-mi5v6512	159	85	randomized	randomized	JJ
cord-304472-mi5v6512	159	86	,	,	,
cord-304472-mi5v6512	159	87	phase	phase	NN
cord-304472-mi5v6512	159	88	2	2	CD
cord-304472-mi5v6512	159	89	clinical	clinical	JJ
cord-304472-mi5v6512	159	90	trial	trial	NN
cord-304472-mi5v6512	159	91	Characterization	characterization	NN
cord-304472-mi5v6512	159	92	of	of	IN
cord-304472-mi5v6512	159	93	the	the	DT
cord-304472-mi5v6512	159	94	type	type	NN
cord-304472-mi5v6512	159	95	-	-	HYPH
cord-304472-mi5v6512	159	96	specific	specific	JJ
cord-304472-mi5v6512	159	97	and	and	CC
cord-304472-mi5v6512	159	98	crossreactive	crossreactive	JJ
cord-304472-mi5v6512	159	99	B	b	NN
cord-304472-mi5v6512	159	100	cell	cell	NN
cord-304472-mi5v6512	159	101	responses	response	NNS
cord-304472-mi5v6512	159	102	elicited	elicit	VBN
cord-304472-mi5v6512	159	103	by	by	IN
cord-304472-mi5v6512	159	104	a	a	DT
cord-304472-mi5v6512	159	105	live	live	RB
cord-304472-mi5v6512	159	106	-	-	HYPH
cord-304472-mi5v6512	159	107	attenuated	attenuated	JJ
cord-304472-mi5v6512	159	108	tetravalent	tetravalent	NN
cord-304472-mi5v6512	159	109	dengue	dengue	NN
cord-304472-mi5v6512	159	110	vaccine	vaccine	NN
cord-304472-mi5v6512	159	111	Long	long	JJ
cord-304472-mi5v6512	159	112	-	-	HYPH
cord-304472-mi5v6512	159	113	term	term	NN
cord-304472-mi5v6512	159	114	safety	safety	NN
cord-304472-mi5v6512	159	115	and	and	CC
cord-304472-mi5v6512	159	116	immunogenicity	immunogenicity	NN
cord-304472-mi5v6512	159	117	of	of	IN
cord-304472-mi5v6512	159	118	a	a	DT
cord-304472-mi5v6512	159	119	tetravalent	tetravalent	NN
cord-304472-mi5v6512	159	120	dengue	dengue	NN
cord-304472-mi5v6512	159	121	vaccine	vaccine	NN
cord-304472-mi5v6512	159	122	candidate	candidate	NN
cord-304472-mi5v6512	159	123	in	in	IN
cord-304472-mi5v6512	159	124	children	child	NNS
cord-304472-mi5v6512	159	125	and	and	CC
cord-304472-mi5v6512	159	126	adults	adult	NNS
cord-304472-mi5v6512	159	127	:	:	:
cord-304472-mi5v6512	159	128	a	a	DT
cord-304472-mi5v6512	159	129	randomized	randomized	JJ
cord-304472-mi5v6512	159	130	,	,	,
cord-304472-mi5v6512	159	131	placebo	placebo	NN
cord-304472-mi5v6512	159	132	-	-	HYPH
cord-304472-mi5v6512	159	133	controlled	control	VBN
cord-304472-mi5v6512	159	134	,	,	,
cord-304472-mi5v6512	159	135	phase	phase	NN
cord-304472-mi5v6512	159	136	2	2	CD
cord-304472-mi5v6512	159	137	study	study	NN
cord-304472-mi5v6512	159	138	Efficacy	Efficacy	NNP
cord-304472-mi5v6512	159	139	of	of	IN
cord-304472-mi5v6512	159	140	a	a	DT
cord-304472-mi5v6512	159	141	tetravalent	tetravalent	NN
cord-304472-mi5v6512	159	142	dengue	dengue	NN
cord-304472-mi5v6512	159	143	vaccine	vaccine	NN
cord-304472-mi5v6512	159	144	in	in	IN
cord-304472-mi5v6512	159	145	healthy	healthy	JJ
cord-304472-mi5v6512	159	146	children	child	NNS
cord-304472-mi5v6512	159	147	and	and	CC
cord-304472-mi5v6512	159	148	adolescents	adolescent	NNS
cord-304472-mi5v6512	160	1	Efficacy	efficacy	NN
cord-304472-mi5v6512	160	2	of	of	IN
cord-304472-mi5v6512	160	3	a	a	DT
cord-304472-mi5v6512	160	4	tetravalent	tetravalent	NN
cord-304472-mi5v6512	160	5	dengue	dengue	NN
cord-304472-mi5v6512	160	6	vaccine	vaccine	NN
cord-304472-mi5v6512	160	7	in	in	IN
cord-304472-mi5v6512	160	8	healthy	healthy	JJ
cord-304472-mi5v6512	160	9	children	child	NNS
cord-304472-mi5v6512	160	10	aged	age	VBN
cord-304472-mi5v6512	160	11	4	4	CD
cord-304472-mi5v6512	160	12	-	-	SYM
cord-304472-mi5v6512	160	13	16	16	CD
cord-304472-mi5v6512	160	14	years	year	NNS
cord-304472-mi5v6512	160	15	:	:	:
cord-304472-mi5v6512	160	16	a	a	DT
cord-304472-mi5v6512	160	17	randomised	randomised	JJ
cord-304472-mi5v6512	160	18	,	,	,
cord-304472-mi5v6512	160	19	placebo	placebo	NN
cord-304472-mi5v6512	160	20	-	-	HYPH
cord-304472-mi5v6512	160	21	controlled	control	VBN
cord-304472-mi5v6512	160	22	,	,	,
cord-304472-mi5v6512	160	23	phase	phase	NN
cord-304472-mi5v6512	160	24	3	3	CD
cord-304472-mi5v6512	160	25	trial	trial	NN
cord-304472-mi5v6512	160	26	Robust	robust	JJ
cord-304472-mi5v6512	160	27	and	and	CC
cord-304472-mi5v6512	160	28	balanced	balanced	JJ
cord-304472-mi5v6512	160	29	immune	immune	JJ
cord-304472-mi5v6512	160	30	responses	response	NNS
cord-304472-mi5v6512	160	31	to	to	IN
cord-304472-mi5v6512	160	32	all	all	DT
cord-304472-mi5v6512	160	33	4	4	CD
cord-304472-mi5v6512	160	34	Dengue	dengue	NN
cord-304472-mi5v6512	160	35	virus	virus	NN
cord-304472-mi5v6512	160	36	serotypes	serotype	NNS
cord-304472-mi5v6512	160	37	following	follow	VBG
cord-304472-mi5v6512	160	38	administration	administration	NN
cord-304472-mi5v6512	160	39	of	of	IN
cord-304472-mi5v6512	160	40	a	a	DT
cord-304472-mi5v6512	160	41	single	single	JJ
cord-304472-mi5v6512	160	42	dose	dose	NN
cord-304472-mi5v6512	160	43	of	of	IN
cord-304472-mi5v6512	160	44	a	a	DT
cord-304472-mi5v6512	160	45	live	live	JJ
cord-304472-mi5v6512	160	46	attenuated	attenuated	JJ
cord-304472-mi5v6512	160	47	tetravalent	tetravalent	NN
cord-304472-mi5v6512	160	48	dengue	dengue	NN
cord-304472-mi5v6512	160	49	vaccine	vaccine	NN
cord-304472-mi5v6512	160	50	to	to	IN
cord-304472-mi5v6512	160	51	healthy	healthy	JJ
cord-304472-mi5v6512	160	52	,	,	,
cord-304472-mi5v6512	160	53	Flavivirus	Flavivirus	NNP
cord-304472-mi5v6512	160	54	-	-	HYPH
cord-304472-mi5v6512	160	55	naive	naive	JJ
cord-304472-mi5v6512	160	56	adults	adult	NNS
cord-304472-mi5v6512	161	1	Human	Human	NNP
cord-304472-mi5v6512	161	2	CD4	CD4	NNP
cord-304472-mi5v6512	161	3	+	+	CC
cord-304472-mi5v6512	161	4	T	t	NN
cord-304472-mi5v6512	161	5	cell	cell	NN
cord-304472-mi5v6512	161	6	responses	response	NNS
cord-304472-mi5v6512	161	7	to	to	IN
cord-304472-mi5v6512	161	8	an	an	DT
cord-304472-mi5v6512	161	9	attenuated	attenuated	JJ
cord-304472-mi5v6512	161	10	tetravalent	tetravalent	NN
cord-304472-mi5v6512	161	11	dengue	dengue	NN
cord-304472-mi5v6512	161	12	vaccine	vaccine	NN
cord-304472-mi5v6512	161	13	parallel	parallel	VBP
cord-304472-mi5v6512	161	14	those	those	DT
cord-304472-mi5v6512	161	15	induced	induce	VBN
cord-304472-mi5v6512	161	16	by	by	IN
cord-304472-mi5v6512	161	17	natural	natural	JJ
cord-304472-mi5v6512	161	18	infection	infection	NN
cord-304472-mi5v6512	161	19	in	in	IN
cord-304472-mi5v6512	161	20	magnitude	magnitude	NN
cord-304472-mi5v6512	161	21	,	,	,
cord-304472-mi5v6512	161	22	HLA	HLA	NNP
cord-304472-mi5v6512	161	23	restriction	restriction	NN
cord-304472-mi5v6512	161	24	,	,	,
cord-304472-mi5v6512	161	25	and	and	CC
cord-304472-mi5v6512	161	26	antigen	antigen	NN
cord-304472-mi5v6512	161	27	specificity	specificity	NN
cord-304472-mi5v6512	162	1	The	the	DT
cord-304472-mi5v6512	162	2	human	human	JJ
cord-304472-mi5v6512	162	3	CD8	CD8	NNP
cord-304472-mi5v6512	162	4	+	+	CC
cord-304472-mi5v6512	162	5	T	T	NNP
cord-304472-mi5v6512	162	6	cell	cell	NN
cord-304472-mi5v6512	162	7	responses	response	NNS
cord-304472-mi5v6512	162	8	induced	induce	VBN
cord-304472-mi5v6512	162	9	by	by	IN
cord-304472-mi5v6512	162	10	a	a	DT
cord-304472-mi5v6512	162	11	live	live	JJ
cord-304472-mi5v6512	162	12	attenuated	attenuated	JJ
cord-304472-mi5v6512	162	13	tetravalent	tetravalent	NN
cord-304472-mi5v6512	162	14	dengue	dengue	NN
cord-304472-mi5v6512	162	15	vaccine	vaccine	NN
cord-304472-mi5v6512	162	16	are	be	VBP
cord-304472-mi5v6512	162	17	directed	direct	VBN
cord-304472-mi5v6512	162	18	against	against	IN
cord-304472-mi5v6512	162	19	highly	highly	RB
cord-304472-mi5v6512	162	20	conserved	conserve	VBN
cord-304472-mi5v6512	162	21	epitopes	epitope	NNS
cord-304472-mi5v6512	163	1	A	a	DT
cord-304472-mi5v6512	163	2	12-month	12-month	JJ
cord-304472-mi5v6512	163	3	-	-	HYPH
cord-304472-mi5v6512	163	4	interval	interval	NN
cord-304472-mi5v6512	163	5	dosing	dosing	NN
cord-304472-mi5v6512	163	6	study	study	NN
cord-304472-mi5v6512	163	7	in	in	IN
cord-304472-mi5v6512	163	8	adults	adult	NNS
cord-304472-mi5v6512	163	9	indicates	indicate	VBZ
cord-304472-mi5v6512	163	10	that	that	IN
cord-304472-mi5v6512	163	11	a	a	DT
cord-304472-mi5v6512	163	12	single	single	JJ
cord-304472-mi5v6512	163	13	dose	dose	NN
cord-304472-mi5v6512	163	14	of	of	IN
cord-304472-mi5v6512	163	15	the	the	DT
cord-304472-mi5v6512	163	16	national	national	NNP
cord-304472-mi5v6512	163	17	institute	institute	NNP
cord-304472-mi5v6512	163	18	of	of	IN
cord-304472-mi5v6512	163	19	allergy	allergy	NNP
cord-304472-mi5v6512	163	20	and	and	CC
cord-304472-mi5v6512	163	21	infectious	infectious	JJ
cord-304472-mi5v6512	163	22	diseases	disease	NNS
cord-304472-mi5v6512	163	23	tetravalent	tetravalent	NN
cord-304472-mi5v6512	163	24	dengue	dengue	NN
cord-304472-mi5v6512	163	25	vaccine	vaccine	NN
cord-304472-mi5v6512	163	26	induces	induce	VBZ
cord-304472-mi5v6512	163	27	a	a	DT
cord-304472-mi5v6512	163	28	robust	robust	JJ
cord-304472-mi5v6512	163	29	neutralizing	neutralize	VBG
cord-304472-mi5v6512	163	30	antibody	antibody	NN
cord-304472-mi5v6512	163	31	response	response	NN
cord-304472-mi5v6512	163	32	Paediatric	Paediatric	NNP
cord-304472-mi5v6512	163	33	Dengue	Dengue	NNP
cord-304472-mi5v6512	163	34	Fever	Fever	NNP
cord-304472-mi5v6512	163	35	diagnosed	diagnose	VBN
cord-304472-mi5v6512	163	36	through	through	IN
cord-304472-mi5v6512	163	37	parents	parent	NNS
cord-304472-mi5v6512	163	38	'	'	POS
cord-304472-mi5v6512	163	39	epidemiologic	epidemiologic	JJ
cord-304472-mi5v6512	163	40	report	report	NN
cord-304472-mi5v6512	163	41	and	and	CC
cord-304472-mi5v6512	163	42	preventive	preventive	JJ
cord-304472-mi5v6512	163	43	strategy	strategy	NN
cord-304472-mi5v6512	163	44	during	during	IN
cord-304472-mi5v6512	163	45	the	the	DT
cord-304472-mi5v6512	163	46	acute	acute	JJ
cord-304472-mi5v6512	163	47	phase	phase	NN
cord-304472-mi5v6512	163	48	of	of	IN
cord-304472-mi5v6512	163	49	infection	infection	NN
cord-304472-mi5v6512	163	50	Dengue	dengue	NN
cord-304472-mi5v6512	163	51	in	in	IN
cord-304472-mi5v6512	163	52	peace	peace	NN
cord-304472-mi5v6512	163	53	corps	corps	NN
cord-304472-mi5v6512	163	54	volunteers	volunteer	NNS
cord-304472-mi5v6512	163	55	Travel	Travel	NNP
cord-304472-mi5v6512	163	56	vaccine	vaccine	NN
cord-304472-mi5v6512	163	57	preventable	preventable	JJ
cord-304472-mi5v6512	163	58	diseases	disease	NNS
cord-304472-mi5v6512	163	59	-	-	HYPH
cord-304472-mi5v6512	163	60	updated	update	VBN
cord-304472-mi5v6512	163	61	logarithmic	logarithmic	JJ
cord-304472-mi5v6512	163	62	scale	scale	NN
cord-304472-mi5v6512	163	63	with	with	IN
cord-304472-mi5v6512	163	64	monthly	monthly	JJ
cord-304472-mi5v6512	163	65	incidence	incidence	NN
cord-304472-mi5v6512	163	66	rates	rate	NNS
cord-304472-mi5v6512	163	67	What	what	WDT
cord-304472-mi5v6512	163	68	proportion	proportion	NN
cord-304472-mi5v6512	163	69	of	of	IN
cord-304472-mi5v6512	163	70	international	international	JJ
cord-304472-mi5v6512	163	71	travellers	traveller	NNS
cord-304472-mi5v6512	163	72	acquire	acquire	VBP
cord-304472-mi5v6512	163	73	a	a	DT
cord-304472-mi5v6512	163	74	travel	travel	NN
cord-304472-mi5v6512	163	75	-	-	HYPH
cord-304472-mi5v6512	163	76	related	relate	VBN
cord-304472-mi5v6512	163	77	illness	illness	NN
cord-304472-mi5v6512	163	78	?	?	.
cord-304472-mi5v6512	164	1	A	a	DT
cord-304472-mi5v6512	164	2	review	review	NN
cord-304472-mi5v6512	164	3	of	of	IN
cord-304472-mi5v6512	164	4	the	the	DT
cord-304472-mi5v6512	164	5	literature	literature	NN
cord-304472-mi5v6512	164	6	Prevention	Prevention	NNP
cord-304472-mi5v6512	164	7	of	of	IN
cord-304472-mi5v6512	164	8	enteric	enteric	JJ
cord-304472-mi5v6512	164	9	fever	fever	NN
cord-304472-mi5v6512	164	10	in	in	IN
cord-304472-mi5v6512	164	11	travellers	traveller	NNS
cord-304472-mi5v6512	164	12	with	with	IN
cord-304472-mi5v6512	164	13	typhoid	typhoid	NN
cord-304472-mi5v6512	164	14	conjugate	conjugate	NN
cord-304472-mi5v6512	164	15	vaccines	vaccine	NNS
cord-304472-mi5v6512	164	16	Perceptions	perception	NNS
cord-304472-mi5v6512	164	17	of	of	IN
cord-304472-mi5v6512	164	18	rabies	rabies	NN
cord-304472-mi5v6512	164	19	risk	risk	NN
cord-304472-mi5v6512	164	20	:	:	:
cord-304472-mi5v6512	164	21	a	a	DT
cord-304472-mi5v6512	164	22	survey	survey	NN
cord-304472-mi5v6512	164	23	of	of	IN
cord-304472-mi5v6512	164	24	travellers	traveller	NNS
cord-304472-mi5v6512	164	25	and	and	CC
cord-304472-mi5v6512	164	26	travel	travel	NN
cord-304472-mi5v6512	164	27	clinics	clinic	NNS
cord-304472-mi5v6512	164	28	from	from	IN
cord-304472-mi5v6512	164	29	Canada	Canada	NNP
cord-304472-mi5v6512	164	30	,	,	,
cord-304472-mi5v6512	164	31	Germany	Germany	NNP
cord-304472-mi5v6512	164	32	,	,	,
cord-304472-mi5v6512	164	33	Sweden	Sweden	NNP
cord-304472-mi5v6512	164	34	and	and	CC
cord-304472-mi5v6512	164	35	the	the	DT
cord-304472-mi5v6512	164	36	UK	UK	NNP
cord-304472-mi5v6512	164	37	Pandemic	Pandemic	NNP
cord-304472-mi5v6512	164	38	yellow	yellow	JJ
cord-304472-mi5v6512	164	39	fever	fever	NN
cord-304472-mi5v6512	164	40	:	:	:
cord-304472-mi5v6512	164	41	a	a	DT
cord-304472-mi5v6512	164	42	potential	potential	JJ
cord-304472-mi5v6512	164	43	threat	threat	NN
cord-304472-mi5v6512	164	44	to	to	IN
cord-304472-mi5v6512	164	45	global	global	JJ
cord-304472-mi5v6512	164	46	health	health	NN
cord-304472-mi5v6512	164	47	via	via	IN
cord-304472-mi5v6512	164	48	travelers	traveler	NNS
cord-304472-mi5v6512	164	49	Recommendations	Recommendations	NNPS
cord-304472-mi5v6512	164	50	for	for	IN
cord-304472-mi5v6512	164	51	travellers	traveller	NNS
cord-304472-mi5v6512	164	52	during	during	IN
cord-304472-mi5v6512	164	53	the	the	DT
cord-304472-mi5v6512	164	54	yellow	yellow	JJ
cord-304472-mi5v6512	164	55	fever	fever	NN
cord-304472-mi5v6512	164	56	outbreaks	outbreak	NNS
cord-304472-mi5v6512	164	57	in	in	IN
cord-304472-mi5v6512	164	58	Brazil-2018	Brazil-2018	NNP
cord-304472-mi5v6512	164	59	Sentinel	Sentinel	NNP
cord-304472-mi5v6512	164	60	surveillance	surveillance	NN
cord-304472-mi5v6512	164	61	in	in	IN
cord-304472-mi5v6512	164	62	travel	travel	NN
cord-304472-mi5v6512	164	63	medicine	medicine	NN
cord-304472-mi5v6512	164	64	:	:	:
cord-304472-mi5v6512	164	65	20	20	CD
cord-304472-mi5v6512	164	66	years	year	NNS
cord-304472-mi5v6512	164	67	of	of	IN
cord-304472-mi5v6512	164	68	GeoSentinel	GeoSentinel	NNP
cord-304472-mi5v6512	164	69	Publications	Publications	NNPS
cord-304472-mi5v6512	164	70	(	(	-LRB-
cord-304472-mi5v6512	164	71	1999	1999	CD
cord-304472-mi5v6512	164	72	-	-	SYM
cord-304472-mi5v6512	164	73	2018	2018	CD
cord-304472-mi5v6512	164	74	)	)	-RRB-
cord-304472-mi5v6512	165	1	Illness	illness	NN
cord-304472-mi5v6512	165	2	among	among	IN
cord-304472-mi5v6512	165	3	US	US	NNP
cord-304472-mi5v6512	165	4	resident	resident	NN
cord-304472-mi5v6512	165	5	student	student	NN
cord-304472-mi5v6512	165	6	travellers	traveller	NNS
cord-304472-mi5v6512	165	7	after	after	IN
cord-304472-mi5v6512	165	8	return	return	NN
cord-304472-mi5v6512	165	9	to	to	IN
cord-304472-mi5v6512	165	10	the	the	DT
cord-304472-mi5v6512	165	11	USA	USA	NNP
cord-304472-mi5v6512	165	12	:	:	:
cord-304472-mi5v6512	165	13	a	a	DT
cord-304472-mi5v6512	165	14	GeoSentinel	GeoSentinel	NNP
cord-304472-mi5v6512	165	15	analysis	analysis	NN
cord-304472-mi5v6512	165	16	Business	business	NN
cord-304472-mi5v6512	165	17	travel	travel	NN
cord-304472-mi5v6512	165	18	-	-	HYPH
cord-304472-mi5v6512	165	19	associated	associate	VBN
cord-304472-mi5v6512	165	20	illness	illness	NN
cord-304472-mi5v6512	165	21	:	:	:
cord-304472-mi5v6512	165	22	a	a	DT
cord-304472-mi5v6512	165	23	GeoSentinel	GeoSentinel	NNP
cord-304472-mi5v6512	165	24	analysis	analysis	NN
cord-304472-mi5v6512	165	25	GeoSentinel	geosentinel	NN
cord-304472-mi5v6512	165	26	surveillance	surveillance	NN
cord-304472-mi5v6512	165	27	of	of	IN
cord-304472-mi5v6512	165	28	illness	illness	NN
cord-304472-mi5v6512	165	29	in	in	IN
cord-304472-mi5v6512	165	30	returned	return	VBN
cord-304472-mi5v6512	165	31	travelers	traveler	NNS
cord-304472-mi5v6512	165	32	Illness	Illness	NNP
cord-304472-mi5v6512	165	33	in	in	IN
cord-304472-mi5v6512	165	34	travelers	traveler	NNS
cord-304472-mi5v6512	165	35	visiting	visit	VBG
cord-304472-mi5v6512	165	36	friends	friend	NNS
cord-304472-mi5v6512	165	37	and	and	CC
cord-304472-mi5v6512	165	38	relatives	relative	NNS
cord-304472-mi5v6512	165	39	:	:	:
cord-304472-mi5v6512	165	40	a	a	DT
cord-304472-mi5v6512	165	41	review	review	NN
cord-304472-mi5v6512	165	42	of	of	IN
cord-304472-mi5v6512	165	43	the	the	DT
cord-304472-mi5v6512	165	44	GeoSentinel	GeoSentinel	NNP
cord-304472-mi5v6512	165	45	surveillance	surveillance	NN
cord-304472-mi5v6512	165	46	network	network	NN
cord-304472-mi5v6512	165	47	Dengue	dengue	NN
cord-304472-mi5v6512	165	48	epidemic	epidemic	NN
cord-304472-mi5v6512	165	49	in	in	IN
cord-304472-mi5v6512	165	50	touba	touba	NNP
cord-304472-mi5v6512	165	51	,	,	,
cord-304472-mi5v6512	165	52	senegal	senegal	NNP
cord-304472-mi5v6512	165	53	:	:	:
cord-304472-mi5v6512	165	54	implications	implication	NNS
cord-304472-mi5v6512	165	55	for	for	IN
cord-304472-mi5v6512	165	56	the	the	DT
cord-304472-mi5v6512	165	57	grand	grand	JJ
cord-304472-mi5v6512	165	58	Magal	Magal	NNP
cord-304472-mi5v6512	165	59	pilgrimage	pilgrimage	NN
cord-304472-mi5v6512	165	60	for	for	IN
cord-304472-mi5v6512	165	61	travelers	traveler	NNS
cord-304472-mi5v6512	165	62	Morbidity	morbidity	NN
cord-304472-mi5v6512	165	63	among	among	IN
cord-304472-mi5v6512	165	64	Israeli	israeli	JJ
cord-304472-mi5v6512	165	65	paediatric	paediatric	JJ
cord-304472-mi5v6512	165	66	travellers	traveller	NNS
cord-304472-mi5v6512	166	1	Fatal	fatal	JJ
cord-304472-mi5v6512	166	2	fulminant	fulminant	JJ
cord-304472-mi5v6512	166	3	hepatitis	hepatitis	NN
cord-304472-mi5v6512	166	4	A	a	NN
cord-304472-mi5v6512	166	5	in	in	IN
cord-304472-mi5v6512	166	6	a	a	DT
cord-304472-mi5v6512	166	7	US	US	NNP
cord-304472-mi5v6512	166	8	traveller	traveller	NN
cord-304472-mi5v6512	166	9	returning	return	VBG
cord-304472-mi5v6512	166	10	from	from	IN
cord-304472-mi5v6512	166	11	Peru	Peru	NNP
cord-304472-mi5v6512	166	12	Japanese	Japanese	NNP
cord-304472-mi5v6512	166	13	encephalitis	encephalitis	RB
cord-304472-mi5v6512	166	14	:	:	:
cord-304472-mi5v6512	166	15	vaccine	vaccine	NN
cord-304472-mi5v6512	166	16	options	option	NNS
cord-304472-mi5v6512	166	17	and	and	CC
cord-304472-mi5v6512	166	18	timing	timing	NN
cord-304472-mi5v6512	166	19	of	of	IN
cord-304472-mi5v6512	166	20	pre	pre	JJ
cord-304472-mi5v6512	166	21	-	-	JJ
cord-304472-mi5v6512	166	22	travel	travel	JJ
cord-304472-mi5v6512	166	23	vaccination	vaccination	NN
cord-304472-mi5v6512	166	24	Recent	recent	JJ
cord-304472-mi5v6512	166	25	and	and	CC
cord-304472-mi5v6512	166	26	historical	historical	JJ
cord-304472-mi5v6512	166	27	trends	trend	NNS
cord-304472-mi5v6512	166	28	in	in	IN
cord-304472-mi5v6512	166	29	the	the	DT
cord-304472-mi5v6512	166	30	epidemiology	epidemiology	NN
cord-304472-mi5v6512	166	31	of	of	IN
cord-304472-mi5v6512	166	32	Japanese	japanese	JJ
cord-304472-mi5v6512	166	33	encephalitis	encephaliti	NNS
cord-304472-mi5v6512	166	34	and	and	CC
cord-304472-mi5v6512	166	35	its	-PRON-	PRP$
cord-304472-mi5v6512	166	36	implication	implication	NN
cord-304472-mi5v6512	166	37	for	for	IN
cord-304472-mi5v6512	166	38	risk	risk	NN
cord-304472-mi5v6512	166	39	assessment	assessment	NN
cord-304472-mi5v6512	166	40	in	in	IN
cord-304472-mi5v6512	166	41	travellers	traveller	NNS
cord-304472-mi5v6512	167	1	What	what	WP
cord-304472-mi5v6512	167	2	is	be	VBZ
cord-304472-mi5v6512	167	3	the	the	DT
cord-304472-mi5v6512	167	4	prospect	prospect	NN
cord-304472-mi5v6512	167	5	of	of	IN
cord-304472-mi5v6512	167	6	a	a	DT
cord-304472-mi5v6512	167	7	safe	safe	JJ
cord-304472-mi5v6512	167	8	and	and	CC
cord-304472-mi5v6512	167	9	effective	effective	JJ
cord-304472-mi5v6512	167	10	dengue	dengue	NN
cord-304472-mi5v6512	167	11	vaccine	vaccine	NN
cord-304472-mi5v6512	167	12	for	for	IN
cord-304472-mi5v6512	167	13	travellers	traveller	NNS
cord-304472-mi5v6512	167	14	?	?	.
cord-304472-mi5v6512	168	1	Mosquito	mosquito	NN
cord-304472-mi5v6512	168	2	repellents	repellent	NNS
cord-304472-mi5v6512	168	3	for	for	IN
cord-304472-mi5v6512	168	4	the	the	DT
cord-304472-mi5v6512	168	5	traveller	traveller	NN
cord-304472-mi5v6512	168	6	:	:	:
cord-304472-mi5v6512	168	7	does	do	VBZ
cord-304472-mi5v6512	168	8	picaridin	picaridin	NNS
cord-304472-mi5v6512	168	9	provide	provide	VB
cord-304472-mi5v6512	168	10	longer	long	JJR
cord-304472-mi5v6512	168	11	protection	protection	NN
cord-304472-mi5v6512	168	12	than	than	IN
cord-304472-mi5v6512	168	13	DEET	DEET	NNP
cord-304472-mi5v6512	168	14	?	?	.
cord-304472-mi5v6512	169	1	Factors	factor	NNS
cord-304472-mi5v6512	169	2	affecting	affect	VBG
cord-304472-mi5v6512	169	3	pre	pre	JJ
cord-304472-mi5v6512	169	4	-	-	JJ
cord-304472-mi5v6512	169	5	travel	travel	JJ
cord-304472-mi5v6512	169	6	health	health	NN
cord-304472-mi5v6512	169	7	seeking	seek	VBG
cord-304472-mi5v6512	169	8	behaviour	behaviour	NN
cord-304472-mi5v6512	169	9	and	and	CC
cord-304472-mi5v6512	169	10	adherence	adherence	NN
cord-304472-mi5v6512	169	11	to	to	IN
cord-304472-mi5v6512	169	12	pre	pre	VB
cord-304472-mi5v6512	169	13	-	-	VB
cord-304472-mi5v6512	169	14	travel	travel	VB
cord-304472-mi5v6512	169	15	health	health	NN
cord-304472-mi5v6512	169	16	advice	advice	NN
cord-304472-mi5v6512	169	17	:	:	:
cord-304472-mi5v6512	169	18	a	a	DT
cord-304472-mi5v6512	169	19	systematic	systematic	JJ
cord-304472-mi5v6512	169	20	review	review	NN
cord-304472-mi5v6512	169	21	Sequential	sequential	JJ
cord-304472-mi5v6512	169	22	immunization	immunization	NN
cord-304472-mi5v6512	169	23	induces	induce	VBZ
cord-304472-mi5v6512	169	24	strong	strong	JJ
cord-304472-mi5v6512	169	25	and	and	CC
cord-304472-mi5v6512	169	26	broad	broad	JJ
cord-304472-mi5v6512	169	27	immunity	immunity	NN
cord-304472-mi5v6512	169	28	against	against	IN
cord-304472-mi5v6512	169	29	all	all	DT
cord-304472-mi5v6512	169	30	four	four	CD
cord-304472-mi5v6512	169	31	dengue	dengue	NN
cord-304472-mi5v6512	169	32	virus	virus	NN
cord-304472-mi5v6512	169	33	serotypes	serotype	NNS
cord-304472-mi5v6512	169	34	Combine	combine	VBP
cord-304472-mi5v6512	169	35	dengue	dengue	NN
cord-304472-mi5v6512	169	36	vaccines	vaccine	NNS
cord-304472-mi5v6512	169	37	to	to	TO
cord-304472-mi5v6512	169	38	optimize	optimize	VB
cord-304472-mi5v6512	169	39	effectiveness	effectiveness	NN
cord-304472-mi5v6512	170	1	This	this	DT
cord-304472-mi5v6512	170	2	is	be	VBZ
cord-304472-mi5v6512	170	3	an	an	DT
cord-304472-mi5v6512	170	4	opinion	opinion	NN
cord-304472-mi5v6512	170	5	paper	paper	NN
cord-304472-mi5v6512	170	6	that	that	WDT
cord-304472-mi5v6512	170	7	discusses	discuss	VBZ
cord-304472-mi5v6512	170	8	heterologous	heterologous	JJ
cord-304472-mi5v6512	170	9	prime	prime	JJ
cord-304472-mi5v6512	170	10	-	-	HYPH
cord-304472-mi5v6512	170	11	boost	boost	NN
cord-304472-mi5v6512	170	12	strategy	strategy	NN
cord-304472-mi5v6512	170	13	by	by	IN
cord-304472-mi5v6512	170	14	giving	give	VBG
cord-304472-mi5v6512	170	15	Takeda	Takeda	NNP
cord-304472-mi5v6512	170	16	's	's	POS
cord-304472-mi5v6512	170	17	TAK-003	tak-003	NN
cord-304472-mi5v6512	170	18	first	first	RB
cord-304472-mi5v6512	170	19	followed	follow	VBN
cord-304472-mi5v6512	170	20	by	by	IN
cord-304472-mi5v6512	170	21	Sanofi	Sanofi	NNP
cord-304472-mi5v6512	170	22	Pasteur	Pasteur	NNP
cord-304472-mi5v6512	170	23	's	's	POS
cord-304472-mi5v6512	170	24	CYD	CYD	NNP
cord-304472-mi5v6512	170	25	-	-	HYPH
cord-304472-mi5v6512	170	26	TDV	TDV	NNP
cord-304472-mi5v6512	170	27	Status	status	NN
cord-304472-mi5v6512	170	28	of	of	IN
cord-304472-mi5v6512	170	29	current	current	JJ
cord-304472-mi5v6512	170	30	and	and	CC
cord-304472-mi5v6512	170	31	under	under	IN
cord-304472-mi5v6512	170	32	-	-	HYPH
cord-304472-mi5v6512	170	33	development	development	NN
cord-304472-mi5v6512	170	34	vaccines	vaccine	NNS
cord-304472-mi5v6512	170	35	Phase	Phase	NNP
cord-304472-mi5v6512	170	36	1	1	CD
cord-304472-mi5v6512	170	37	randomized	randomized	JJ
cord-304472-mi5v6512	170	38	study	study	NN
cord-304472-mi5v6512	170	39	of	of	IN
cord-304472-mi5v6512	170	40	a	a	DT
cord-304472-mi5v6512	170	41	tetravalent	tetravalent	NN
cord-304472-mi5v6512	170	42	dengue	dengue	NN
cord-304472-mi5v6512	170	43	purified	purify	VBN
cord-304472-mi5v6512	170	44	inactivated	inactivate	VBN
cord-304472-mi5v6512	170	45	vaccine	vaccine	NN
cord-304472-mi5v6512	170	46	in	in	IN
cord-304472-mi5v6512	170	47	healthy	healthy	JJ
cord-304472-mi5v6512	170	48	adults	adult	NNS
cord-304472-mi5v6512	170	49	in	in	IN
cord-304472-mi5v6512	170	50	the	the	DT
cord-304472-mi5v6512	170	51	United	United	NNP
cord-304472-mi5v6512	170	52	States	States	NNP
cord-304472-mi5v6512	170	53	Phase	Phase	NNP
cord-304472-mi5v6512	170	54	I	-PRON-	PRP
cord-304472-mi5v6512	170	55	randomized	randomize	VBD
cord-304472-mi5v6512	170	56	study	study	NN
cord-304472-mi5v6512	170	57	of	of	IN
cord-304472-mi5v6512	170	58	a	a	DT
cord-304472-mi5v6512	170	59	tetravalent	tetravalent	NN
cord-304472-mi5v6512	170	60	dengue	dengue	NN
cord-304472-mi5v6512	170	61	Dengue	Dengue	NNP
cord-304472-mi5v6512	170	62	vaccine	vaccine	NN
cord-304472-mi5v6512	170	63	development	development	NN
cord-304472-mi5v6512	170	64	Wilder	Wilder	NNP
cord-304472-mi5v6512	170	65	purified	purify	VBN
cord-304472-mi5v6512	170	66	inactivated	inactivated	JJ
cord-304472-mi5v6512	170	67	vaccine	vaccine	NN
cord-304472-mi5v6512	170	68	in	in	IN
cord-304472-mi5v6512	170	69	healthy	healthy	JJ
cord-304472-mi5v6512	170	70	adults	adult	NNS
cord-304472-mi5v6512	170	71	from	from	IN
cord-304472-mi5v6512	170	72	Puerto	Puerto	NNP
cord-304472-mi5v6512	170	73	Rico	Rico	NNP
cord-304472-mi5v6512	170	74	Dengue	Dengue	NNP
cord-304472-mi5v6512	170	75	,	,	,
cord-304472-mi5v6512	170	76	Zika	Zika	NNP
cord-304472-mi5v6512	170	77	and	and	CC
cord-304472-mi5v6512	170	78	chikungunya	chikungunya	NN
cord-304472-mi5v6512	170	79	during	during	IN
cord-304472-mi5v6512	170	80	pregnancy	pregnancy	NN
cord-304472-mi5v6512	170	81	:	:	:
cord-304472-mi5v6512	171	1	preand	preand	NNP
cord-304472-mi5v6512	171	2	post	post	JJ
cord-304472-mi5v6512	171	3	-	-	JJ
cord-304472-mi5v6512	171	4	travel	travel	JJ
cord-304472-mi5v6512	171	5	advice	advice	NN
cord-304472-mi5v6512	171	6	and	and	CC
cord-304472-mi5v6512	171	7	clinical	clinical	JJ
cord-304472-mi5v6512	171	8	management	management	NN
cord-304472-mi5v6512	171	9	A	a	NN
cord-304472-mi5v6512	171	10	:	:	:
cord-304472-mi5v6512	171	11	Can	Can	MD
cord-304472-mi5v6512	171	12	dengue	dengue	VB
cord-304472-mi5v6512	171	13	virus	virus	NN
cord-304472-mi5v6512	171	14	be	be	VB
cord-304472-mi5v6512	171	15	sexually	sexually	RB
cord-304472-mi5v6512	171	16	transmitted	transmit	VBN
cord-304472-mi5v6512	171	17	?	?	.
cord-304472-mi5v6512	172	1	Dengue	dengue	NN
cord-304472-mi5v6512	172	2	virus	virus	NN
cord-304472-mi5v6512	172	3	not	not	RB
cord-304472-mi5v6512	172	4	detected	detect	VBN
cord-304472-mi5v6512	172	5	in	in	IN
cord-304472-mi5v6512	172	6	human	human	JJ
cord-304472-mi5v6512	172	7	semen	semen	NN
cord-304472-mi5v6512	172	8	Incidence	incidence	NN
cord-304472-mi5v6512	172	9	of	of	IN
cord-304472-mi5v6512	172	10	Guillain	Guillain	NNP
cord-304472-mi5v6512	172	11	-	-	HYPH
cord-304472-mi5v6512	172	12	Barre	Barre	NNP
cord-304472-mi5v6512	172	13	Syndrome	Syndrome	NNP
cord-304472-mi5v6512	172	14	(	(	-LRB-
cord-304472-mi5v6512	172	15	GBS	GBS	NNP
cord-304472-mi5v6512	172	16	)	)	-RRB-
cord-304472-mi5v6512	172	17	in	in	IN
cord-304472-mi5v6512	172	18	Latin	Latin	NNP
cord-304472-mi5v6512	172	19	America	America	NNP
cord-304472-mi5v6512	172	20	and	and	CC
cord-304472-mi5v6512	172	21	the	the	DT
cord-304472-mi5v6512	172	22	Caribbean	Caribbean	NNP
cord-304472-mi5v6512	172	23	before	before	RB
cord-304472-mi5v6512	172	24	and	and	CC
cord-304472-mi5v6512	172	25	during	during	IN
cord-304472-mi5v6512	172	26	the	the	DT
cord-304472-mi5v6512	172	27	2015	2015	CD
cord-304472-mi5v6512	172	28	-	-	SYM
cord-304472-mi5v6512	172	29	2016	2016	CD
cord-304472-mi5v6512	172	30	Zika	Zika	NNP
cord-304472-mi5v6512	172	31	virus	virus	NN
cord-304472-mi5v6512	172	32	epidemic	epidemic	NN
cord-304472-mi5v6512	172	33	:	:	:
cord-304472-mi5v6512	172	34	a	a	DT
cord-304472-mi5v6512	172	35	systematic	systematic	JJ
cord-304472-mi5v6512	172	36	review	review	NN
cord-304472-mi5v6512	172	37	and	and	CC
cord-304472-mi5v6512	172	38	meta	meta	NNP
cord-304472-mi5v6512	172	39	-	-	HYPH
cord-304472-mi5v6512	172	40	analysis	analysis	NN
cord-304472-mi5v6512	172	41	Recombination	Recombination	NNP
cord-304472-mi5v6512	172	42	of	of	IN
cord-304472-mi5v6512	172	43	B	B	NNP
cord-304472-mi5v6512	172	44	-	-	:
cord-304472-mi5v6512	172	45	and	and	CC
cord-304472-mi5v6512	172	46	T	t	NN
cord-304472-mi5v6512	172	47	-	-	HYPH
cord-304472-mi5v6512	172	48	cell	cell	NN
cord-304472-mi5v6512	172	49	epitoperich	epitoperich	NNP
cord-304472-mi5v6512	172	50	loci	locus	NNS
cord-304472-mi5v6512	172	51	from	from	IN
cord-304472-mi5v6512	172	52	Aedes	Aedes	NNP
cord-304472-mi5v6512	172	53	-	-	:
cord-304472-mi5v6512	172	54	and	and	CC
cord-304472-mi5v6512	172	55	Culex	Culex	NNP
cord-304472-mi5v6512	172	56	-	-	HYPH
cord-304472-mi5v6512	172	57	borne	bear	VBN
cord-304472-mi5v6512	172	58	flaviviruses	flavivirus	NNS
cord-304472-mi5v6512	172	59	shapes	shape	NNS
cord-304472-mi5v6512	173	1	Zika	Zika	NNP
cord-304472-mi5v6512	173	2	virus	virus	NN
cord-304472-mi5v6512	173	3	epidemiology	epidemiology	NN
cord-304472-mi5v6512	173	4	Comprehensive	comprehensive	JJ
cord-304472-mi5v6512	173	5	immunoprofiling	immunoprofiling	NN
cord-304472-mi5v6512	173	6	of	of	IN
cord-304472-mi5v6512	173	7	pediatric	pediatric	JJ
cord-304472-mi5v6512	173	8	Zika	Zika	NNP
cord-304472-mi5v6512	173	9	reveals	reveal	VBZ
cord-304472-mi5v6512	173	10	key	key	JJ
cord-304472-mi5v6512	173	11	role	role	NN
cord-304472-mi5v6512	173	12	for	for	IN
cord-304472-mi5v6512	173	13	monocytes	monocyte	NNS
cord-304472-mi5v6512	173	14	in	in	IN
cord-304472-mi5v6512	173	15	the	the	DT
cord-304472-mi5v6512	173	16	acute	acute	JJ
cord-304472-mi5v6512	173	17	phase	phase	NN
cord-304472-mi5v6512	173	18	and	and	CC
cord-304472-mi5v6512	173	19	no	no	DT
cord-304472-mi5v6512	173	20	effect	effect	NN
cord-304472-mi5v6512	173	21	of	of	IN
cord-304472-mi5v6512	173	22	prior	prior	JJ
cord-304472-mi5v6512	173	23	dengue	dengue	NN
cord-304472-mi5v6512	173	24	virus	virus	NN
cord-304472-mi5v6512	173	25	infection	infection	NN
cord-304472-mi5v6512	173	26	Primary	primary	JJ
cord-304472-mi5v6512	173	27	and	and	CC
cord-304472-mi5v6512	173	28	secondary	secondary	JJ
cord-304472-mi5v6512	173	29	dengue	dengue	NN
cord-304472-mi5v6512	173	30	virus	virus	NN
cord-304472-mi5v6512	173	31	infections	infection	NNS
cord-304472-mi5v6512	173	32	elicit	elicit	VBP
cord-304472-mi5v6512	173	33	similar	similar	JJ
cord-304472-mi5v6512	173	34	memory	memory	NN
cord-304472-mi5v6512	173	35	B	b	NN
cord-304472-mi5v6512	173	36	-	-	HYPH
cord-304472-mi5v6512	173	37	Cell	cell	NN
cord-304472-mi5v6512	173	38	responses	response	NNS
cord-304472-mi5v6512	173	39	,	,	,
cord-304472-mi5v6512	173	40	but	but	CC
cord-304472-mi5v6512	173	41	breadth	breadth	NN
cord-304472-mi5v6512	173	42	to	to	IN
cord-304472-mi5v6512	173	43	other	other	JJ
cord-304472-mi5v6512	173	44	serotypes	serotype	NNS
cord-304472-mi5v6512	173	45	and	and	CC
cord-304472-mi5v6512	173	46	cross	cross	NN
cord-304472-mi5v6512	173	47	-	-	NN
cord-304472-mi5v6512	173	48	reactivity	reactivity	NN
cord-304472-mi5v6512	173	49	to	to	IN
cord-304472-mi5v6512	173	50	Zika	Zika	NNP
cord-304472-mi5v6512	173	51	virus	virus	NN
cord-304472-mi5v6512	173	52	is	be	VBZ
cord-304472-mi5v6512	173	53	higher	high	JJR
cord-304472-mi5v6512	173	54	in	in	IN
cord-304472-mi5v6512	173	55	secondary	secondary	JJ
cord-304472-mi5v6512	173	56	dengue	dengue	NN
cord-304472-mi5v6512	173	57	Laboratory	Laboratory	NNP
cord-304472-mi5v6512	173	58	study	study	NN
cord-304472-mi5v6512	173	59	that	that	WDT
cord-304472-mi5v6512	173	60	investigates	investigate	VBZ
cord-304472-mi5v6512	173	61	the	the	DT
cord-304472-mi5v6512	173	62	role	role	NN
cord-304472-mi5v6512	173	63	of	of	IN
cord-304472-mi5v6512	173	64	prior	prior	JJ
cord-304472-mi5v6512	173	65	dengue	dengue	NN
cord-304472-mi5v6512	173	66	infections	infection	NNS
cord-304472-mi5v6512	173	67	on	on	IN
cord-304472-mi5v6512	173	68	the	the	DT
cord-304472-mi5v6512	173	69	immune	immune	JJ
cord-304472-mi5v6512	173	70	response	response	NN
cord-304472-mi5v6512	173	71	Impact	Impact	NNP
cord-304472-mi5v6512	173	72	of	of	IN
cord-304472-mi5v6512	173	73	pre	pre	JJ
cord-304472-mi5v6512	173	74	-	-	JJ
cord-304472-mi5v6512	173	75	existing	existing	JJ
cord-304472-mi5v6512	173	76	dengue	dengue	NN
cord-304472-mi5v6512	173	77	immunity	immunity	NN
cord-304472-mi5v6512	173	78	on	on	IN
cord-304472-mi5v6512	173	79	human	human	JJ
cord-304472-mi5v6512	173	80	antibody	antibody	NN
cord-304472-mi5v6512	173	81	and	and	CC
cord-304472-mi5v6512	173	82	memory	memory	NN
cord-304472-mi5v6512	173	83	B	b	NN
cord-304472-mi5v6512	173	84	cell	cell	NN
cord-304472-mi5v6512	173	85	responses	response	NNS
cord-304472-mi5v6512	173	86	to	to	IN
cord-304472-mi5v6512	173	87	Zika	Zika	NNP
cord-304472-mi5v6512	173	88	Impact	Impact	NNP
cord-304472-mi5v6512	173	89	of	of	IN
cord-304472-mi5v6512	173	90	preexisting	preexist	VBG
cord-304472-mi5v6512	173	91	dengue	dengue	NN
cord-304472-mi5v6512	173	92	immunity	immunity	NN
cord-304472-mi5v6512	173	93	on	on	IN
cord-304472-mi5v6512	173	94	Zika	Zika	NNP
cord-304472-mi5v6512	173	95	virus	virus	NN
cord-304472-mi5v6512	173	96	emergence	emergence	NN
cord-304472-mi5v6512	173	97	in	in	IN
cord-304472-mi5v6512	173	98	a	a	DT
cord-304472-mi5v6512	173	99	dengue	dengue	NN
cord-304472-mi5v6512	173	100	endemic	endemic	JJ
cord-304472-mi5v6512	173	101	region	region	NN
cord-304472-mi5v6512	174	1	This	this	DT
cord-304472-mi5v6512	174	2	paper	paper	NN
cord-304472-mi5v6512	174	3	discusses	discuss	VBZ
cord-304472-mi5v6512	174	4	the	the	DT
cord-304472-mi5v6512	174	5	immunological	immunological	JJ
cord-304472-mi5v6512	174	6	interaction	interaction	NN
cord-304472-mi5v6512	174	7	between	between	IN
cord-304472-mi5v6512	174	8	Zika	Zika	NNP
cord-304472-mi5v6512	174	9	and	and	CC
cord-304472-mi5v6512	174	10	dengue	dengue	NN
cord-304472-mi5v6512	174	11	viruses	virus	NNS
cord-304472-mi5v6512	174	12	Co	co	NN
cord-304472-mi5v6512	174	13	-	-	NN
cord-304472-mi5v6512	174	14	infection	infection	NN
cord-304472-mi5v6512	174	15	between	between	IN
cord-304472-mi5v6512	174	16	Zika	Zika	NNP
cord-304472-mi5v6512	174	17	and	and	CC
cord-304472-mi5v6512	174	18	different	different	JJ
cord-304472-mi5v6512	174	19	Dengue	dengue	NN
cord-304472-mi5v6512	174	20	serotypes	serotype	NNS
cord-304472-mi5v6512	174	21	during	during	IN
cord-304472-mi5v6512	174	22	DENV	DENV	NNP
cord-304472-mi5v6512	174	23	outbreak	outbreak	NN
cord-304472-mi5v6512	174	24	in	in	IN
cord-304472-mi5v6512	174	25	Brazil	Brazil	NNP
cord-304472-mi5v6512	174	26	COVID-19	COVID-19	NNP
cord-304472-mi5v6512	174	27	and	and	CC
cord-304472-mi5v6512	174	28	dengue	dengue	NN
cord-304472-mi5v6512	174	29	co	co	NN
cord-304472-mi5v6512	174	30	-	-	NN
cord-304472-mi5v6512	174	31	infection	infection	NN
cord-304472-mi5v6512	174	32	in	in	IN
cord-304472-mi5v6512	174	33	a	a	DT
cord-304472-mi5v6512	174	34	returning	return	VBG
cord-304472-mi5v6512	174	35	traveller	traveller	NN
cord-304472-mi5v6512	174	36	Preventing	prevent	VBG
cord-304472-mi5v6512	174	37	dengue	dengue	NN
cord-304472-mi5v6512	174	38	epidemics	epidemic	NNS
cord-304472-mi5v6512	174	39	during	during	IN
cord-304472-mi5v6512	174	40	the	the	DT
cord-304472-mi5v6512	174	41	COVID-19	COVID-19	NNP
cord-304472-mi5v6512	174	42	pandemic	pandemic	NN
cord-304472-mi5v6512	175	1	Nothing	nothing	NN
cord-304472-mi5v6512	175	2	declared	declare	VBD
cord-304472-mi5v6512	175	3	.	.	.
cord-304472-mi5v6512	176	1	Disclaimer	Disclaimer	NNP
cord-304472-mi5v6512	176	2	AWS	AWS	NNP
cord-304472-mi5v6512	176	3	serves	serve	VBZ
cord-304472-mi5v6512	176	4	as	as	IN
cord-304472-mi5v6512	176	5	consultant	consultant	NN
cord-304472-mi5v6512	176	6	to	to	IN
cord-304472-mi5v6512	176	7	the	the	DT
cord-304472-mi5v6512	176	8	World	World	NNP
cord-304472-mi5v6512	176	9	Health	Health	NNP
cord-304472-mi5v6512	176	10	Organization	Organization	NNP
cord-304472-mi5v6512	176	11	with	with	IN
cord-304472-mi5v6512	176	12	regards	regard	NNS
cord-304472-mi5v6512	176	13	to	to	IN
cord-304472-mi5v6512	176	14	dengue	dengue	NN
cord-304472-mi5v6512	176	15	vaccines	vaccine	NNS
cord-304472-mi5v6512	176	16	.	.	.
cord-304472-mi5v6512	177	1	The	the	DT
cord-304472-mi5v6512	177	2	views	view	NNS
cord-304472-mi5v6512	177	3	expressed	express	VBN
cord-304472-mi5v6512	177	4	in	in	IN
cord-304472-mi5v6512	177	5	this	this	DT
cord-304472-mi5v6512	177	6	article	article	NN
cord-304472-mi5v6512	177	7	are	be	VBP
cord-304472-mi5v6512	177	8	those	those	DT
cord-304472-mi5v6512	177	9	of	of	IN
cord-304472-mi5v6512	177	10	the	the	DT
cord-304472-mi5v6512	177	11	author	author	NN
cord-304472-mi5v6512	177	12	and	and	CC
cord-304472-mi5v6512	177	13	do	do	VBP
cord-304472-mi5v6512	177	14	not	not	RB
cord-304472-mi5v6512	177	15	necessarily	necessarily	RB
cord-304472-mi5v6512	177	16	represent	represent	VB
cord-304472-mi5v6512	177	17	the	the	DT
cord-304472-mi5v6512	177	18	decisions	decision	NNS
cord-304472-mi5v6512	177	19	or	or	CC
cord-304472-mi5v6512	177	20	policies	policy	NNS
cord-304472-mi5v6512	177	21	of	of	IN
cord-304472-mi5v6512	177	22	the	the	DT
cord-304472-mi5v6512	177	23	World	World	NNP
cord-304472-mi5v6512	177	24	Health	Health	NNP
cord-304472-mi5v6512	177	25	Organization	Organization	NNP
cord-304472-mi5v6512	177	26	.	.	.
cord-304472-mi5v6512	177	27	 	 	_SP